iso3,indicator,method,simple_method,kp,area_name,area_level,age_group,year,count_lower,count_estimate,count_upper,prop_lower,prop_estimate,prop_upper,denominator,ref,link,dataset_id,dataset,uid,data_checked,source_found,duplicate_of,is_aggregate,ethic,study_idx,observation_idx
ZAF,prevalence,lab,lab,MSM,Ehlanzeni DM,NA,NA,2012,NA,NA,NA,0.091,0.137,0.196,259,Lane et al,NA,CDC_fe722391cc77c6b9fc2dbae29c567392,CDC,cfa34b506111fe1522fcf7042e850ded,Yes,yes,NA,NA,NA,242,261
ZAF,prevalence,lab,lab,MSM,Gert Sibande DM,NA,Y015_049,2012,NA,NA,NA,0.21100000000000002,0.283,0.353,295,Lane et al,NA,KP Atlas_78c39931c851fe6e841c2c78a346ad6e,KP Atlas,86b1c07a98b6415fa34faf5cd3d3ca92,Yes,yes,NA,NA,NA,242,264
ZAF,prevalence,lab,lab,MSM,Cape Town,NA,NA,2012,NA,NA,NA,0.147,0.223,0.301,339,Marang Men's Study,NA,CDC_6a2a42213f50d8ce04cc1f4b855e9f74,CDC,01edca834d2f39d8b4831c90324aaab1,Yes,yes,NA,NA,NA,241,265
ZAF,prevalence,lab,lab,MSM,Johannesburg,NA,NA,2012,NA,NA,NA,0.204,0.268,0.356,280,Marang Men's Study,NA,CDC_31a51d40ded43d31a06d4093c81f687f,CDC,0c13ca2165ae0f8dc74001eef1f027e5,Yes,yes,NA,NA,NA,241,267
ZAF,prevalence,lab,lab,MSM,Durban,NA,NA,2012,NA,NA,NA,0.379,0.482,0.554,287,Marang Men's Study (2014),NA,CDC_32b8d6b542a25734000c910d1e5d90d6,CDC,94070c04b795ddc14f8f7cd9e3609bdc,Yes,yes,NA,NA,NA,241,299
ZAF,prevalence,lab,lab,MSM,Cape Town,NA,NA,2012,NA,NA,NA,NA,0.44,NA,200,Rebe et al 2015,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138315#sec013,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,253,314
AGO,prevalence,lab,lab,MSM,Benguela,NA,NA,2017,NA,NA,NA,0,0.03,0.05,256,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,CDC_4593e9347fcfb113d986bfaee0796a4f,CDC,bc951fa36d6bc345735de79352b2aa3c,Yes,yes,NA,NA,NA,3,315
ZAF,prevalence,lab,lab,PWID,Cape Town,NA,NA,2017,NA,NA,NA,0.077,0.114,0.152,348,TipVal 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,239,383
ZAF,prevalence,lab,lab,PWID,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.066445183,NA,301,Scheibe et al (2019),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,384
ZAF,prevalence,lab,lab,PWID,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.07,NA,252,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec4,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,385
ZAF,prevalence,lab,lab,PWID,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.09,NA,49,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec5,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,386
ZAF,prevalence,lab,lab,TGW,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.571428571,NA,21,Jobson et al,https://www.tandfonline.com/doi/full/10.1080/09540121.2018.1465175?scroll=top&needAccess=true,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,245,392
ZAF,prevalence,lab,NA,FSW,Cape Town,NA,Y015_049,2013,NA,NA,NA,0.301,0.397,0.498,649,UCSF (2015): South Africa Health Monitoring Study (SAHMS),NA,CDC_b96a9851923906adcbc12e681cbf0d34,CDC,5e88833c6b71a883c5d41a1f7104c73b,Yes,yes,NA,NA,NA,243,393
ZAF,prevalence,lab,NA,FSW,Durban,NA,Y015_049,2013,NA,NA,NA,0.375,0.535,0.656,741,UCSF (2015): South Africa Health Monitoring Study (SAHMS),NA,CDC_e9123663c54541d6e9c0fa40b678ac06,CDC,436bdb7a6eed03b06c6a37eac72df520,Yes,yes,NA,NA,NA,243,394
ZAF,prevalence,lab,NA,FSW,Johannesburg,NA,Y015_049,2013,NA,NA,NA,0.565,0.718,0.812,762,UCSF (2015): South Africa Health Monitoring Study (SAHMS),NA,CDC_277f6990a0c6569764c3752d3729fba4,CDC,6e25c6537fccdefadcbb871660dbe78b,Yes,yes,NA,NA,NA,243,404
ZAF,prevalence,lab,lab,FSW,Johannesburg,NA,NA,2014,NA,NA,NA,0.69,0.751,0.801,249,Black et al,https://sti.bmj.com/content/92/7/495,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,256,405
ZAF,prevalence,lab,lab,TGW,Cape Town/Port Elizabeth,NA,NA,2016,NA,NA,NA,NA,0.590909091,NA,22,Sullivan et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7527763/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,247,423
ZAF,prevalence,lab,lab,PWID,Durban,NA,NA,2017,NA,NA,NA,NA,0.169811321,NA,318,Scheibe et al (2019),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,440
ZAF,prevalence,lab,lab,PWID,Durban,NA,NA,2017,NA,NA,NA,NA,0.15,NA,287,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec6,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,441
ZAF,prevalence,lab,lab,PWID,Durban,NA,NA,2017,NA,NA,NA,NA,0.39,NA,31,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec7,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,442
AGO,prevalence,lab,lab,FSW,Benguela,NA,NA,2017,NA,NA,NA,0.02,0.05,0.07,343,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,CDC_e1c872aeeef88173025df03e760ce1c4,CDC,e9b7a13b92c7531c985bb03ef836598a,Yes,yes,NA,NA,NA,3,579
AGO,prevalence,lab,lab,MSM,Bie,NA,NA,2017,NA,NA,NA,0.1,0.07,0.12,68,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,580
AGO,prevalence,lab,lab,FSW,Bie,NA,NA,2017,NA,NA,NA,0.06,0.12,0.18,340,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,581
AGO,prevalence,lab,lab,MSM,Cabinda,NA,NA,2017,NA,NA,NA,0,0.03,0.09,39,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,582
AGO,prevalence,lab,lab,FSW,Cabinda,NA,NA,2017,NA,NA,NA,0.03,0.06,0.1,184,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,583
AGO,prevalence,lab,lab,MSM,Cunene,NA,NA,2017,NA,NA,NA,0,0.02,0.05,196,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,584
AGO,prevalence,lab,lab,FSW,Cunene,NA,NA,2017,NA,NA,NA,0.03,0.05,0.07,506,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,585
AGO,prevalence,lab,lab,TGW,Angola,NA,NA,2017,NA,NA,NA,NA,0.09,NA,89,Mapeamento Programatico E Prevalencia De VIH E Outras Its Entre Populacoes Chave De Angola: Estudo PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,3,587
AGO,prevalence,lab,lab,MSM,Luanda,NA,NA,2017,NA,NA,NA,0,0.02,0.03,457,Mapeamento Programático e Prevalência de VIH e outras ITS entre Populações Chave de Angola: Estudo PLACE 2017,NA,KP Atlas_7813c95626aa1baa5077fb6500fc8fa2,KP Atlas,20c68c8ee3c8844f9b9f8821b2afcc12,Yes,yes,NA,NA,NA,3,588
AGO,prevalence,lab,lab,FSW,Luanda,NA,NA,2017,NA,NA,NA,0.05,0.08,0.11,503,Mapeamento Programático e Prevalência de VIH e outras ITS entre Populações Chave de Angola: Estudo PLACE 2017,NA,KP Atlas_79c56e7c7ab41d23c004f21c9e69eda7,KP Atlas,63e606ed2a16242fa3e71e47048422f6,Yes,yes,NA,NA,NA,3,589
AGO,prevalence,lab,lab,FSW,Namacunde,NA,Y015_024,2010,NA,NA,NA,NA,0.0812,NA,431,365. AGO Fidel,https://scholarworks.gsu.edu/cgi/viewcontent.cgi?article=1384&context=iph_theses,GF_669309938399ad5fdcab38da1e5d9338,GF,447dc7667ab33f6f9cadca02783fb75f,Yes,yes,NA,NA,NA,365,592
AGO,prevalence,lab,lab,MSM,Luanda,NA,NA,2011,NA,NA,NA,0.013,0.037,0.066,328,4. AGO 2011 BBS,NA,CDC_fec9345dafe2f3f21c03cef658515fdd,CDC,0f03019f9b689ec1c3a0a82ffb0f32a7,Yes,yes,NA,NA,NA,4,597
BDI,prevalence,lab,lab,FSW,Burundi,NA,NA,2014,NA,NA,NA,NA,0.213,NA,429,Burundi PLACE Report,NA,CDC_46f4349d3b38886a58d3def611d5c54d,CDC,eb04e7ac7cddd308897c07de6221ea45,Yes,yes,NA,NA,NA,5,616
BDI,prevalence,lab,lab,MSM,Burundi,NA,NA,2014,NA,NA,NA,NA,0.048,NA,290,Burundi PLACE Report,NA,CDC_4dbd026185d67867a7ba612a699db934,CDC,a361e2c8d50b93ef0ea1e602ec428d7f,Yes,yes,NA,NA,NA,5,617
BDI,prevalence,lab,lab,PWID,Burundi,NA,NA,2017,NA,NA,NA,NA,0.102,NA,127,Platt et al,https://pubmed.ncbi.nlm.nih.gov/30809876/,KP Atlas_e052a8115f2f7d45898d02c6ff80081a,KP Atlas,8fe34bbe34ed65fa1a7c7a6e6f9c99b1,Yes,yes,NA,NA,NA,6,632
UGA,prevalence,lab,Lab,PWID,Uganda,NA,NA,2019,NA,NA,NA,NA,0.45,NA,511,Platt et al,https://pubmed.ncbi.nlm.nih.gov/30809876/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,6,640
BDI,prevalence,lab,lab,FSW,"Bujumbura Mairie, Bujumbura Rural, Bubanza, Cibitoke, Muramvya, Mwaro",NA,NA,2021,NA,NA,NA,NA,0.382,NA,498,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,644
BDI,prevalence,lab,lab,MSM,"Bujumbura Mairie, Bujumbura Rural, Bubanza, Cibitoke, Muramvya, Mwaro",NA,NA,2021,NA,NA,NA,NA,0.10800000000000001,NA,246,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,645
BDI,prevalence,lab,lab,PWID,"Bujumbura Mairie, Bujumbura Rural, Bubanza, Cibitoke, Muramvya, Mwaro",NA,NA,2021,NA,NA,NA,NA,0.08,NA,178,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,646
BDI,prevalence,lab,lab,FSW,"Gitega, Cankuzo, Rutana, Ruyigi",NA,NA,2021,NA,NA,NA,NA,0.24600000000000002,NA,248,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,647
BDI,prevalence,lab,lab,FSW,Bujumbura Mairie,NA,NA,2011,NA,NA,NA,NA,0.083,NA,407,"ENQUETE DE SEROPREVALENCE ET SOCIOCOMPORTEMENTALE DU VIH FOCALISEE SUR LES GROUPES A PLUS HAUT RISQUE, RAPPORT DE L'ETUDE (VOLUME 0: RESUME EXECUTIF)",NA,GF_dc0b1b1f9b2c23e1acee0b483d753fab,GF,48795245830017350f41e6b99da44ad6,Yes,yes,NA,NA,NA,8,716
BDI,prevalence,lab,lab,MSM,Bujumbura Mairie,NA,NA,2011,NA,NA,NA,NA,0.023,NA,370,"ENQUETE DE SEROPREVALENCE ET SOCIOCOMPORTEMENTALE DU VIH FOCALISEE SUR LES GROUPES A PLUS HAUT RISQUE, RAPPORT DE L'ETUDE (VOLUME 0: RESUME EXECUTIF)",NA,GF_c748ba880c5ffa3131377cb571cbe0df,GF,997d52509e9f138ebfbfdfc378f6f871,Yes,yes,NA,NA,NA,8,717
NGA,prevalence,lab,lab,FSW,Abia,NA,NA,2014,NA,NA,NA,NA,0.04,NA,276,BBS 2014,NA,GF_70fb7605f9e5c42966c5ee790106db6f,GF,cc9e56e1cbb4e18fc7d8020c3197fa4a,Yes,yes,NA,NA,NA,160,718
BEN,prevalence,lab,lab,FSW,Alibori,NA,NA,2011,NA,NA,NA,0.138,0.27,0.441,38,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,719
BEN,prevalence,lab,lab,FSW,Atacora,NA,NA,2011,NA,NA,NA,0.27,0.12,0.218,49,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,723
BEN,prevalence,lab,lab,FSW,Atlantique,NA,NA,2011,NA,NA,NA,0.169,0.263,0.37,78,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,727
NGA,prevalence,lab,lab,FSW,Abia,NA,NA,2014,NA,NA,NA,NA,0.101,NA,269,BBS 2014,NA,GF_04e456cb257ac114d5735a570e7e827d,GF,65ac9121ddfa62075d5e0050669a240d,Yes,yes,NA,NA,NA,160,728
NGA,prevalence,lab,lab,FSW,Abia,NA,Y015_049,2020,NA,NA,NA,NA,0.061,NA,413,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,731
NGA,prevalence,lab,lab,FSW,Akwa Ibom,NA,Y015_049,2020,NA,NA,NA,NA,0.114,NA,411,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,733
BEN,prevalence,lab,lab,FSW,Borgou,NA,NA,2011,NA,NA,NA,0.71,0.141,0.233,80,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,737
BEN,prevalence,lab,lab,FSW,Collines,NA,NA,2011,NA,NA,NA,0.26,0.98,0.205,52,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,744
BEN,prevalence,lab,lab,FSW,Couffo,NA,NA,2011,NA,NA,NA,0.67,0.138,0.37,32,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,745
BEN,prevalence,lab,lab,FSW,Donga,NA,NA,2011,NA,NA,NA,NA,0.111,NA,10,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,746
BEN,prevalence,lab,lab,FSW,Littoral,NA,NA,2011,NA,NA,NA,0.211,0.262,0.304,338,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,747
BEN,prevalence,lab,lab,FSW,Mono,NA,NA,2011,NA,NA,NA,NA,0,NA,52,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,748
BEN,prevalence,lab,lab,FSW,Oueme,NA,NA,2011,NA,NA,NA,0.161,0.218,0.284,180,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,749
BEN,prevalence,lab,lab,FSW,Plateau,NA,NA,2011,NA,NA,NA,0.08,0.2,0.303,52,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,750
BEN,prevalence,lab,lab,FSW,Zou,NA,NA,2011,NA,NA,NA,0.91,0.189,0.309,55,2012 Benin IBBS FSW and waitress,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,9,751
BEN,prevalence,lab,lab,FSW,Alibori,NA,NA,2015,NA,NA,NA,0.115,0.138,0.161,53,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_05bd1651420ae2a135d2c45b797f7e97,GF,c9da4ea59cd6117dfd1f13c3d1dbf930,Yes,yes,NA,NA,NA,11,752
BEN,prevalence,lab,lab,FSW,Atacora,NA,NA,2015,NA,NA,NA,0.033,0.041,0.049,50,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_3e575f429b1afd0acdfce81c7329fb26,GF,3a823f5c8a5d39d7d904dfe96eb36053,Yes,yes,NA,NA,NA,11,754
BEN,prevalence,lab,lab,FSW,Atlantique,NA,NA,2015,NA,NA,NA,0.202,0.209,0.216,110,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_7c65e0f0b8d94da10e26f61c28e623a8,GF,3a929d297bc5bc5bbb2fe560dc517431,Yes,yes,NA,NA,NA,11,755
BEN,prevalence,lab,lab,FSW,Bourgou,NA,NA,2015,NA,NA,NA,0.145,0.153,0.161,86,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_3aa4d15a0024e1f7b1c246d81cf34cfc,GF,baab9d11aeb44734aa4327a5805519e9,Yes,yes,NA,NA,NA,11,759
BEN,prevalence,lab,lab,FSW,Collines,NA,NA,2015,NA,NA,NA,NA,0,NA,18,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_082e2f59fb5ef74073f4eafed4b67c81,GF,01a834acb4a7330583d2922b9a3b028c,Yes,yes,NA,NA,NA,11,761
BEN,prevalence,lab,lab,FSW,Couffo,NA,NA,2015,NA,NA,NA,0.041,0.1,0.159,15,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_a4f62952d28bf429122bf4bc6fc08796,GF,7b3c42517d52a2043e0667a4767b3352,Yes,yes,NA,NA,NA,11,766
BEN,prevalence,lab,lab,FSW,Donga,NA,NA,2015,NA,NA,NA,0.122,0.2,0.278,10,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_3a48c10a028b4c609a41f59e4e3cbf72,GF,2aa0e3e7ab9f50a3fb4f3b79f577237b,Yes,yes,NA,NA,NA,11,767
BEN,prevalence,lab,lab,FSW,Littoral,NA,NA,2015,NA,NA,NA,0.166,0.168,0.169,533,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_d9b86c88db3c892368cbada8c6df9f49,GF,4e74f9f394aabf57954587758eb5f8b0,Yes,yes,NA,NA,NA,11,768
BEN,prevalence,lab,lab,FSW,Mono,NA,NA,2015,NA,NA,NA,0.045,0.143,0.241,8,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_24be7c7e929aeacaa56f3cc41b944c35,GF,4a38669c1afd5f34d5f7e45e2f07cd4a,Yes,yes,NA,NA,NA,11,769
BEN,prevalence,lab,lab,FSW,Oueme,NA,NA,2015,NA,NA,NA,0.168,0.175,0.183,99,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_740dc43c83e828fcb3a7267e19c6c282,GF,f5f9d0117375ac2943c26875fef742d5,Yes,yes,NA,NA,NA,11,773
BEN,prevalence,lab,lab,FSW,Plateau,NA,NA,2015,NA,NA,NA,0.206,0.233,0.261,31,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_e6589f3a638c02142e8680251262d980,GF,3bbaecbae881185ec6f6fadad0bd54e4,Yes,yes,NA,NA,NA,11,774
BEN,prevalence,lab,lab,FSW,Zou,NA,NA,2015,NA,NA,NA,0.097,0.101,0.104,167,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2015) (Professionnelles de Sexe & Serveuses de Bar et Restaurants)",NA,GF_a52bae8ebdda511d66bd815a6efbae03,GF,9fe78f80e394785af499360fc1efdb56,Yes,yes,NA,NA,NA,11,775
BEN,prevalence,lab,lab,FSW,Alibori,NA,NA,2017,NA,NA,NA,NA,0.14300000000000002,NA,54,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,785
BEN,prevalence,lab,lab,FSW,Atacora,NA,NA,2017,NA,NA,NA,NA,0.11699999999999999,NA,62,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,787
BEN,prevalence,lab,lab,FSW,Atlantique,NA,NA,2017,NA,NA,NA,NA,0.068,NA,107,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,788
BEN,prevalence,lab,lab,FSW,Borgou,NA,NA,2017,NA,NA,NA,NA,0.04,NA,104,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,789
BEN,prevalence,lab,lab,FSW,Littoral,NA,NA,2017,NA,NA,NA,NA,0.099,NA,395,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,790
BEN,prevalence,lab,lab,FSW,Mono,NA,NA,2017,NA,NA,NA,NA,0.063,NA,17,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,791
BEN,prevalence,lab,lab,MSM,Abomey-Calavi,NA,NA,2014,NA,NA,NA,NA,0.045454545,NA,22,Etude De Suivi De Cohorte Pour l'Estimation De l'Incidence Du VIH Et De La Taille De La Population Des HSH Au Benin,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,13,795
BEN,prevalence,lab,lab,MSM,Come,NA,NA,2014,NA,NA,NA,NA,0,NA,21,Etude De Suivi De Cohorte Pour l'Estimation De l'Incidence Du VIH Et De La Taille De La Population Des HSH Au Benin,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,13,796
BEN,prevalence,lab,lab,MSM,Cotonou,NA,NA,2014,NA,NA,NA,NA,0.046391753,NA,194,Etude De Suivi De Cohorte Pour l'Estimation De l'Incidence Du VIH Et De La Taille De La Population Des HSH Au Benin,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,13,797
BEN,prevalence,lab,lab,MSM,Parakou,NA,NA,2014,NA,NA,NA,NA,0.009615385,NA,104,Etude De Suivi De Cohorte Pour l'Estimation De l'Incidence Du VIH Et De La Taille De La Population Des HSH Au Benin,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,13,799
BEN,prevalence,lab,lab,MSM,Abomey-Calavi,NA,NA,2013,NA,NA,NA,NA,0.28,NA,55,2013 Benin IBBS (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,14,800
NGA,prevalence,lab,lab,FSW,Anambra,NA,Y015_049,2020,NA,NA,NA,NA,0.065,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,804
NGA,prevalence,lab,lab,FSW,Benue,NA,Y015_049,2020,NA,NA,NA,NA,0.20199999999999999,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,805
BEN,prevalence,lab,lab,MSM,Cotonou,NA,NA,2013,NA,NA,NA,NA,0.178,NA,162,2013 Benin IBBS (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,14,806
BEN,prevalence,lab,lab,MSM,Porto-Novo,NA,NA,2013,NA,NA,NA,NA,0.299,NA,NA,2013 Benin IBBS (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,14,808
BEN,prevalence,lab,lab,PWID,"Porto-Novo, Seme-Krake, Cotonou, Ouidah, Come, Hillacondji, Bohicon, Abomey and Parakou",NA,NA,2013,NA,NA,NA,NA,0.067,NA,112,EnquÍte de surveillance de deuxiËme generation du VIH et des IST auprËs des utilisateurs de drogues injectables au Benin,NA,GF_35e0289c764b431a09145143e5d4802e,GF,3f5c72dce85bdbe1c819ee6b355b00ca,Yes,yes,NA,NA,NA,15,809
NGA,prevalence,lab,lab,FSW,Gombe,NA,Y015_049,2020,NA,NA,NA,NA,0.243,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,812
NGA,prevalence,lab,lab,FSW,Kaduna,NA,Y015_049,2020,NA,NA,NA,NA,0.265,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,814
NGA,prevalence,lab,lab,FSW,Kano,NA,Y015_049,2020,NA,NA,NA,NA,0.133,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,815
BEN,prevalence,lab,lab,PWID,Atacora/Donga,NA,NA,2017,NA,NA,NA,0,0.091,0.261,11,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,819
BEN,prevalence,lab,lab,PWID,Atlantique/Littoral,NA,NA,2017,NA,NA,NA,0.0053,0.025,0.0447,242,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,820
NGA,prevalence,lab,lab,FSW,Lagos,NA,Y015_049,2020,NA,NA,NA,NA,0.128,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,821
NGA,prevalence,lab,lab,FSW,Nassarawa,NA,Y015_049,2020,NA,NA,NA,NA,0.239,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,822
NGA,prevalence,lab,lab,FSW,Oyo,NA,Y015_049,2020,NA,NA,NA,NA,0.128,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,823
BEN,prevalence,lab,lab,PWID,Borgou/Alibori,NA,NA,2017,NA,NA,NA,NA,0,NA,53,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,824
BEN,prevalence,lab,lab,PWID,Mono/Couffo,NA,NA,2017,NA,NA,NA,0,0.075,0.1566,40,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,825
BEN,prevalence,lab,lab,PWID,Oueme/Plateau,NA,NA,2017,NA,NA,NA,NA,0,NA,75,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,828
BEN,prevalence,lab,lab,PWID,Zou/Collines,NA,NA,2017,NA,NA,NA,0,0.013000000000000001,0.038599999999999995,75,"ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION RELATIVE AUX IST, VIH ET SIDA (ESDGE) EDITION 2017 Cibles: Consommateurs de Drogues par Injection (CDI)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,17,831
BEN,prevalence,lab,lab,TGW,Abomey-Calavi,NA,NA,2020,NA,NA,NA,NA,0.321,NA,53,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,834
NGA,prevalence,lab,lab,FSW,Rivers,NA,Y015_049,2020,NA,NA,NA,NA,0.07,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,837
NGA,prevalence,lab,lab,FSW,Taraba,NA,Y015_049,2020,NA,NA,NA,NA,0.18100000000000002,NA,415,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,840
BEN,prevalence,lab,lab,TGW,Bohicon,NA,NA,2020,NA,NA,NA,NA,0.222,NA,9,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,858
BEN,prevalence,lab,lab,TGW,Cotonou,NA,NA,2020,NA,NA,NA,NA,0.231,NA,143,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,859
BEN,prevalence,lab,lab,TGW,Ouidah,NA,NA,2020,NA,NA,NA,NA,0.127,NA,55,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,860
BEN,prevalence,lab,lab,TGW,Parakou,NA,NA,2020,NA,NA,NA,NA,0.091,NA,11,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,861
BEN,prevalence,lab,lab,TGW,Porto-Novo,NA,NA,2020,NA,NA,NA,NA,0.167,NA,6,"ENQUETE BIO-COMPORTEMENTALE, CARTOGRAPHIE ET ESTIMATION DE LA TAILLE DES TRANSGENRES AU BENIN, 2020",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,22,864
BFA,prevalence,lab,lab,FSW,Boucle du Mouhon,NA,NA,2017,NA,NA,NA,NA,0.093,NA,324,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_53afcdde1257ddd9432a20c34da997b7,GF,f9286874f08dd10dca3093b19d493aa6,Yes,yes,NA,NA,NA,29,888
BEN,prevalence,lab,lab,PWID,Atlantique/Littoral,NA,NA,2015,NA,NA,NA,NA,0.055,NA,163,Enquete De Surveillance De Deuxieme Generation (Comportementale Et Biologique) 2015 (PWID),NA,GF_319f83110651c9ed9c567d2301fdc803,GF,4e6b2951677cb057530fa5f91f1526f3,Yes,yes,NA,NA,NA,23,904
NGA,prevalence,lab,lab,MSM,Abia,NA,Y015_049,2020,NA,NA,NA,NA,0.106,NA,369,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,905
NGA,prevalence,lab,lab,MSM,Akwa Ibom,NA,Y015_049,2020,NA,NA,NA,NA,0.212,NA,370,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,906
NGA,prevalence,lab,lab,MSM,Anambra,NA,Y015_049,2020,NA,NA,NA,NA,0.172,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,907
BEN,prevalence,lab,lab,PWID,Borgou/Alibori,NA,NA,2015,NA,NA,NA,NA,0.039,NA,76,Enquete De Surveillance De Deuxieme Generation (Comportementale Et Biologique) 2015 (PWID),NA,GF_0b5078060242ed296a0edae98c966765,GF,2babe1b9b0aa9ac7bf51a16708fdba7c,Yes,yes,NA,NA,NA,23,908
BEN,prevalence,lab,lab,PWID,Mono/Couffo,NA,NA,2015,NA,NA,NA,NA,0.05,NA,40,Enquete De Surveillance De Deuxieme Generation (Comportementale Et Biologique) 2015 (PWID),NA,GF_04327fd9e392b1338a685e2c6634528b,GF,fe24150c3a5ba0b5ffd2383f91be3f6c,Yes,yes,NA,NA,NA,23,909
BEN,prevalence,lab,lab,PWID,Oueme/Plateau,NA,NA,2015,NA,NA,NA,NA,0.034,NA,59,Enquete De Surveillance De Deuxieme Generation (Comportementale Et Biologique) 2015 (PWID),NA,GF_bf6db08ab8a29698633d049c012eb187,GF,4441bc5759f612ff1d658311fe6f0c0d,Yes,yes,NA,NA,NA,23,910
BEN,prevalence,lab,lab,PWID,Zou/Collines,NA,NA,2015,NA,NA,NA,NA,0.025,NA,40,Enquete De Surveillance De Deuxieme Generation (Comportementale Et Biologique) 2015 (PWID),NA,GF_27e5204cae70eb7c29131b717b51d187,GF,1162ecab55b93e611145c88451c489bc,Yes,yes,NA,NA,NA,23,911
BFA,prevalence,lab,lab,FSW,Banfora,NA,NA,2010,NA,NA,NA,NA,0.077,NA,52,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_3cacd85c2a5fdc00d4a2b4903e6d20d8,KP Atlas,a92ecf14bc8b39effa04ba80be5495f2,Yes,yes,NA,NA,NA,24,912
BFA,prevalence,lab,lab,FSW,Bittou,NA,NA,2010,NA,NA,NA,NA,0.362,NA,47,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_faa552a90b5a791aedd5a00550ff2cd7,KP Atlas,130dbdd57c2eea80d423da5c78a2342c,Yes,yes,NA,NA,NA,24,913
BFA,prevalence,lab,lab,FSW,Bobo-Dioulasso,NA,NA,2010,NA,NA,NA,NA,0.204,NA,294,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_f43e32eae87928658b89e205a7be1555,KP Atlas,d119352de8faa26c8eb56a3df637724d,Yes,yes,NA,NA,NA,24,914
BFA,prevalence,lab,lab,FSW,Fada N'Gourma,NA,NA,2010,NA,NA,NA,NA,0.081,NA,37,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_eb4a11a8850d9c0187ae654df09e618e,KP Atlas,ead9225814b3ec399ef86f1a5aa3d767,Yes,yes,NA,NA,NA,24,915
BFA,prevalence,lab,lab,FSW,Gaoua,NA,NA,2010,NA,NA,NA,NA,0.18,NA,49,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_829a0c45d3de283000cd79561f70eac6,KP Atlas,7aedb332700c9d362b059f9e0712d99f,Yes,yes,NA,NA,NA,24,916
BFA,prevalence,lab,lab,FSW,Koudougou,NA,NA,2010,NA,NA,NA,NA,0.143,NA,49,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_2347d80f7e0fffc903359aa2cb837471,KP Atlas,1f95723033f93ad50ecf2e32c881af81,Yes,yes,NA,NA,NA,24,917
BFA,prevalence,lab,lab,FSW,Ouagadaougou,NA,NA,2010,NA,NA,NA,NA,0.149,NA,285,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_2c648fa51da70f4ed1e668411cf0971e,KP Atlas,9911ebfdeab921ca7e922e87e384a420,Yes,yes,NA,NA,NA,24,918
BFA,prevalence,lab,lab,FSW,Ouahigouya,NA,NA,2010,NA,NA,NA,NA,0.095,NA,43,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_9711e0bf814090ea6b513b5aa00f2e85,KP Atlas,57144b14cd28b5e9ee8eb2616379601d,Yes,yes,NA,NA,NA,24,919
BFA,prevalence,lab,lab,FSW,Pouytenga,NA,NA,2010,NA,NA,NA,NA,0.118,NA,52,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_ddbca6a30d6b5e4c6e07ae8422dc6c2b,KP Atlas,d3d8494892cc3fbd29d848bd55ccf6d0,Yes,yes,NA,NA,NA,24,920
BFA,prevalence,lab,lab,FSW,Tenkodogo,NA,NA,2010,NA,NA,NA,NA,0.115,NA,52,ENQU TE DE SURVEILLANCE COMPORTEMENTALE AUPR»S DES GROUPES A HAUT RISQUE : TRAVAILLEUSES DU SEXE (TS) ET LEURS CLIENTS AU BURKINA FASO,NA,KP Atlas_b1a00da8888b18886cf37140af4c49f5,KP Atlas,5fb15af5ea5cddbb89ed06095b7218a8,Yes,yes,NA,NA,NA,24,921
BFA,prevalence,lab,lab,MSM,"Bobo-Dioulasso, Ouagadougou",NA,NA,2013,NA,NA,NA,NA,0.0326087,NA,552,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,922
BFA,prevalence,lab,lab,TGW,"Bobo-Dioulasso, Ouagadougou",NA,NA,2013,NA,NA,NA,NA,0.02777778,NA,108,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,923
CIV,prevalence,lab,lab,MSM,"Abidjan, Bouake, Gagnoa, Yamoussoukro",NA,NA,2016,NA,NA,NA,NA,0.07963446,NA,766,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,925
CIV,prevalence,lab,lab,TGW,"Abidjan, Bouake, Gagnoa, Yamoussoukro",NA,NA,2016,NA,NA,NA,NA,0.25503356,NA,298,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,926
GMB,prevalence,lab,lab,MSM,Banjul,NA,NA,2011,NA,NA,NA,NA,0.09,NA,200,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,927
GMB,prevalence,lab,lab,TGW,Banjul,NA,NA,2011,NA,NA,NA,NA,0.5,NA,4,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,928
LSO,prevalence,lab,lab,MSM,Maputsoe and Maseru,NA,NA,2014,NA,NA,NA,NA,0.285714286,NA,455,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,929
LSO,prevalence,lab,lab,TGW,Maputsoe and Maseru,NA,NA,2014,NA,NA,NA,NA,0.591549296,NA,71,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,930
MWI,prevalence,lab,lab,MSM,Lilongwe,NA,NA,2012,NA,NA,NA,NA,0.152091255,NA,263,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,931
MWI,prevalence,lab,lab,TGW,Lilongwe,NA,NA,2012,NA,NA,NA,NA,0.16,NA,75,Poteat et al,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,932
MWI,prevalence,lab,lab,TGW,Blantyre,NA,NA,2020,NA,NA,NA,NA,0.159090909,NA,88,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,933
MWI,prevalence,lab,lab,TGW,Karonga,NA,NA,2020,NA,NA,NA,NA,0,NA,18,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,934
MWI,prevalence,lab,lab,TGW,Lilongwe,NA,NA,2020,NA,NA,NA,NA,0.131578947,NA,190,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,935
MWI,prevalence,lab,lab,TGW,Mangochi,NA,NA,2020,NA,NA,NA,NA,0.223404255,NA,94,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,936
MWI,prevalence,lab,lab,TGW,Nkhatabay,NA,NA,2020,NA,NA,NA,NA,0.096774194,NA,62,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,937
MWI,prevalence,lab,lab,TGW,Zomba,NA,NA,2020,NA,NA,NA,NA,0.079545455,NA,88,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,938
SEN,prevalence,lab,lab,MSM,Dakar,NA,NA,2015,NA,NA,NA,NA,0.278409091,NA,528,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,939
SEN,prevalence,lab,lab,TGW,Dakar,NA,NA,2015,NA,NA,NA,NA,0.371859296,NA,199,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,940
SWZ,prevalence,lab,lab,MSM,Mbabane,NA,NA,2011,NA,NA,NA,NA,0.18627451,NA,204,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,941
SWZ,prevalence,lab,lab,TGW,Mbabane,NA,NA,2011,NA,NA,NA,NA,0.141666667,NA,120,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,942
TGO,prevalence,lab,lab,MSM,"Kara, Lome",NA,NA,2013,NA,NA,NA,NA,0.084664537,NA,626,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,943
TGO,prevalence,lab,lab,TGW,"Kara, Lome",NA,NA,2013,NA,NA,NA,NA,0.176470588,NA,51,Poteat et al.,https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002422,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,26,944
CIV,prevalence,lab,lab,MSM,Abidjan,NA,NA,2017,NA,NA,NA,NA,0.3255,NA,129,Yaya et al,https://academic.oup.com/cid/article/73/12/2184/6144992?login=true#no-access-message#no-access-message,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,28,949
MLI,prevalence,lab,lab,MSM,Bamako,NA,NA,2017,NA,NA,NA,NA,0.329,NA,210,Yaya et al,https://academic.oup.com/cid/article/73/12/2184/6144992?login=true#no-access-message#no-access-message,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,28,950
BFA,prevalence,lab,lab,FSW,Cascades,NA,NA,2017,NA,NA,NA,NA,0.153,NA,111,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_bfecce1c3ed6ed0db0704b6c2ab92362,GF,cc314b81df5f464fbb8fd01afb8d3a7f,Yes,yes,NA,NA,NA,29,952
BFA,prevalence,lab,lab,FSW,Centre,NA,NA,2017,NA,NA,NA,NA,0.06,NA,1334,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_0f279b3b4e91d37030dbd8ef6d14349c,GF,2e2f440f4d9695dab7edce2ef07f0b04,Yes,yes,NA,NA,NA,29,953
BFA,prevalence,lab,lab,FSW,Centre-Est,NA,NA,2017,NA,NA,NA,NA,0.064,NA,377,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_754b65904aa5fae30b66dad1c91938cd,GF,dce6525d45a49fcdda7b87a48d54e7a6,Yes,yes,NA,NA,NA,29,954
BFA,prevalence,lab,lab,FSW,Centre-Nord,NA,NA,2017,NA,NA,NA,NA,0.035,NA,202,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_47b54a20b8915784f4e4637149b9424c,GF,baf2b77944ab2026b0b6ec022dd32b32,Yes,yes,NA,NA,NA,29,955
BFA,prevalence,lab,lab,FSW,Centre-Ouest,NA,NA,2017,NA,NA,NA,NA,0.073,NA,164,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_800c6ea813b71785a634b537e1c5429f,GF,61fc28ffbf7e4f66446046257fd6e4d2,Yes,yes,NA,NA,NA,29,956
BFA,prevalence,lab,lab,FSW,Centre-Sud,NA,NA,2017,NA,NA,NA,NA,0.06,NA,116,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_fadc2a19dccb1ce06aac6b92f331e6a8,GF,c76e1e9328ce88edbfa2335c685a24e6,Yes,yes,NA,NA,NA,29,957
BFA,prevalence,lab,lab,FSW,Est,NA,NA,2017,NA,NA,NA,NA,0.04,NA,321,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_2595dca7f6f577717b9cfa58de9dae28,GF,20fbf320e6634daa22e27649c423379c,Yes,yes,NA,NA,NA,29,958
BFA,prevalence,lab,lab,FSW,Hauts Bassins,NA,NA,2017,NA,NA,NA,NA,0.049,NA,1081,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_bb6f6dc42edcc268a3b310ea1f04c731,GF,e3411fe641d1d26e82121566c767d784,Yes,yes,NA,NA,NA,29,959
BFA,prevalence,lab,lab,FSW,Nord,NA,NA,2017,NA,NA,NA,NA,0.032,NA,222,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_115ae7ccd1eb29ea0beca91e97326053,GF,ba6b21c85ab5c8eca55f1a784120d790,Yes,yes,NA,NA,NA,29,960
BFA,prevalence,lab,lab,FSW,Plateau Central,NA,NA,2017,NA,NA,NA,NA,0.037,NA,187,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_8ffb8006c6708d37b2982863f41e862d,GF,dc46c62d7414fd1234a29237e4687423,Yes,yes,NA,NA,NA,29,961
BFA,prevalence,lab,lab,FSW,Sahel,NA,NA,2017,NA,NA,NA,NA,0.018,NA,170,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_14f8f9befa462f678905eb465e5721ff,GF,f569677b94c61533a0261ac589ae6795,Yes,yes,NA,NA,NA,29,962
BFA,prevalence,lab,lab,FSW,Sud-Ouest,NA,NA,2017,NA,NA,NA,NA,0.042,NA,165,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_4655a84710693d1c8a2734ef34459b84,GF,5e1a2a42053b738225c016d8f381c32a,Yes,yes,NA,NA,NA,29,963
BFA,prevalence,lab,lab,MSM,Boucle du Mouhoun,NA,NA,2017,NA,NA,NA,NA,0,NA,3,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_00d2631b601f85da697329e944247957,GF,e30a2ebb96e0a6da1492998d5ea473d8,Yes,yes,NA,NA,NA,29,965
BFA,prevalence,lab,lab,MSM,Cascades,NA,NA,2017,NA,NA,NA,NA,0.033,NA,60,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_00dd5a2ec4a53008838d3163ce937ef6,GF,21a71d2b2d5bdceead0a41a7e419d8d6,Yes,yes,NA,NA,NA,29,968
BFA,prevalence,lab,lab,MSM,Centre,NA,NA,2017,NA,NA,NA,NA,0.014,NA,276,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_bf6093a60720011c7292b312f77baa75,GF,05b748ef7c73081b67c4c401714d4502,Yes,yes,NA,NA,NA,29,969
BFA,prevalence,lab,lab,MSM,Centre-Est,NA,NA,2017,NA,NA,NA,NA,0,NA,25,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_70b5958bb6c141faf789650f305d8b12,GF,ab7a28fcbb3bf08cb2e839abd7578b3f,Yes,yes,NA,NA,NA,29,970
BFA,prevalence,lab,lab,MSM,Centre-ouest,NA,NA,2017,NA,NA,NA,NA,0.091,NA,11,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_bfa7d2d758aba75b8407c69c3cc578a2,GF,54ff7d773d783a981376a6a1eff06ba8,Yes,yes,NA,NA,NA,29,971
BFA,prevalence,lab,lab,MSM,Hauts Bassins,NA,NA,2017,NA,NA,NA,NA,0.019,NA,206,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_84c65aed27e11a9cb77faa6ed8aadec5,GF,21c2affedd54f889a948dbd13775e817,Yes,yes,NA,NA,NA,29,972
BFA,prevalence,lab,lab,MSM,Nord,NA,NA,2017,NA,NA,NA,NA,0,NA,11,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,GF_09dfbcdabdd3c7d1c60bb7e6a1d4c0ef,GF,19367f6030f380515cca03de4460cd84,Yes,yes,NA,NA,NA,29,973
BFA,prevalence,lab,lab,PWID,Boucle du Mouhon,NA,NA,2017,NA,NA,NA,NA,0,NA,30,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,975
BFA,prevalence,lab,lab,PWID,Cascades,NA,NA,2017,NA,NA,NA,NA,0,NA,19,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,979
BFA,prevalence,lab,lab,PWID,Centre,NA,NA,2017,NA,NA,NA,NA,0.011000000000000001,NA,362,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,980
BFA,prevalence,lab,lab,PWID,Centre-Ouest,NA,NA,2017,NA,NA,NA,NA,0,NA,1,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,981
BFA,prevalence,lab,lab,PWID,Centre-Sud,NA,NA,2017,NA,NA,NA,NA,0.017,NA,60,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,982
BFA,prevalence,lab,lab,PWID,Hauts Bassins,NA,NA,2017,NA,NA,NA,NA,0.009,NA,116,"CARTOGRAPHIE PROGRAMMATIQUE, ESTIMATION DE LA TAILLE ET ENQUETE BIO- COMPORTEMENTALE PARMI LES POPULATIONS CLES (PS, HSH, UD) AU BURKINA FASO",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,29,983
CAF,prevalence,lab,NA,FSW,Bangui,NA,Y015_049,2019,NA,NA,NA,NA,0.117,NA,1051,Rapport_IBBS_PS_28_04_2020,NA,KP Atlas_cfa35949cb86c0744cca2df091a55fdf,KP Atlas,69e63ed62b28521a36cc1cdf35837d00,Yes,yes,NA,NA,NA,35,1011
CAF,prevalence,lab,NA,FSW,"Boali, Bouar, Carnot, Berberati",NA,Y015_049,2019,NA,NA,NA,NA,0.221,NA,482,Rapport_IBBS_PS_28_04_2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,35,1015
BWA,prevalence,lab,lab,TGW,Gaberone,NA,NA,2017,NA,NA,NA,NA,0.5,NA,11,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1017
BWA,prevalence,lab,lab,MSM,Chobe,NA,NA,2017,NA,NA,NA,NA,0.13,NA,59,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1018
BWA,prevalence,lab,lab,FSW,Chobe,NA,NA,2017,NA,NA,NA,0.688,0.72,0.746,152,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1019
BWA,prevalence,lab,lab,MSM,Francistown,NA,NA,2017,NA,NA,NA,NA,0.24,NA,131,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1020
BWA,prevalence,lab,lab,FSW,Francistown,NA,NA,2017,NA,NA,NA,0.312,0.37,0.432,272,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1021
BWA,prevalence,lab,lab,MSM,Gaborone,NA,NA,2017,NA,NA,NA,NA,0.18,NA,264,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1022
BWA,prevalence,lab,lab,FSW,Gaborone,NA,NA,2017,NA,NA,NA,0.476,0.58,0.669,305,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1024
BWA,prevalence,lab,lab,MSM,Maun,NA,NA,2017,NA,NA,NA,NA,0.11,NA,101,2017 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,31,1026
BWA,prevalence,lab,lab,FSW,Maun,NA,NA,2017,NA,NA,NA,0.228,0.28,0.345,260,2017 BBS,NA,KP Atlas_f937b38075f9623e4acfbb264c799efa,KP Atlas,80c5cf8de1649d9a02af9d98b5fc4a7a,Yes,yes,NA,NA,NA,31,1027
BWA,prevalence,lab,lab,MSM,Palapye,NA,NA,2017,NA,NA,NA,NA,0.06,NA,181,2017 BBS,NA,KP Atlas_5c313e1bc08fde9795725924c6368be9,KP Atlas,7bdacd42dbcabd94d2b111c59e9faa6e,Yes,yes,NA,NA,NA,31,1045
BWA,prevalence,lab,lab,FSW,Palapye,NA,NA,2017,NA,NA,NA,0.343,0.4,0.464,268,2017 BBS,NA,KP Atlas_31f23aa121b3a86edd280d6573a110f0,KP Atlas,fcfc44e355d044df1f670f79415ad9d8,Yes,yes,NA,NA,NA,31,1046
GHA,prevalence,lab,lab,MSM,Ashanti,NA,NA,2017,NA,NA,NA,0.209,0.25,0.306,511,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1047
BWA,prevalence,lab,lab,MSM,Francistown,NA,NA,2012,NA,NA,NA,0.07,0.12,0.17,145,BBSS 2012,NA,GF_ae1dd739bf47db148465f8e84f5aaaff,GF,c9e082fd4d9767e61f6cdfa86f0ea4d4,Yes,yes,NA,NA,NA,32,1057
BWA,prevalence,lab,lab,FSW,Francistown,NA,NA,2012,NA,NA,NA,0.46,0.54,0.61,412,BBSS 2012,NA,GF_f7fb6e6ba1bd7469084d283d04bc94f9,GF,331891b0ac074fb2782bb685749fe8cf,Yes,yes,NA,NA,NA,32,1058
BWA,prevalence,lab,lab,MSM,Gaborone,NA,NA,2012,NA,NA,NA,0.8,0.12,0.16,275,BBSS 2012,NA,GF_257a05b74820728cf05e225092117b55,GF,2d64580076cb1791acc468460f5d9294,Yes,yes,NA,NA,NA,32,1069
BWA,prevalence,lab,lab,FSW,Gaborone,NA,NA,2012,NA,NA,NA,NA,0.66,NA,404,BBSS 2012,NA,GF_e62e77edf2e2b70c6840769543151a05,GF,7481bc68ef3ddc2dcb6f7f620c0f4adc,Yes,yes,NA,NA,NA,32,1070
BWA,prevalence,lab,lab,MSM,Kasane,NA,NA,2012,NA,NA,NA,0.09,0.26,0.43,30,BBSS 2012,NA,GF_bc20ffdcff0e3ff0a50da4d0e677cd05,GF,99443d93fe17545dc52ce401bf9c5400,Yes,yes,NA,NA,NA,32,1071
BWA,prevalence,lab,lab,FSW,Kasane,NA,NA,2012,NA,NA,NA,0.57,0.69,0.8,131,BBSS 2012,NA,GF_3da96e943ae54829ee715582d5050890,GF,98faf1b832b5dc641083185089e346b0,Yes,yes,NA,NA,NA,32,1072
CAF,prevalence,lab,lab,MSM,Bangui,NA,NA,2010,NA,NA,NA,NA,0.6444,NA,42,Bouassa et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967740/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,34,1079
CIV,prevalence,lab,lab,MSM,Abidjan,NA,Y015_024,2012,NA,NA,NA,NA,0.124,NA,355,"…TUDE SUR LE VIH ET LES FACTEURS DE RISQUES ASSOCI…S CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES A ABIDJAN, C‘TE DíIVOIRE",NA,KP Atlas_8af5b9c862f5f85f91a6a2e9266794d6,KP Atlas,c643d921ad189cbe6c1702aa59cff4fb,Yes,yes,NA,NA,NA,38,1087
CIV,prevalence,lab,lab,MSM,Abidjan,NA,Y015_049,2012,NA,NA,NA,0.13,0.18,0.231,601,"…TUDE SUR LE VIH ET LES FACTEURS DE RISQUES ASSOCI…S CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES A ABIDJAN, C‘TE DíIVOIRE",NA,KP Atlas_e749013c2afc27a7c15bf7bb48ba57be,KP Atlas,8361d97bba353c0d1099fe75a48b9a44,Yes,yes,NA,NA,NA,38,1088
CIV,prevalence,lab,lab,MSM,Abidjan,NA,Y025_049,2012,NA,NA,NA,NA,0.258,NA,226,"…TUDE SUR LE VIH ET LES FACTEURS DE RISQUES ASSOCI…S CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES A ABIDJAN, C‘TE DíIVOIRE",NA,KP Atlas_7eda114dee484f4956a8a8e925cdcda6,KP Atlas,60bb5deadef23cbad4a6f8f4c11c506d,Yes,yes,NA,NA,NA,38,1089
NGA,prevalence,lab,lab,MSM,Benue,NA,Y015_049,2020,NA,NA,NA,NA,0.21,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1090
CIV,prevalence,lab,lab,MSM,Abidjan,NA,NA,2015,NA,NA,NA,NA,0.293,NA,351,"Etude Biologique Et Comportementale Des IST, Du VIH Et Du Sida Chez Les Hommes Ayant Des Rapports Sexuels Avec Des Hommes Des Villes D,Aoabidjan, Agboville, Bouakeaa, Gagnoa, Et Yamoussoukro",NA,GF_54e5ac928c3ced218d28d6c21931b712,GF,58b0c1eedcc8955dc45155eeba1840f6,Yes,yes,NA,NA,NA,41,1091
CIV,prevalence,lab,lab,MSM,Agboville,NA,NA,2015,NA,NA,NA,NA,0.046,NA,200,"Etude Biologique Et Comportementale Des IST, Du VIH Et Du Sida Chez Les Hommes Ayant Des Rapports Sexuels Avec Des Hommes Des Villes D,Aoabidjan, Agboville, Bouakeaa, Gagnoa, Et Yamoussoukro",NA,GF_2865c4079ed2411f1787b83fdcb04e00,GF,87b5c3c9ae72b0e28cfcfcdbc2301724,Yes,yes,NA,NA,NA,41,1092
CIV,prevalence,lab,lab,MSM,Bouake,NA,NA,2015,NA,NA,NA,NA,0.035,NA,350,"Etude Biologique Et Comportementale Des IST, Du VIH Et Du Sida Chez Les Hommes Ayant Des Rapports Sexuels Avec Des Hommes Des Villes D,Aoabidjan, Agboville, Bouakeaa, Gagnoa, Et Yamoussoukro",NA,GF_1e54088b46b24feae50eb9b5c42c4892,GF,64f8f7e613c4f138f79953e86d81ee16,Yes,yes,NA,NA,NA,41,1093
CIV,prevalence,lab,lab,MSM,Gagnoa,NA,NA,2015,NA,NA,NA,NA,0.047,NA,150,"Etude Biologique Et Comportementale Des IST, Du VIH Et Du Sida Chez Les Hommes Ayant Des Rapports Sexuels Avec Des Hommes Des Villes D,Aoabidjan, Agboville, Bouakeaa, Gagnoa, Et Yamoussoukro",NA,GF_10e171bd68a837f634c03b0f5fcbdfc3,GF,c993ecf1725295ebfef654be5d235392,Yes,yes,NA,NA,NA,41,1103
CIV,prevalence,lab,lab,MSM,Yamoussoukro,NA,NA,2015,NA,NA,NA,NA,0.1,NA,250,"Etude Biologique Et Comportementale Des IST, Du VIH Et Du Sida Chez Les Hommes Ayant Des Rapports Sexuels Avec Des Hommes Des Villes D,Aoabidjan, Agboville, Bouakeaa, Gagnoa, Et Yamoussoukro",NA,GF_b764d6321a630d7042433aa5b0286bc2,GF,61dc687c7ba2fb494e5445a02b4411a9,Yes,yes,NA,NA,NA,41,1106
CIV,prevalence,lab,lab,MSM,Abidjan,NA,NA,2014,NA,NA,NA,0.234,0.39,0.546,41,Bouscaillou et al.,https://www.sciencedirect.com/science/article/pii/S0955395916300196,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,42,1113
CIV,prevalence,lab,lab,FSW,ABOISSO,NA,NA,2020,NA,NA,NA,NA,0.052000000000000005,NA,200,"Enquete Bio-Comportementale Et Cartographique En Direction Des Travailleuses De Sexe Dans Cinq Localites De La Cote D'ivoire : Katiola, Yamoussoukro, Soubre, Aboisso, Agboville.",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,46,1125
CIV,prevalence,lab,lab,FSW,Agboville,NA,NA,2020,NA,NA,NA,NA,0.028999999999999998,NA,230,"Enquete Bio-Comportementale Et Cartographique En Direction Des Travailleuses De Sexe Dans Cinq Localites De La Cote D'ivoire : Katiola, Yamoussoukro, Soubre, Aboisso, Agboville.",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,46,1128
CIV,prevalence,lab,lab,FSW,Katiola,NA,NA,2020,NA,NA,NA,NA,0.071,NA,347,"Enquete Bio-Comportementale Et Cartographique En Direction Des Travailleuses De Sexe Dans Cinq Localites De La Cote D'ivoire : Katiola, Yamoussoukro, Soubre, Aboisso, Agboville.",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,46,1131
CIV,prevalence,lab,lab,FSW,Soubre,NA,NA,2020,NA,NA,NA,NA,0.034,NA,200,"Enquete Bio-Comportementale Et Cartographique En Direction Des Travailleuses De Sexe Dans Cinq Localites De La Cote D'ivoire : Katiola, Yamoussoukro, Soubre, Aboisso, Agboville.",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,46,1134
CIV,prevalence,lab,lab,FSW,Yamoussoukro,NA,NA,2020,NA,NA,NA,NA,0.039,NA,200,"Enquete Bio-Comportementale Et Cartographique En Direction Des Travailleuses De Sexe Dans Cinq Localites De La Cote D'ivoire : Katiola, Yamoussoukro, Soubre, Aboisso, Agboville.",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,46,1138
NGA,prevalence,lab,lab,MSM,Gombe,NA,Y015_049,2020,NA,NA,NA,NA,0.073,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1146
NGA,prevalence,lab,lab,MSM,Kaduna,NA,Y015_049,2020,NA,NA,NA,NA,0.168,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1148
CIV,prevalence,lab,lab,MSM,Abengourou,NA,Y015_999,2019,NA,NA,NA,0.073,0.113,0.152,184,"Enqueacte Bio Comportementale Du VIH Et De La Syphilis Chez Les Hommes Ayant Des Rapports Sexuels Avec D,Aoautres Hommes (HSH) Dans Les Villes De Divo, Daloa, Abengourou, Bouafleaa Et Korhogo",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,48,1150
CIV,prevalence,lab,lab,MSM,Bouafle,NA,Y015_999,2019,NA,NA,NA,0.026000000000000002,0.052000000000000005,0.08199999999999999,202,"Enqueacte Bio Comportementale Du VIH Et De La Syphilis Chez Les Hommes Ayant Des Rapports Sexuels Avec D,Aoautres Hommes (HSH) Dans Les Villes De Divo, Daloa, Abengourou, Bouafleaa Et Korhogo",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,48,1152
CIV,prevalence,lab,lab,MSM,Daloa,NA,Y015_999,2019,NA,NA,NA,0.07,0.094,0.11900000000000001,387,"Enqueacte Bio Comportementale Du VIH Et De La Syphilis Chez Les Hommes Ayant Des Rapports Sexuels Avec D,Aoautres Hommes (HSH) Dans Les Villes De Divo, Daloa, Abengourou, Bouafleaa Et Korhogo",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,48,1154
CIV,prevalence,lab,lab,MSM,Divo,NA,Y015_999,2019,NA,NA,NA,1,0.026000000000000002,0.040999999999999995,200,"Enqueacte Bio Comportementale Du VIH Et De La Syphilis Chez Les Hommes Ayant Des Rapports Sexuels Avec D,Aoautres Hommes (HSH) Dans Les Villes De Divo, Daloa, Abengourou, Bouafleaa Et Korhogo",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,48,1156
CIV,prevalence,lab,lab,MSM,Korhogo,NA,Y015_999,2019,NA,NA,NA,0.002,0.028999999999999998,0.057,292,"Enqueacte Bio Comportementale Du VIH Et De La Syphilis Chez Les Hommes Ayant Des Rapports Sexuels Avec D,Aoautres Hommes (HSH) Dans Les Villes De Divo, Daloa, Abengourou, Bouafleaa Et Korhogo",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,48,1157
CMR,prevalence,lab,lab,FSW,Bamenda,NA,NA,2016,NA,NA,NA,0.26899999999999996,0.33899999999999997,0.418,341,2016 BBS,NA,KP Atlas_5562763cad6d8ca78bfcdcc8f4690f17,KP Atlas,9b23849af90ce0977abafba0eb3d2259,Yes,yes,NA,NA,NA,53,1243
CMR,prevalence,lab,lab,MSM,Bamenda,NA,Y015_049,2016,NA,NA,NA,0.007,0.017,0.039,208,2016 BBS,NA,CDC_9c2ac57ddb0fb8d351e6773f077c71ef,CDC,cf7aa8e88046a0ab98ae7d230306c250,Yes,yes,NA,NA,NA,53,1244
CMR,prevalence,lab,lab,FSW,Bertoua,NA,NA,2016,NA,NA,NA,0.133,0.187,0.257,304,2016 BBS,NA,KP Atlas_859b3af8e6023d870295dafeafa98319,KP Atlas,3cbdeb54bd6acc8d9e50c0a490a234b7,Yes,yes,NA,NA,NA,53,1247
CMR,prevalence,lab,lab,MSM,Bertoua,NA,Y015_049,2016,NA,NA,NA,0.040999999999999995,0.07200000000000001,0.125,251,2016 BBS,NA,KP Atlas_7fcc794f985217d561f99b6aefb20073,KP Atlas,9d99bdafa550fbfa0b4ec5adf36667ad,Yes,yes,NA,NA,NA,53,1248
CMR,prevalence,lab,lab,FSW,Douala,NA,NA,2016,NA,NA,NA,0.23800000000000002,0.303,0.377,457,2016 BBS,NA,KP Atlas_80512869027a8a453a54a0f578880aa5,KP Atlas,b6fa12da09b7b4bb631b49ef4d551d98,Yes,yes,NA,NA,NA,53,1256
CMR,prevalence,lab,lab,MSM,Douala,NA,Y015_049,2016,NA,NA,NA,0.133,0.205,0.304,354,2016 BBS,NA,CDC_d8842e3e568fc988006ff6a823ac73e1,CDC,33e594424831856de2064fc650d37f92,Yes,yes,NA,NA,NA,53,1257
CMR,prevalence,lab,lab,FSW,Kribi,NA,NA,2016,NA,NA,NA,0.10400000000000001,0.136,0.17600000000000002,579,2016 BBS,NA,KP Atlas_ba54188a2141528a5f2e7310ff654936,KP Atlas,e64261469518bc6a45a0160f00efda76,Yes,yes,NA,NA,NA,53,1258
CMR,prevalence,lab,lab,MSM,Kribi,NA,Y015_049,2016,NA,NA,NA,0.013999999999999999,0.03,0.064,204,2016 BBS,NA,GF_228053a5085c524eb954dc448fd520e2,GF,7138ffe0c00f7222ae57570a6a6b8f55,Yes,yes,NA,NA,NA,53,1259
CMR,prevalence,lab,lab,FSW,Yaounde,NA,NA,2016,NA,NA,NA,0.16899999999999998,0.21100000000000002,0.259,574,2016 BBS,NA,KP Atlas_a4afa406675a140989d819db76c9614c,KP Atlas,84ddd4fe71a3b173bb589838b2c7c385,Yes,yes,NA,NA,NA,53,1260
CMR,prevalence,lab,lab,MSM,Yaounde,NA,Y015_049,2016,NA,NA,NA,0.33,0.431,0.537,306,2016 BBS,NA,CDC_9f0aba86cfedafcec5ef7a778489f20a,CDC,492e837f87a0ef2b411425b0c3655268,Yes,yes,NA,NA,NA,53,1264
COD,prevalence,lab,lab,MSM,Kinshasa,NA,NA,2011,NA,NA,NA,NA,0.318,NA,267,RAPPORT DE LíENQUETE SUR LES FACTEURS EXPLICATIFS DE LA SEROPREVALENCE ELEVEE DE LíINFECTION A VIH/SIDA CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC LES HOMMES DE KINSHASA,NA,GF_a292678904f6cb27628fe100404d87a5,GF,1214574693a615f48276ebd57c6d89c3,Yes,yes,NA,NA,NA,61,1289
COD,prevalence,lab,lab,FSW,Bukavu,NA,NA,2012,NA,NA,NA,NA,0.032,NA,595,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,CDC_c5fdf5c38989d3d6b3f8a1201cb85998,CDC,a3681c5193b5610a96e769dbfc813628,Yes,yes,NA,NA,NA,60,1291
COD,prevalence,lab,lab,FSW,Equateur,NA,NA,2012,NA,NA,NA,NA,0.027,NA,518,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,GF_284b2371e63835b248fa3709c64cdb99,GF,87298904e078054ac1b1dc6b39591de2,Yes,yes,NA,NA,NA,60,1293
CMR,prevalence,lab,lab,MSM,Douala,NA,Y015_049,2011,NA,NA,NA,0.16,0.242,0.312,255,ETUDE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC LES HOMMES AU CAMEROUN,NA,KP Atlas_45f4f4f0fd33fb6a33a2ee0f19935d73,KP Atlas,588799bf5d4bc404877e8ef897385d8f,Yes,yes,NA,NA,NA,56,1296
CMR,prevalence,lab,lab,MSM,Yaounde,NA,Y015_049,2011,NA,NA,NA,0.313,0.443,0.532,205,ETUDE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC LES HOMMES AU CAMEROUN,NA,KP Atlas_eec7041a18f7be2427c27d6a44bb2b76,KP Atlas,8c8207e669450dac1dc9090d1b3982a8,Yes,yes,NA,NA,NA,56,1297
COD,prevalence,lab,lab,FSW,Goma,NA,NA,2012,NA,NA,NA,NA,0.088,NA,667,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,KP Atlas_8c98c0e1555705b413e942c6ad18a853,KP Atlas,780caa5883ff6c01e1c5282ed67b9bfa,Yes,yes,NA,NA,NA,60,1298
COD,prevalence,lab,lab,FSW,Kananga,NA,NA,2012,NA,NA,NA,NA,0.072,NA,629,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,KP Atlas_eb61be53deec9e201254a5dfb8c72f7c,KP Atlas,b3f502934beeb3e4262ad25477af4ea4,Yes,yes,NA,NA,NA,60,1299
COD,prevalence,lab,lab,FSW,Kikwit,NA,NA,2012,NA,NA,NA,NA,0.044,NA,430,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,KP Atlas_42cf444b5fc0499cf64af0f6b0ffadea,KP Atlas,12088990caa7e8ef0df66fc9bb5ee2b4,Yes,yes,NA,NA,NA,60,1301
COD,prevalence,lab,lab,FSW,Kindu,NA,NA,2012,NA,NA,NA,NA,0.044,NA,315,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,KP Atlas_466f22ac492d3dbbea200cbcbf4603da,KP Atlas,e72222217cddb4b730f92a7a94a013ee,Yes,yes,NA,NA,NA,60,1304
COD,prevalence,lab,lab,FSW,Bas-Uele,NA,NA,2019,NA,NA,NA,0.043,0.045,0.048,450,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1316
COD,prevalence,lab,lab,FSW,Haut-Katanga,NA,NA,2019,NA,NA,NA,0.033,0.046,0.06,570,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1318
COD,prevalence,lab,lab,FSW,Kinshasa,NA,NA,2012,NA,NA,NA,NA,0.098,NA,498,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,CDC_a161fe3917b5997705beb56e43bea4f0,CDC,b164fbdf3bda24406c31d4104dfe8f6f,Yes,yes,NA,NA,NA,60,1319
COD,prevalence,lab,lab,MSM,Haut-Katanga,NA,NA,2019,NA,NA,NA,0.016,0.049,0.082,349,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1321
COD,prevalence,lab,lab,PWID,Haut-Katanga,NA,NA,2019,NA,NA,NA,0,0.002,0.024,230,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1322
COD,prevalence,lab,lab,FSW,Kisangani,NA,NA,2012,NA,NA,NA,NA,0.041,NA,535,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,GF_3efc25bb9db41597985a0af909de3c66,GF,e8d3050b87294289df539cd369ae27e5,Yes,yes,NA,NA,NA,60,1323
COD,prevalence,lab,lab,FSW,Haut-Uele,NA,NA,2019,NA,NA,NA,0.06,0.081,0.102,459,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1326
COD,prevalence,lab,lab,FSW,Ituri,NA,NA,2019,NA,NA,NA,0.058,0.068,0.077,461,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1327
COD,prevalence,lab,lab,FSW,Lubumbashi,NA,NA,2012,NA,NA,NA,NA,0.107,NA,618,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,KP Atlas_7469f2081719e0a70d6337af46a77572,KP Atlas,8e059d8647baf547fbe51950fbe7e73e,Yes,yes,NA,NA,NA,60,1328
COD,prevalence,lab,lab,MSM,Ituri,NA,NA,2019,NA,NA,NA,0.005,0.008,0.012,444,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1330
COD,prevalence,lab,lab,PWID,Ituri,NA,NA,2019,NA,NA,NA,0.016,0.017,0.019,438,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1331
COD,prevalence,lab,lab,FSW,Matadi,NA,NA,2012,NA,NA,NA,NA,0.024,NA,502,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,CDC_c16516cfc077edfd44aba78720dfdb01,CDC,84f1a86d32e328613ac184b5629bf371,Yes,yes,NA,NA,NA,60,1332
COD,prevalence,lab,lab,FSW,Kasai-Oriental,NA,NA,2019,NA,NA,NA,0.091,0.118,0.146,471,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1335
COD,prevalence,lab,lab,MSM,Kinshasa,NA,NA,2019,NA,NA,NA,0.063,0.089,0.125,842,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1341
COD,prevalence,lab,lab,PWID,Kinshasa,NA,NA,2019,NA,NA,NA,0.014,0.048,0.082,596,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1344
COD,prevalence,lab,lab,FSW,Kongo-Central,NA,NA,2019,NA,NA,NA,0.031,0.039,0.047,409,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1345
COD,prevalence,lab,lab,MSM,Kongo-Central,NA,NA,2019,NA,NA,NA,0.014,0.021,0.027,447,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1347
COD,prevalence,lab,lab,PWID,Kongo-Central,NA,NA,2019,NA,NA,NA,0.004,0.007,0.01,396,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1348
COD,prevalence,lab,lab,FSW,Kwilu,NA,NA,2019,NA,NA,NA,0.033,0.044,0.056,441,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1349
COD,prevalence,lab,lab,FSW,Lomami,NA,NA,2019,NA,NA,NA,0.071,0.082,0.093,438,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1371
COD,prevalence,lab,lab,FSW,Lualaba,NA,NA,2019,NA,NA,NA,0.041,0.074,0.108,410,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1372
COD,prevalence,lab,lab,FSW,Maniema,NA,NA,2019,NA,NA,NA,0.037,0.057,0.077,479,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1396
COD,prevalence,lab,lab,FSW,Nord-Kivu,NA,NA,2019,NA,NA,NA,0.091,0.118,0.146,471,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1397
COD,prevalence,lab,lab,FSW,Sud-Kivu,NA,NA,2019,NA,NA,NA,0.064,0.075,0.086,471,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1401
COD,prevalence,lab,lab,FSW,Tshopo,NA,NA,2019,NA,NA,NA,0.066,0.095,0.124,471,"Enquete De Surveillance Bio-Comportementale Aupres Des Populations Cles A Risque De L'infection Par Le VIH Dans 14 Provinces, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,58,1415
NGA,prevalence,lab,lab,MSM,Kano,NA,Y015_049,2020,NA,NA,NA,NA,0.10800000000000001,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1438
NGA,prevalence,lab,lab,MSM,Lagos,NA,Y015_049,2020,NA,NA,NA,NA,0.27399999999999997,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1439
NGA,prevalence,lab,lab,MSM,Nassarawa,NA,Y015_049,2020,NA,NA,NA,NA,0.22,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1440
NGA,prevalence,lab,lab,MSM,Oyo,NA,Y015_049,2020,NA,NA,NA,NA,0.371,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1441
NGA,prevalence,lab,lab,MSM,Rivers,NA,Y015_049,2020,NA,NA,NA,NA,0.358,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1442
NGA,prevalence,lab,lab,MSM,Taraba,NA,Y015_049,2020,NA,NA,NA,NA,0.263,NA,314,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1443
NGA,prevalence,lab,lab,PWID,Abia,NA,Y015_049,2020,NA,NA,NA,NA,0.040999999999999995,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1447
NGA,prevalence,lab,lab,PWID,Akwa Ibom,NA,Y015_049,2020,NA,NA,NA,NA,0.038,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1448
NGA,prevalence,lab,lab,PWID,Anambra,NA,Y015_049,2020,NA,NA,NA,NA,0.022000000000000002,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1449
NGA,prevalence,lab,lab,PWID,Benue,NA,Y015_049,2020,NA,NA,NA,NA,0.23399999999999999,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1450
NGA,prevalence,lab,lab,PWID,Gombe,NA,Y015_049,2020,NA,NA,NA,NA,0.092,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1451
NGA,prevalence,lab,lab,PWID,Kaduna,NA,Y015_049,2020,NA,NA,NA,NA,0.025,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1452
NGA,prevalence,lab,lab,PWID,Kano,NA,Y015_049,2020,NA,NA,NA,NA,0.052000000000000005,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1453
NGA,prevalence,lab,lab,PWID,Lagos,NA,Y015_049,2020,NA,NA,NA,NA,0.08199999999999999,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1454
NGA,prevalence,lab,lab,PWID,Nassarawa,NA,Y015_049,2020,NA,NA,NA,NA,0.008,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1455
NGA,prevalence,lab,lab,PWID,Oyo,NA,Y015_049,2020,NA,NA,NA,NA,0.054000000000000006,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1456
NGA,prevalence,lab,lab,PWID,Rivers,NA,Y015_049,2020,NA,NA,NA,NA,0.08,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1457
NGA,prevalence,lab,lab,PWID,Taraba,NA,Y015_049,2020,NA,NA,NA,NA,0.027000000000000003,NA,368,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1458
NGA,prevalence,lab,lab,TGW,Abia,NA,Y015_049,2020,NA,NA,NA,NA,0.155,NA,369,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1467
NGA,prevalence,lab,lab,TGW,Akwa Ibom,NA,Y015_049,2020,NA,NA,NA,NA,0.228,NA,369,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1468
NGA,prevalence,lab,lab,TGW,Anambra,NA,Y015_049,2020,NA,NA,NA,NA,0.048,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1469
NGA,prevalence,lab,lab,TGW,Benue,NA,Y015_049,2020,NA,NA,NA,NA,0.121,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1470
NGA,prevalence,lab,lab,TGW,Gombe,NA,Y015_049,2020,NA,NA,NA,NA,0.15,NA,363,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1471
NGA,prevalence,lab,lab,TGW,Kaduna,NA,Y015_049,2020,NA,NA,NA,NA,0.094,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1472
NGA,prevalence,lab,lab,TGW,Kano,NA,Y015_049,2020,NA,NA,NA,NA,0.07,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1479
NGA,prevalence,lab,lab,TGW,Lagos,NA,Y015_049,2020,NA,NA,NA,NA,0.28800000000000003,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,1480
HTI,prevalence,lab,NA,FSW,Artibonite,NA,Y015_049,2016,NA,NA,NA,NA,0.13,NA,182,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1481
HTI,prevalence,lab,NA,MSM,Artibonite,NA,Y015_049,2016,NA,NA,NA,NA,0.04,NA,238,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1482
HTI,prevalence,lab,NA,TGW,Artibonite,NA,Y015_049,2016,NA,NA,NA,NA,0.61,NA,29,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1483
HTI,prevalence,lab,NA,FSW,Grand'Anse,NA,Y015_049,2016,NA,NA,NA,NA,0.14,NA,7,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1490
HTI,prevalence,lab,NA,MSM,Grand'Anse,NA,Y015_049,2016,NA,NA,NA,NA,0.3,NA,10,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1491
HTI,prevalence,lab,NA,TGW,Grand'Anse,NA,Y015_049,2016,NA,NA,NA,NA,0.8,NA,5,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1492
HTI,prevalence,lab,NA,FSW,Nippes,NA,Y015_049,2016,NA,NA,NA,NA,0.06,NA,32,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1493
HTI,prevalence,lab,NA,MSM,Nippes,NA,Y015_049,2016,NA,NA,NA,NA,0.05,NA,21,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1494
HTI,prevalence,lab,NA,TGW,Nippes,NA,Y015_049,2016,NA,NA,NA,NA,0,NA,1,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1495
HTI,prevalence,lab,NA,FSW,Nord,NA,Y015_049,2016,NA,NA,NA,NA,0.11,NA,56,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1496
COD,prevalence,lab,lab,FSW,Mbuji-Mayi,NA,NA,2012,NA,NA,NA,NA,0.142,NA,646,ENQUETE INTEGREE DE SURVEILLANCE COMPORTEMENTALE ET DE SEROPREVALENCE en REPUBLIQUE DEMOCRATIQUE DU CONGO RAPPORT DíENQUETE,NA,CDC_c66e3aa7cb24e4727af4f6292e157233,CDC,7fe2c9b9f10e06107f03a5467f511a6f,Yes,yes,NA,NA,NA,60,1497
HTI,prevalence,lab,NA,MSM,Nord,NA,Y015_049,2016,NA,NA,NA,NA,0.04,NA,23,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1498
HTI,prevalence,lab,NA,TGW,Nord,NA,Y015_049,2016,NA,NA,NA,NA,0,NA,4,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1499
COD,prevalence,lab,lab,PWID,Centre Hospitalaire Saint Hilaire,NA,NA,2014,NA,NA,NA,NA,0.133,NA,98,Rapport Annuel 2014,NA,GF_62faf6e36e34ae076dddff5588013a3a,GF,4bbf938cd37444d24daaeff05a017c63,Yes,yes,NA,NA,0,62,1500
COD,prevalence,lab,lab,FSW,Kinshasa,NA,NA,2014,NA,NA,NA,NA,0.15,NA,421,Rapport Annuel 2014,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,62,1501
COD,prevalence,lab,lab,MSM,Kinshasa,NA,NA,2014,NA,NA,NA,NA,0.095,NA,834,Rapport Annuel 2014,NA,GF_2061ec119cefe56b4f6ac5ad352ce748,GF,b30a6fbe6000bb470d9c5a50dff01e07,Yes,yes,NA,NA,NA,62,1502
COD,prevalence,lab,lab,PWID,Kinshasa,NA,NA,2014,NA,NA,NA,NA,0.133,NA,98,Rapport Annuel 2014,NA,KP Atlas_d6314a430a63a75ebbe3448ffe51dfb4,KP Atlas,9e8ce9c2b81be9b91bd6cf6d85eed677,Yes,yes,NA,NA,NA,62,1503
COG,prevalence,lab,lab,FSW,"Brazzaville, Pointe Noire, Dolisie, Nkayi, Pokola",NA,NA,2012,NA,NA,NA,NA,0.075,NA,756,"Enquete Comportementale Couplee A La Serologie VIH Chez Les Professionnelles Du Sexe, Les Hommes Ayant Des Rapports Sexuels Avec Les Hommes Et Les Detenus En Republique Du Congo Rapport Final",NA,GF_20aa2dc6313f844e8b6a4b424161776e,GF,427f5b56e2ecaf7f70c272c3cdb92aae,Yes,yes,NA,NA,NA,66,1511
COG,prevalence,lab,lab,MSM,"Brazzaville, Pointe Noire,
Dolisie, Nkayi, Pokola",NA,NA,2012,NA,NA,NA,NA,0.261,NA,153,"Enquete Comportementale Couplee A La Serologie VIH Chez Les Professionnelles Du Sexe, Les Hommes Ayant Des Rapports Sexuels Avec Les Hommes Et Les Detenus En Republique Du Congo Rapport Final",NA,GF_b0097663d88ee3dc99695bd4dd294715,GF,b2720180efc5b509b75533790c43bec3,Yes,yes,NA,NA,NA,66,1512
ETH,prevalence,lab,lab,FSW,Adama,NA,NA,2013,NA,NA,NA,0.18,0.25,0.33,435,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,CDC_8a0b7dc987e57884d89ea858ebaa0d4d,CDC,747abf81cbc0f7b30de96825cd38137c,Yes,yes,NA,NA,NA,68,1522
ETH,prevalence,lab,lab,FSW,Addis Ababa,NA,NA,2013,NA,NA,NA,0.14,0.179,0.22,935,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_04c7d395c0e5db4584e50fe9d9585040,KP Atlas,ff7afb7717225ff7b821ef78a3c24862,Yes,yes,NA,NA,NA,68,1523
ETH,prevalence,lab,lab,FSW,Bahir Dar,NA,NA,2013,NA,NA,NA,0.25,0.32,0.39,488,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,CDC_e4eeb5fa7911693c559f4c43761a13d4,CDC,07937c3a056cc75d7f4c8939251a60b2,Yes,yes,NA,NA,NA,68,1526
ETH,prevalence,lab,lab,FSW,Dire Dawa Town,NA,NA,2013,NA,NA,NA,0.21,0.278,0.37,429,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_3bf7fa9b6d0c17508b19dc66f51e7c80,KP Atlas,678796ef28346d4dc354b2498e08e7f2,Yes,yes,NA,NA,NA,68,1527
ETH,prevalence,lab,lab,FSW,Gambela,NA,NA,2013,NA,NA,NA,0.18,0.26,0.34,327,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,GF_08f71b8f664afc0c02c2e2ee3f183838,GF,54237fe23bebdb0c1c6dd026e017bfe2,Yes,yes,NA,NA,NA,68,1528
ETH,prevalence,lab,lab,FSW,Hawasa,NA,NA,2013,NA,NA,NA,0.09,0.139,0.19,439,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_552ba50ff1e93b5617b1d0a32608a2ee,KP Atlas,e72733b9b7c2291653ef09ec353b8881,Yes,yes,NA,NA,NA,68,1531
ETH,prevalence,lab,lab,FSW,Kombolcha,NA,NA,2013,NA,NA,NA,0.22,0.287,0.25,353,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_7371d3fcd8ecdf26eb04ec6fb70a22fd,KP Atlas,24462eb07d022ebba4a1440e8deb35a5,Yes,yes,NA,NA,NA,68,1532
ETH,prevalence,lab,lab,FSW,Logia,NA,NA,2013,NA,NA,NA,0.16,0.258,0.37,179,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_7bd35b8451fa3ea185f85692aaf85ee2,KP Atlas,2bf17dc2ba7355c432558f76e487522b,Yes,yes,NA,NA,NA,68,1534
ETH,prevalence,lab,lab,FSW,Mekele,NA,NA,2013,NA,NA,NA,0.26,0.32,0.38,403,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,CDC_231e49370cdbf7c557fd49f52cac6fc2,CDC,2d21c08c93fa23eebb5c1d5a5e879f0e,Yes,yes,NA,NA,NA,68,1535
ETH,prevalence,lab,lab,FSW,Metema,NA,NA,2013,NA,NA,NA,0.12,0.17,0.22,NA,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,CDC_07cbf1eb4e07f4f3a877adae373fc3a1,CDC,07d3bb434fa7e8d680028922da72c9b1,Yes,yes,NA,NA,NA,68,1538
ETH,prevalence,lab,lab,FSW,Shashemene Town,NA,NA,2013,NA,NA,NA,0.12,0.157,0.2,494,"Ethiopian National Key Population HIV Bio-behavioral Surveillance Round I, 2013 Report",NA,KP Atlas_bd2e4194b2997ebb2e4891b7a8e28c23,KP Atlas,542424686f715f265c01a4a2b80523f6,Yes,yes,NA,NA,NA,68,1539
ETH,prevalence,lab,lab,FSW,Adama,NA,NA,2020,NA,NA,NA,NA,0.161,NA,676,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1544
ETH,prevalence,lab,lab,FSW,Addis Ababa,NA,NA,2020,NA,NA,NA,NA,0.154,NA,1101,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1545
ETH,prevalence,lab,lab,FSW,Arba Minch,NA,NA,2020,NA,NA,NA,NA,0.183,NA,251,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1546
ETH,prevalence,lab,lab,FSW,Bahir Dar,NA,NA,2020,NA,NA,NA,NA,0.282,NA,372,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1547
ETH,prevalence,lab,lab,FSW,Dilla,NA,NA,2020,NA,NA,NA,NA,0.16699999999999998,NA,251,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1548
ETH,prevalence,lab,lab,FSW,Dire Dawa Town,NA,NA,2020,NA,NA,NA,NA,0.237,NA,434,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1549
ETH,prevalence,lab,lab,FSW,Gambella,NA,NA,2020,NA,NA,NA,NA,0.21600000000000003,NA,468,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1550
ETH,prevalence,lab,lab,FSW,Gonder,NA,NA,2020,NA,NA,NA,NA,0.2,NA,250,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1551
ETH,prevalence,lab,lab,FSW,Harar,NA,NA,2020,NA,NA,NA,NA,0.231,NA,242,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1552
ETH,prevalence,lab,lab,FSW,Hawassa,NA,NA,2020,NA,NA,NA,NA,0.14400000000000002,NA,522,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1553
ETH,prevalence,lab,lab,FSW,Jimma,NA,NA,2020,NA,NA,NA,NA,0.248,NA,254,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1554
ETH,prevalence,lab,lab,FSW,Kombolcha/Dese,NA,NA,2020,NA,NA,NA,NA,0.203,NA,251,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1555
ETH,prevalence,lab,lab,FSW,Logia/Semera,NA,NA,2020,NA,NA,NA,NA,0.175,NA,251,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1556
ETH,prevalence,lab,lab,FSW,Mizan,NA,NA,2020,NA,NA,NA,NA,0.153,NA,255,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1557
ETH,prevalence,lab,lab,FSW,Nekemte,NA,NA,2020,NA,NA,NA,NA,0.198,NA,257,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1558
ETH,prevalence,lab,lab,FSW,Shashemene Town,NA,NA,2020,NA,NA,NA,NA,0.14,NA,250,"SIZE ESTIMATION, HIV and other stis prevalence among Female sex workers in Ethiopia: National HIV and other STIs Bio-Behavioral Survey (NHSBS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,69,1559
ETH,prevalence,lab,lab,PWID,Addis Ababa,NA,NA,2015,NA,NA,NA,NA,0.06,NA,237,Demissie et al,https://pubmed.ncbi.nlm.nih.gov/30319040/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,70,1572
GHA,prevalence,lab,lab,MSM,Accra/Tema,NA,NA,2011,NA,NA,NA,0.278,0.343,0.411,456,2011 Men's Study,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,72,1574
GHA,prevalence,lab,lab,MSM,Cape Coast/Takoradi,NA,NA,2011,NA,NA,NA,0.018,0.047,0.075,398,2011 Men's Study,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,72,1575
GHA,prevalence,lab,lab,MSM,Koforidua,NA,NA,2011,NA,NA,NA,0.042,0.113,0.17,146,2011 Men's Study,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,72,1576
GHA,prevalence,lab,lab,MSM,Kumasi,NA,NA,2011,NA,NA,NA,0.07,0.136,0.205,302,2011 Men's Study,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,72,1577
GHA,prevalence,lab,lab,MSM,"Bono, Bono East, Ahafo",NA,NA,2017,NA,NA,NA,0.026,0.04,0.062,504,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1579
GHA,prevalence,lab,lab,MSM,Central,NA,NA,2017,NA,NA,NA,0.075,0.1,0.135,503,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1580
GHA,prevalence,lab,lab,MSM,Eastern,NA,NA,2017,NA,NA,NA,0.065,0.09,0.122,501,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1581
GHA,prevalence,lab,lab,MSM,Greater Accra,NA,NA,2017,NA,NA,NA,0.372,0.424,0.477,546,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1582
GHA,prevalence,lab,lab,MSM,Northern,NA,NA,2017,NA,NA,NA,0.026,0.043,0.069,510,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1583
GHA,prevalence,lab,lab,MSM,Volta,NA,NA,2017,NA,NA,NA,0.107,0.14,0.18,505,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1584
GHA,prevalence,lab,lab,MSM,Western,NA,NA,2017,NA,NA,NA,0.078,0.1,0.137,515,2017 Ghana Men's study,https://www.ghanaids.gov.gh/mcadmin/Uploads/Ghana%20Men%27s%20Study%20Report(2).pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1585
GHA,prevalence,lab,lab,TGW,Ghana,NA,NA,2017,NA,NA,NA,NA,0.281,NA,31,2017 Ghana Men's study,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,74,1586
GHA,prevalence,lab,lab,FSW,Ahafo,NA,NA,2019,NA,NA,NA,NA,0.025,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1645
GHA,prevalence,lab,lab,FSW,Ashanti,NA,NA,2019,NA,NA,NA,NA,0.039,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1646
GHA,prevalence,lab,lab,FSW,Bono,NA,NA,2019,NA,NA,NA,NA,0.035,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1647
GHA,prevalence,lab,lab,FSW,Bono East,NA,NA,2019,NA,NA,NA,NA,0.066,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1648
GHA,prevalence,lab,lab,FSW,Central,NA,NA,2019,NA,NA,NA,NA,0.025,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1649
GHA,prevalence,lab,lab,FSW,Eastern,NA,NA,2019,NA,NA,NA,NA,0.044,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1650
GHA,prevalence,lab,lab,FSW,Greater Accra,NA,NA,2019,NA,NA,NA,NA,0.055,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1651
GHA,prevalence,lab,lab,FSW,North East,NA,NA,2019,NA,NA,NA,NA,0,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1652
GHA,prevalence,lab,lab,FSW,Northern,NA,NA,2019,NA,NA,NA,NA,0.025,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1653
GHA,prevalence,lab,lab,FSW,Oti,NA,NA,2019,NA,NA,NA,NA,0.014,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1654
GHA,prevalence,lab,lab,FSW,Savannah,NA,NA,2019,NA,NA,NA,NA,0.037,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1655
GHA,prevalence,lab,lab,FSW,Upper East,NA,NA,2019,NA,NA,NA,NA,0.078,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1656
GHA,prevalence,lab,lab,FSW,Upper West,NA,NA,2019,NA,NA,NA,NA,0.077,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1657
GHA,prevalence,lab,lab,FSW,Volta,NA,NA,2019,NA,NA,NA,NA,0.043,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1658
GHA,prevalence,lab,lab,FSW,Western,NA,NA,2019,NA,NA,NA,NA,0.064,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1659
GHA,prevalence,lab,lab,FSW,Western North,NA,NA,2019,NA,NA,NA,NA,0.06,NA,389,2019 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,76,1663
GHA,prevalence,lab,lab,FSW,Ashanti,NA,NA,2015,NA,NA,NA,NA,0.09,NA,463,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1679
GHA,prevalence,lab,lab,FSW,"Bono, Bono East, Ahafo",NA,NA,2015,NA,NA,NA,NA,0.062,NA,404,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1680
GHA,prevalence,lab,lab,FSW,Central,NA,NA,2015,NA,NA,NA,NA,0.08,NA,414,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1681
GHA,prevalence,lab,lab,FSW,Eastern,NA,NA,2015,NA,NA,NA,NA,0.077,NA,788,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1682
GHA,prevalence,lab,lab,FSW,Greater Accra,NA,NA,2015,NA,NA,NA,NA,0.09,NA,327,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1683
GHA,prevalence,lab,lab,FSW,Nothern,NA,NA,2015,NA,NA,NA,NA,0.083,NA,207,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1691
GHA,prevalence,lab,lab,FSW,Upper East,NA,NA,2015,NA,NA,NA,NA,0.029,NA,358,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1692
GHA,prevalence,lab,lab,FSW,Upper West,NA,NA,2015,NA,NA,NA,NA,0.059,NA,150,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1693
GHA,prevalence,lab,lab,FSW,Volta,NA,NA,2015,NA,NA,NA,NA,0.051,NA,375,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1694
GHA,prevalence,lab,lab,FSW,Western,NA,NA,2015,NA,NA,NA,NA,0.053,NA,400,2015 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,79,1695
GHA,prevalence,lab,lab,PWID,Kumasi,NA,NA,2018,NA,NA,NA,NA,0.06,NA,221,Messersmith et al,https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00510-7,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,82,1703
GHA,prevalence,lab,lab,PWID,Ashanti,NA,NA,2021,NA,NA,NA,NA,0.041,NA,80,RAPID ASSESSMENT OF PEOPLE WHO USE DRUGS (PWUD) AND PEOPLE WHO INJECT DRUGS (PWID) IN GHANA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,83,1704
GHA,prevalence,lab,lab,PWID,Greater Accra,NA,NA,2021,NA,NA,NA,NA,0.022,NA,142,RAPID ASSESSMENT OF PEOPLE WHO USE DRUGS (PWUD) AND PEOPLE WHO INJECT DRUGS (PWID) IN GHANA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,83,1705
GHA,prevalence,lab,lab,PWID,Northern,NA,NA,2021,NA,NA,NA,NA,0,NA,21,RAPID ASSESSMENT OF PEOPLE WHO USE DRUGS (PWUD) AND PEOPLE WHO INJECT DRUGS (PWID) IN GHANA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,83,1706
GHA,prevalence,lab,lab,PWID,Western,NA,NA,2021,NA,NA,NA,NA,0.021,NA,99,RAPID ASSESSMENT OF PEOPLE WHO USE DRUGS (PWUD) AND PEOPLE WHO INJECT DRUGS (PWID) IN GHANA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,83,1707
GIN,prevalence,lab,lab,FSW,Boke,NA,NA,2017,NA,NA,NA,0.101,0.16,0.227,119,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_ced5c12b822bdbf80afcc7ef51cb062d,GF,a0611157b158074048f60a834818a670,Yes,yes,NA,NA,NA,84,1708
GIN,prevalence,lab,lab,FSW,Conakry,NA,NA,2017,NA,NA,NA,0.086,0.113,0.139,532,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_e431db4df546c426aee0590364bf21bb,GF,4d986d706f87747e57c98a69fb8dc23c,Yes,yes,NA,NA,NA,84,1709
GIN,prevalence,lab,lab,FSW,Faranah,NA,NA,2017,NA,NA,NA,NA,0,NA,26,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_1de51ac418409e5498f2d992f0e4c82d,GF,3953e526ba64ea95b1749f561ac33e4b,Yes,yes,NA,NA,NA,84,1710
GIN,prevalence,lab,lab,FSW,Kankan,NA,NA,2017,NA,NA,NA,0.022,0.058,0.101,139,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_31e7088be848be8716c5a4e045fe480f,GF,e50885bb81a795e193606612b101bda6,Yes,yes,NA,NA,NA,84,1713
GIN,prevalence,lab,lab,FSW,Kindia,NA,NA,2017,NA,NA,NA,0.045,0.091,0.144,132,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_664f381306d4e6d53d020217b874c327,GF,5d100d9bb7dd07a706051b38965a5783,Yes,yes,NA,NA,NA,84,1714
GIN,prevalence,lab,lab,FSW,Labe,NA,NA,2017,NA,NA,NA,0.135,0.27,0.432,37,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_e4dd3efa2ba0b7776d41e25c34f49504,GF,d50cdbbdf1716eeb6044730faa07c50e,Yes,yes,NA,NA,NA,84,1715
GIN,prevalence,lab,lab,FSW,Mamou,NA,NA,2017,NA,NA,NA,0,0.133,0.333,15,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_8b292edff29e5e4d09ccfcf4a6a76fa9,GF,dc3cf4fe5b3680ba6ee910e24eafa640,Yes,yes,NA,NA,NA,84,1716
GIN,prevalence,lab,lab,FSW,nzerekore,NA,NA,2017,NA,NA,NA,NA,0,NA,36,"ETUDE DE SURVEILLANCE COMPORTEMENTALE ET BIOLOGIQUE (ESCOMB) SUR LES IST, LE VIH/SIDA ET LA SYPHILIS AUPRES DES POPULATIONS CLES ET GROUPES VULNERABLES",NA,GF_d3c12f355034534dca894644daaad00f,GF,b4a87da4c433fbb764714b1a59ae7ebd,Yes,yes,NA,NA,NA,84,1717
GIN,prevalence,lab,lab,MSM,Boke,NA,NA,2017,NA,NA,NA,NA,0.121,NA,33,Etude de Surveillance Comportementale et Biologique sur le VIH auprËs des Hommes ayant des relations Sexuelles avec des Hommes (HSH) EN GUINEE. (ESCOMB),NA,GF_295d2b882b02f9b651cb1c6be1ddbd54,GF,1d039afeb1761fabe59df6dfdc5f561e,Yes,yes,NA,NA,NA,90,1741
GIN,prevalence,lab,lab,MSM,Conakry,NA,NA,2017,NA,NA,NA,NA,0.09,NA,199,Etude de Surveillance Comportementale et Biologique sur le VIH auprËs des Hommes ayant des relations Sexuelles avec des Hommes (HSH) EN GUINEE. (ESCOMB),NA,GF_3230e9d917a5e37a9b2d7ec6dbc61a91,GF,45cfb66a52e04658c0492bebf4c1f07f,Yes,yes,NA,NA,NA,90,1742
GIN,prevalence,lab,lab,MSM,Kankan,NA,NA,2017,NA,NA,NA,NA,0.146,NA,48,Etude de Surveillance Comportementale et Biologique sur le VIH auprËs des Hommes ayant des relations Sexuelles avec des Hommes (HSH) EN GUINEE. (ESCOMB),NA,GF_f32cbafabef60b4ce3a51d3e50b3134e,GF,f0d38a20c5a31430244e347f354710a3,Yes,yes,NA,NA,NA,90,1744
GIN,prevalence,lab,lab,MSM,Labe,NA,NA,2017,NA,NA,NA,NA,0.083,NA,36,Etude de Surveillance Comportementale et Biologique sur le VIH auprËs des Hommes ayant des relations Sexuelles avec des Hommes (HSH) EN GUINEE. (ESCOMB),NA,GF_d00fdf141614f6445e6ecb841f8d3983,GF,563cb6f6cc98259fbd999f165c12f8d5,Yes,yes,NA,NA,NA,90,1748
GIN,prevalence,lab,lab,MSM,nzerekore,NA,NA,2017,NA,NA,NA,NA,0.171,NA,70,Etude de Surveillance Comportementale et Biologique sur le VIH auprËs des Hommes ayant des relations Sexuelles avec des Hommes (HSH) EN GUINEE. (ESCOMB),NA,GF_c8027e4d287fa28a09abbdb20b49fa51,GF,1161f5765b299fd49f2e6447c3b7779d,Yes,yes,NA,NA,NA,90,1749
GMB,prevalence,lab,lab,FSW,"Banjul City, Kanifing Municipal, Barra, Farafenni, and Soma",NA,NA,2011,NA,NA,NA,NA,0.159,NA,251,Peitzmeier et al,NA,GF_b6627a93fd85fd8e3ee333d023030e1e,GF,af70c2c55254653cc055ce015e532278,Yes,yes,NA,NA,NA,92,1750
GMB,prevalence,lab,lab,MSM,"Banjul City, Kanifing Municipal",NA,NA,2011,NA,NA,NA,NA,0.098,NA,205,Mason et al,NA,GF_1ce5c67e15d05b5e13f2d8b39cdbc224,GF,806b3f595232c11c16d838ab9fe5f586,Yes,yes,NA,NA,NA,93,1751
GMB,prevalence,lab,lab,FSW,"Banjul City, Kanifing Municipal",NA,NA,2017,NA,NA,NA,NA,0.11,NA,354,BBS 2017,NA,KP Atlas_09a908281a183d994e52783eb1e257a6,KP Atlas,2223c32a5f8c1d67ff51ce59f49379bf,Yes,yes,NA,NA,NA,94,1752
GMB,prevalence,lab,lab,MSM,"Banjul City, Kanifing Municipal",NA,NA,2017,NA,NA,NA,NA,0.355,NA,151,BBS 2017,NA,KP Atlas_38380716148e0f6b36e174778abde099,KP Atlas,7bd26a06b48130cdf693b35dc68df18a,Yes,yes,NA,NA,NA,94,1753
GNB,prevalence,lab,lab,MSM,Bissau,NA,NA,2010,NA,NA,NA,NA,0.25,NA,11,ESTUDO EXPLORAT”RIO DE HOMENS QUE FAZEM SEXO COM HOMENS NA GUINE-BISSAU,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,97,1754
GNB,prevalence,lab,lab,FSW,Bissau,NA,NA,2017,NA,NA,NA,NA,0.194,NA,360,2017 IBBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,98,1755
GNB,prevalence,lab,lab,FSW,Gabu,NA,NA,2017,NA,NA,NA,NA,0.34,NA,50,2018 IBBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,98,1756
GNB,prevalence,lab,lab,MSM,Guinea-Bissau,NA,Y015_049,2017,NA,NA,NA,NA,0.03,NA,367,Estudo Biolo_gico e Sócio Comportamental e estimativa do tamanho nas populações mais expostas ao risco de infeção pelo VIH na República da Guine-Bissau,NA,KP Atlas_dee3230887b30e21b4752bfe343490ac,KP Atlas,b5931bd213d592284614757517e50d43,Yes,yes,NA,NA,NA,98,1757
KEN,prevalence,lab,lab,MSM,Kisumu,NA,Y015_049,2010,NA,NA,NA,0.075,0.111,0.159,415,"2010ñ2011 Integrated Biological and Behavioural Surveillance Survey among Key Populations in Nairobi and Kisumu, Kenya",NA,KP Atlas_a8fb98eeff61187d559949fdce8fd636,KP Atlas,a528b42f54f09a79851d074d9d9f1769,Yes,yes,NA,NA,NA,101,1760
HTI,prevalence,lab,NA,FSW,Nord-Est,NA,Y015_049,2016,NA,NA,NA,NA,0.11,NA,44,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1761
HTI,prevalence,lab,NA,MSM,Nord-Est,NA,Y015_049,2016,NA,NA,NA,NA,0,NA,49,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1762
KEN,prevalence,lab,lab,FSW,Nairobi,NA,NA,2011,NA,NA,NA,0.24600000000000002,0.293,0.349,563,"2010ñ2011 Integrated Biological and Behavioural Surveillance Survey among Key Populations in Nairobi and Kisumu, Kenya",NA,CDC_faec1153ebff13545787ecb8653ca541,CDC,d21592fccdf8e73b5dac6c93ef356632,Yes,yes,NA,NA,NA,101,1763
KEN,prevalence,lab,lab,PWID,Nairobi City,NA,NA,2011,NA,NA,NA,0.123,0.187,0.267,263,"2010ñ2011 Integrated Biological and Behavioural Surveillance Survey among Key Populations in Nairobi and Kisumu, Kenya",NA,KP Atlas_434368096565179679da67392cbc3d2a,KP Atlas,1b70e9a818373a2c2ac8d09a658ccf15,Yes,yes,NA,NA,NA,101,1765
KEN,prevalence,lab,lab,PWID,Malindi,NA,NA,2013,NA,NA,NA,NA,0.855,NA,186,Mwatelah et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,103,1767
KEN,prevalence,lab,lab,PWID,Mombasa,NA,NA,2013,NA,NA,NA,NA,0.423,NA,371,Webale | Degenhardt et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,104,1768
KEN,prevalence,lab,lab,PWID,Malindi,NA,NA,2010,NA,NA,NA,NA,0.22690000000000002,NA,154,Singh et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,105,1769
KEN,prevalence,lab,lab,MSM,Nairobi,NA,Y015_049,2010,NA,NA,NA,0.131,0.182,0.236,563,"2010–2011 Integrated Biological and Behavioural Surveillance Survey among Key Populations in Nairobi and Kisumu, Kenya",NA,KP Atlas_7441970de5ca598feb6bedba59f92d9e,KP Atlas,d28599107d419df5decc152692e16b77,Yes,yes,NA,NA,NA,101,1771
LBR,prevalence,lab,lab,FSW,Grand Bassa,NA,NA,2013,NA,NA,NA,NA,0,NA,33,364. LBR 2013 BBS FSW MSM PWID,NA,GF_fc7658c5fb79f2f1fe154caf3cad9a04,GF,79c32f27d557638a18db6eac3ce172c4,Yes,yes,NA,NA,NA,364,1786
LBR,prevalence,lab,lab,MSM,Grand Bassa,NA,NA,2013,NA,NA,NA,NA,1,NA,1,364. LBR 2013 BBS FsW MSM PWID,NA,GF_79b3d9023fdc76b9b22c86e3b80a0fd5,GF,94d1d53329580010d4690d2539eabda7,Yes,yes,NA,NA,NA,364,1787
LBR,prevalence,lab,lab,PWID,Grand Bassa,NA,NA,2013,NA,NA,NA,NA,0.018,NA,55,364. LBR 2013 BBS FSW MSM PWID,NA,GF_1c1057efd96f006e5c4701d7000108c3,GF,5e4c71678480f5d2d156e5bf08ef7090,Yes,yes,NA,NA,NA,364,1788
LBR,prevalence,lab,lab,FSW,Grand Gedeh,NA,NA,2013,NA,NA,NA,NA,0.034,NA,29,364. LBR 2013 BBS FSW MSM PWID,NA,GF_0253a5748884d7a9c8fdd787cc85cae5,GF,877869866aa89be8db0556bbacb08f94,Yes,yes,NA,NA,NA,364,1789
LBR,prevalence,lab,lab,MSM,Grand Gedeh,NA,NA,2013,NA,NA,NA,NA,0,NA,6,364. LBR 2013 BBS FsW MSM PWID,NA,GF_c69aa18f0413f495bd0970f57a5f6829,GF,1f21216f4238932a304ab2c18e2da550,Yes,yes,NA,NA,NA,364,1790
LBR,prevalence,lab,lab,PWID,Grand Gedeh,NA,NA,2013,NA,NA,NA,NA,0,NA,4,364. LBR 2013 BBS FSW MSM PWID,NA,GF_9e2270214b698eebc039bb37f4c29288,GF,359a835fdded9034a856579cb16a52bc,Yes,yes,NA,NA,NA,364,1791
LBR,prevalence,lab,lab,FSW,Margibi,NA,NA,2013,NA,NA,NA,NA,0.114,NA,35,364. LBR 2013 BBS FSW MSM PWID,NA,GF_e2e7171e93ca532b0839114e0ee2cb44,GF,00b96b9e76e8858990cc5525953a0411,Yes,yes,NA,NA,NA,364,1795
LBR,prevalence,lab,lab,MSM,Margibi,NA,NA,2013,NA,NA,NA,NA,0.033,NA,30,364. LBR 2013 BBS FsW MSM PWID,NA,GF_7c980ea8b1ca15970f6f8a8982269a8a,GF,1a391342569b7fdff003f8e6fd2f9593,Yes,yes,NA,NA,NA,364,1796
LBR,prevalence,lab,lab,FSW,Montserrado,NA,NA,2013,NA,NA,NA,NA,0.126,NA,207,364. LBR 2013 BBS FSW MSM PWID,NA,GF_113019b2c72c0af0bf876e15b6701569,GF,08f478f93f5f90c62adebb115720b287,Yes,yes,NA,NA,NA,364,1797
LBR,prevalence,lab,lab,MSM,Montserrado,NA,NA,2013,NA,NA,NA,NA,0.222,NA,167,364. LBR 2013 BBS FsW MSM PWID,NA,GF_4e9b5ef4a3b6f1fde7616e8348e9967f,GF,62fca4698cb31816d8a86fa71e38d56c,Yes,yes,NA,NA,NA,364,1798
LBR,prevalence,lab,lab,PWID,Montserrado,NA,NA,2013,NA,NA,NA,NA,0.034,NA,88,364. LBR 2013 BBS FSW MSM PWID,NA,GF_4c92c762045f68c320f0cbe4a0108c76,GF,b714da27e94cb254ca28fbad76b9bb7b,Yes,yes,NA,NA,NA,364,1799
LBR,prevalence,lab,lab,FSW,Nimba,NA,NA,2013,NA,NA,NA,NA,0.071,NA,42,364. LBR 2013 BBS FSW MSM PWID,NA,GF_11d3a18290a35e5bb13491a2ffc9acb8,GF,dea372f4daa4fd4ff004cd82470a50ea,Yes,yes,NA,NA,NA,364,1800
LBR,prevalence,lab,lab,MSM,Nimba,NA,NA,2013,NA,NA,NA,NA,0.667,NA,3,364. LBR 2013 BBS FsW MSM PWID,NA,GF_e7500afdff78f46635328ad0a6ba5089,GF,a4cb8da657e96b00f274912d4631603a,Yes,yes,NA,NA,NA,364,1801
LBR,prevalence,lab,lab,PWID,Nimba,NA,NA,2013,NA,NA,NA,NA,0.25,NA,8,364. LBR 2013 BBS FSW MSM PWID,NA,GF_ca96fad66dcb0e54874cffefa3e78622,GF,af4bbdfa4f2894f37fb2c14450c93937,Yes,yes,NA,NA,NA,364,1802
MLI,prevalence,lab,lab,MSM,Bamako,NA,NA,2015,NA,NA,NA,NA,0.137,NA,550,"…tude bio-comportementale sur les hommes qui ont des rapports sexuels avec des hommes ‡ Bamako Mali, 2014-15",NA,KP Atlas_2937513d82cff9d53803874626bd8bd7,KP Atlas,c046e995ce4e5a2111cead57d2676e03,Yes,yes,NA,NA,NA,128,1818
KEN,prevalence,lab,lab,MSM,Nairobi,NA,NA,2017,NA,NA,NA,NA,0.289272031,NA,522,Smith et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,108,1825
KEN,prevalence,lab,lab,TGW,Nairobi,NA,NA,2017,NA,NA,NA,NA,0.4,NA,70,Smith et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,108,1826
HTI,prevalence,lab,NA,TGW,Nord-Est,NA,Y015_049,2016,NA,NA,NA,NA,0.17,NA,13,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1832
ZAF,prevalence,lab,lab,TGW,Cape Town,NA,NA,2016,NA,NA,NA,NA,0.433,NA,30,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,1852
KEN,prevalence,lab,lab,TGW,Kisumu,NA,NA,2016,NA,NA,NA,NA,0.25,NA,32,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,1855
KEN,prevalence,lab,lab,MSM,Kisumu,NA,NA,2016,NA,NA,NA,NA,0.146,NA,137,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,1857
MWI,prevalence,lab,lab,TGW,Blantyre,NA,NA,2016,NA,NA,NA,NA,0.316,NA,38,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,1858
ZAF,prevalence,lab,lab,FSW,N3 highway corridor,NA,NA,2014,NA,NA,NA,NA,0.884,NA,173,FSW truckers survey,https://www.researchgate.net/profile/Mike-Grasso/publication/291505854_Preliminary_Findings_from_the_KPN3_Study_Key_Populations_Along_the_N3_Highway_South_Africa/links/56a3661708ae1b6511305ac8/Preliminary-Findings-from-the-KPN3-Study-Key-Populations-Along-the-N3-Highway-South-Africa.pdf,CDC_b557ebb9656e7c9f36cca18edef31816,CDC,c8d6a847e16ef1054b8639643d46caf0,Yes,yes,NA,NA,NA,251,1861
KEN,prevalence,lab,lab,PWID,Coast,NA,NA,2012,NA,NA,NA,0.17300000000000001,0.205,0.23600000000000002,1122,Kurth | Degenhardt et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,114,1864
KEN,prevalence,lab,lab,PWID,Nairobi,NA,NA,2012,NA,NA,NA,0.10800000000000001,0.145,0.182,663,Kurth | Degenhardt et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,114,1865
KEN,prevalence,lab,lab,MSM,Kisumu,NA,NA,2016,NA,NA,NA,NA,0.105,NA,711,Kunzweiler et al,https://www.tandfonline.com/doi/full/10.1080/09540121.2018.1510109,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,115,1866
KEN,prevalence,lab,lab,MSM,Nairobi,NA,NA,2017,NA,NA,NA,NA,0.3,NA,608,TRANSFORM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527758/#jia225603-sup-0001,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,116,1867
KEN,prevalence,lab,lab,MSM,Kenya,NA,NA,2019,NA,NA,NA,0.146,0.168,0.189,1200,Bhattacharjee et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319161/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,117,1868
KEN,prevalence,lab,lab,MSM,Nairobi,NA,NA,2021,NA,NA,NA,NA,0.425,NA,80,Gebrebrhan et al.,https://journals.lww.com/aidsonline/Fulltext/2021/06010/Rectal_microbiota_diversity_in_Kenyan_MSM_is.10.aspx,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,118,1869
KEN,prevalence,lab,lab,MSM,"Malindi, Mtwapa",NA,NA,2019,NA,NA,NA,NA,0.124,NA,452,Dijkstra,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186249/#sup1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,120,1870
KEN,prevalence,lab,lab,PWID,Kilifi,NA,NA,2018,NA,NA,NA,NA,0.184931507,NA,292,Oguya et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,122,1871
KEN,prevalence,lab,lab,PWID,Kisauni,NA,NA,2018,NA,NA,NA,NA,0.197530864,NA,81,Oguya et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,122,1873
KEN,prevalence,lab,lab,PWID,Malindi,NA,NA,2018,NA,NA,NA,NA,0.21875,NA,96,Oguya et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,122,1874
KEN,prevalence,lab,lab,PWID,Mombasa,NA,NA,2018,NA,NA,NA,NA,0.188235294,NA,85,Oguya et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,122,1875
KEN,prevalence,lab,lab,PWID,Nairobi,NA,NA,2018,NA,NA,NA,NA,0.201166181,NA,343,Oguya et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,122,1877
LSO,prevalence,lab,lab,FSW,Butha-Buthe,NA,NA,2019,NA,NA,NA,0.33299999999999996,0.392,0.45299999999999996,406,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1899
LSO,prevalence,lab,lab,MSM,Butha-Buthe,NA,NA,2019,NA,NA,NA,NA,0.242,NA,117,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1900
LSO,prevalence,lab,lab,FSW,Leribe,NA,NA,2019,NA,NA,NA,0.506,0.569,0.63,461,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1901
LSO,prevalence,lab,lab,MSM,Leribe,NA,NA,2019,NA,NA,NA,NA,0.355,NA,88,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1902
LSO,prevalence,lab,lab,FSW,Mafeteng,NA,NA,2019,NA,NA,NA,0.384,0.425,0.519,327,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1903
LSO,prevalence,lab,lab,MSM,Mafeteng,NA,NA,2019,NA,NA,NA,NA,0.07400000000000001,NA,300,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1904
LSO,prevalence,lab,lab,FSW,Maseru,NA,NA,2019,NA,NA,NA,0.41600000000000004,0.47600000000000003,0.546,461,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1905
LSO,prevalence,lab,lab,MSM,Maseru,NA,NA,2019,NA,NA,NA,NA,0.313,NA,323,IBBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,125,1907
LSO,prevalence,lab,lab,FSW,Maputsoe,NA,NA,2014,NA,NA,NA,NA,0.704,NA,334,"Characterizing HIV Prevention, Treatment and Care needs Among†Men who have Sex with Men and Female Sex Workers in Lesotho",NA,GF_f70d891ebdffd86185f8d9d44ff386ad,GF,e1d4ca78086b95fe24e38be372943e5b,Yes,private,NA,NA,NA,127,1909
LSO,prevalence,lab,lab,MSM,Maputsoe,NA,Y015_049,2014,NA,NA,NA,NA,0.354,NA,211,"Characterizing HIV Prevention, Treatment and Care needs Among†Men who have Sex with Men and Female Sex Workers in Lesotho",NA,KP Atlas_2d4991e2c557a5934c78205dd1b37de9,KP Atlas,db74e559416c7ff25b1d76c9e64a8225,Yes,private,NA,NA,NA,127,1910
LSO,prevalence,lab,lab,MSM,Maseru,NA,NA,2014,NA,NA,NA,NA,0.311,NA,318,"Characterizing HIV Prevention, Treatment and Care needs Among†Men who have Sex with Men and Female Sex Workers in Lesotho",NA,GF_ca922cb47fef897ca5a6952b74d85a27,GF,5655640fddbbf008b3e8d324d1cefa11,Yes,yes,NA,NA,NA,127,1911
LSO,prevalence,lab,lab,FSW,Maseru,NA,NA,2014,NA,NA,NA,NA,0.731,NA,410,"HIV-related Risk Behaviors and Prevalence among Two Key PopulationsóFemale Sex Workers (FSW) and Men who have Sex with Men (MSM)óin Maseru, Lesotho",NA,GF_d62c1254cc0ae684bafcee0b90df57a4,GF,f639987efc2931130bfaba4c6a421d42,Yes,yes,NA,NA,NA,127,1912
LSO,prevalence,lab,lab,MSM,Maseru,NA,NA,2014,NA,NA,NA,NA,0.317,NA,315,"HIV-related Risk Behaviors and Prevalence among Two Key PopulationsóFemale Sex Workers (FSW) and Men who have Sex with Men (MSM)óin Maseru, Lesotho",NA,GF_c3c669b803dd072fa34d25dd2e8aca3d,GF,bbaa7846ca12c0a2400874d52a8913e2,Yes,yes,NA,NA,NA,127,1913
HTI,prevalence,lab,NA,FSW,Nord-Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.02,NA,62,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1914
HTI,prevalence,lab,NA,MSM,Nord-Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.04,NA,25,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1915
HTI,prevalence,lab,NA,TGW,Nord-Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.8,NA,5,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1916
HTI,prevalence,lab,NA,FSW,Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.09,NA,529,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1918
HTI,prevalence,lab,NA,MSM,Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.06,NA,120,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1919
MLI,prevalence,lab,lab,TGW,Bamako,NA,NA,2019,NA,NA,NA,0.0536,0.1491,0.2445,82,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_b5e466a3e88e35d487cb287ff037518e,KP Atlas,447d43ecfe5ed7b99e7a75c24917ab69,Yes,yes,NA,NA,NA,130,1920
MLI,prevalence,lab,lab,TGW,Kayes,NA,NA,2019,NA,NA,NA,0.0368,0.2623,0.4868,34,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_c65527218eee0145f8d37a83ad7a335c,KP Atlas,8263f0be42fdb7676f91b98323255537,Yes,yes,NA,NA,NA,130,1921
MLI,prevalence,lab,lab,TGW,Koulikoro,NA,NA,2019,NA,NA,NA,0.0409,0.1177,0.1941,43,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_84164ffa5470f63429ba6d215d955f9d,KP Atlas,244b5f90e9435bccc64587c2e1bba9e8,Yes,yes,NA,NA,NA,130,1922
HTI,prevalence,lab,NA,TGW,Ouest,NA,Y015_049,2016,NA,NA,NA,NA,0.53,NA,39,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1924
HTI,prevalence,lab,NA,FSW,Sud,NA,Y015_049,2016,NA,NA,NA,NA,0.15,NA,34,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1925
MLI,prevalence,lab,lab,TGW,Mopti,NA,NA,2019,NA,NA,NA,0,0.0502,0.1321,39,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_5c63ba827349d7833b9535538c4e691f,KP Atlas,33bcac2f133303fc962086f1febb647c,Yes,yes,NA,NA,NA,130,1929
MLI,prevalence,lab,lab,TGW,Segou,NA,NA,2019,NA,NA,NA,0.0093,0.0322,0.0562,36,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_9fc3d956bbf30eef721295d8987e4f63,KP Atlas,85c69e2529436a7ce3ecd395ef08de0b,Yes,yes,NA,NA,NA,130,1930
MLI,prevalence,lab,lab,TGW,Sikasso,NA,NA,2019,NA,NA,NA,NA,0,NA,40,ANALYSE DE LA SITUATION DES PERSONNES TRANSGENRES AU MALI EN RELATION AVEC L'INFECTION A VIH ET LE SIDA,NA,KP Atlas_b9141c7c18deb144c9f0a899df15e961,KP Atlas,12da25bafbfd5422e82a268c4938d714,Yes,yes,NA,NA,NA,130,1931
HTI,prevalence,lab,NA,MSM,Sud,NA,Y015_049,2016,NA,NA,NA,NA,0.05,NA,22,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1933
HTI,prevalence,lab,NA,TGW,Sud,NA,Y015_049,2016,NA,NA,NA,NA,0.5,NA,2,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1934
HTI,prevalence,lab,NA,FSW,Sud-Est,NA,Y015_049,2016,NA,NA,NA,NA,0.02,NA,44,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1936
HTI,prevalence,lab,NA,MSM,Sud-Est,NA,Y015_049,2016,NA,NA,NA,NA,0,NA,14,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1937
HTI,prevalence,lab,NA,TGW,Sud-Est,NA,Y015_049,2016,NA,NA,NA,NA,0.45,NA,11,2017 PLACE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,NA,1938
MLI,prevalence,lab,lab,MSM,Bamako,NA,Y015_049,2019,NA,NA,NA,0.146,0.196,0.246,245,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_332fbc45a26e24df1873566830f5b134,KP Atlas,15ec45ebc926fb9556dee14e7f63c413,Yes,yes,NA,NA,NA,131,1943
MLI,prevalence,lab,lab,MSM,Gao,NA,Y015_049,2019,NA,NA,NA,NA,0,NA,72,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_ff27dbf76cb51d7cd0fbbc1a23640a65,KP Atlas,245499810f1051c856bc68ecc29ef64f,Yes,yes,NA,NA,NA,131,1944
MLI,prevalence,lab,lab,MSM,Kayes,NA,Y015_049,2019,NA,NA,NA,0.093,0.147,0.21,163,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_771e6fa15268cea18dda3b61d6e4711e,KP Atlas,ac12174416602b95936e710066d9a74b,Yes,yes,NA,NA,NA,131,1945
MLI,prevalence,lab,lab,MSM,Bamako,NA,NA,2015,NA,NA,NA,0.056,0.095,0.135,387,Hakim et al,NA,CDC_f45c8b0bc952a96fcf83218e1bc245fe,CDC,c35c35232edc416e7a04e9402439df25,Yes,yes,NA,NA,NA,132,1946
MLI,prevalence,lab,lab,TGW,Bamako,NA,NA,2015,NA,NA,NA,0.139,0.246,0.353,165,Hakim et al,NA,CDC_82d83f378215f99af779c41519303231,CDC,b1b15c90a2376254361bd5c6e3622654,Yes,yes,NA,NA,NA,132,1951
MLI,prevalence,lab,lab,FSW,Bamako,NA,NA,2019,NA,NA,NA,NA,0.096,NA,301,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_6e30b22c01f5b00847a68823291b1693,KP Atlas,cd42b8267dba07c69a673951e0581733,Yes,yes,NA,NA,CDC,136,1960
MLI,prevalence,lab,lab,FSW,Gao,NA,NA,2019,NA,NA,NA,NA,0.091,NA,55,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_6eeb4641500bf2ac040ec6f19106a30b,KP Atlas,d1640f37a86f7d14564a2aa01f481481,Yes,yes,NA,NA,CDC,136,1961
MLI,prevalence,lab,lab,FSW,Kayes,NA,NA,2019,NA,NA,NA,NA,0.066,NA,288,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_faf1146205e1458502c046e58880fd1d,KP Atlas,3978e16bb230168925ee93b5d0b9a7a7,Yes,yes,NA,NA,CDC,136,1962
MLI,prevalence,lab,lab,FSW,Koulikoro,NA,NA,2019,NA,NA,NA,NA,0.103,NA,145,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_36324f99f72da88c91a01e82c1a6c3e1,KP Atlas,b16a7aa05364b6ac176d43ca43196e6e,Yes,yes,NA,NA,CDC,136,1963
MLI,prevalence,lab,lab,FSW,Mopti,NA,NA,2019,NA,NA,NA,NA,0.094,NA,53,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_4fc6a380144a4f7d0253d5beddb74476,KP Atlas,2e7ee53fa93506a5bb027d37d69045a6,Yes,yes,NA,NA,CDC,136,1964
MLI,prevalence,lab,lab,FSW,Segou,NA,NA,2019,NA,NA,NA,NA,0.113,NA,142,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_fc4814c042f16dc02dbb0e9275a98149,KP Atlas,56f3747d2e490313cdf33a8353c7215a,Yes,yes,NA,NA,CDC,136,1965
MLI,prevalence,lab,lab,FSW,Sikasso,NA,NA,2019,NA,NA,NA,NA,0.074,NA,269,"Etude Bio-comportementale IST, VIH et tuberculose chez les femmes travailleuses du sexe et les routiers au Mali 2017-2019",NA,KP Atlas_58055d6282ea12d459db6f0bd429eb53,KP Atlas,5ac6b38bf35c47c7dc4e016d20df4726,Yes,yes,NA,NA,CDC,136,1966
MLI,prevalence,lab,lab,FSW,Bamako,NA,NA,2018,NA,NA,NA,0.163,0.204,0.25,353,Tounkara,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,137,1968
MLI,prevalence,lab,lab,MSM,Bamako,NA,NA,2019,NA,NA,NA,NA,0.32,NA,50,Koyalta et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252282/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,138,1970
MOZ,prevalence,lab,lab,MSM,Beira,NA,NA,2011,NA,NA,NA,0.057999999999999996,0.091,0.126,583,BBS 2011,NA,CDC_c98042f7c3c9a228ab440de058b9b373,CDC,162122684ee919cc61b50cc64e640b4c,Yes,yes,NA,NA,NA,139,1972
MOZ,prevalence,lab,lab,MSM,Cidade de Maputo,NA,Y015_049,2011,NA,NA,NA,0.047,0.082,0.126,496,BBS 2011,NA,KP Atlas_2e2ef7a0cfe6be0bfc6a4df763c1d8b2,KP Atlas,a5cafc3c13a3bed6067fbda3bea337cf,Yes,yes,NA,NA,NA,139,1973
MOZ,prevalence,lab,lab,MSM,Nampula,NA,NA,2011,NA,NA,NA,0.011000000000000001,0.037,0.071,353,BBS 2011,NA,GF_0dce3eb18825a27ecc7562856d017277,GF,600dc63b9eb87619e3eb118eeabe1517,Yes,yes,NA,NA,NA,139,1974
MOZ,prevalence,lab,lab,FSW,Beira,NA,NA,2012,NA,NA,NA,0.18600000000000003,0.236,0.29100000000000004,411,BBS 2012,NA,CDC_08b561fef9450ed8359e7dd3524e979d,CDC,7d0b1ff808d8d61e17f5ceabb942b884,Yes,yes,NA,NA,NA,140,1980
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,NA,2012,NA,NA,NA,0.245,0.312,0.375,400,BBS 2012,NA,CDC_17f09f081eae5353a4edb9ba8e77f8ce,CDC,2dce38ef61de50dffcc8178c7e2b194d,Yes,yes,NA,NA,NA,140,1981
MOZ,prevalence,lab,lab,FSW,Nampula,NA,NA,2012,NA,NA,NA,0.133,0.178,0.22699999999999998,429,BBS 2012,NA,CDC_e1600036c70541f68006e8c20fa0dd43,CDC,7429e679c7372fe0c2242688f52d68d4,Yes,yes,NA,NA,NA,140,1985
MOZ,prevalence,lab,lab,PWID,Cidade de Maputo,NA,NA,2014,NA,NA,NA,0.401,0.501,0.59,319,BBS 2014,NA,KP Atlas_3a3791dc0fc6334b21f3bd17ff40c787,KP Atlas,76f116f800ce81b780988360892748d3,Yes,yes,NA,NA,NA,141,1995
MOZ,prevalence,lab,lab,PWID,Nampula,NA,NA,2014,NA,NA,NA,0.109,0.199,0.292,126,BBS 2014,NA,KP Atlas_5bf52cf0b34b3526aa3c6643bff55595,KP Atlas,72b8b35ae08bfaaa988cf8e6e1d3d13b,Yes,yes,NA,NA,NA,141,2005
MOZ,prevalence,lab,lab,FSW,"Beira, Dondo",NA,NA,2017,NA,NA,NA,NA,0.22,NA,367,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2012
MOZ,prevalence,lab,lab,MSM,"Beira, Dondo",NA,NA,2017,NA,NA,NA,NA,0.14,NA,290,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2014
MOZ,prevalence,lab,lab,TGW,"Beira, Dondo",NA,NA,2017,NA,NA,NA,NA,0.11,NA,22,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2015
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,NA,2017,NA,NA,NA,NA,0.13,NA,343,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2016
MOZ,prevalence,lab,lab,MSM,Cidade de Maputo,NA,NA,2017,NA,NA,NA,NA,0.05,NA,61,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2017
MOZ,prevalence,lab,lab,TGW,Cidade de Maputo,NA,NA,2017,NA,NA,NA,NA,0.35,NA,23,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2019
MOZ,prevalence,lab,lab,FSW,"Inchope, Chimoio, Manica",NA,NA,2017,NA,NA,NA,NA,0.28,NA,273,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2020
MOZ,prevalence,lab,lab,MSM,"Inchope, Chimoio, Manica",NA,NA,2017,NA,NA,NA,NA,0.06,NA,96,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2021
MOZ,prevalence,lab,lab,TGW,"Inchope, Chimoio, Manica",NA,NA,2017,NA,NA,NA,NA,0.08,NA,41,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2022
MOZ,prevalence,lab,lab,FSW,"Tete, Changara, Moatize",NA,NA,2017,NA,NA,NA,NA,0.13,NA,212,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2025
MOZ,prevalence,lab,lab,MSM,"Tete, Changara, Moatize",NA,NA,2017,NA,NA,NA,NA,0.01,NA,70,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2026
MOZ,prevalence,lab,lab,TGW,"Tete, Changara, Moatize",NA,NA,2017,NA,NA,NA,NA,0.06,NA,32,PLACE 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,142,2027
NER,prevalence,lab,NA,FSW,Agadez,NA,NA,2015,NA,NA,NA,0.09,0.157,0.259,70,2015 ESDG,NA,KP Atlas_06f9f9e4fc09c85daf5b65b9e234a582,KP Atlas,8ae95a4470c911562055ff0b7d01de43,Yes,yes,NA,NA,NA,373,2081
NER,prevalence,lab,NA,FSW,Diffa,NA,NA,2015,NA,NA,NA,0.497,0.769,0.912,13,2015 ESDG,NA,KP Atlas_5f736128b2d5c6c0bcef1d58aebff832,KP Atlas,73344b14061a6dacf3b196da666e209b,Yes,yes,NA,NA,NA,373,2082
NER,prevalence,lab,NA,FSW,Dosso,NA,NA,2015,NA,NA,NA,0.032,0.118,0.343,17,2015 ESDG,NA,KP Atlas_a75e3f5e50497d9fd03881a838285044,KP Atlas,7d24a2c5ebe5c49ff19518b861d62452,Yes,yes,NA,NA,NA,373,2083
NER,prevalence,lab,NA,FSW,Maradi,NA,NA,2015,NA,NA,NA,0.168,0.237,0.322,114,2015 ESDG,NA,KP Atlas_10394f2ee3219a2e5b04841e162ec982,KP Atlas,314501a45b335399c93a97f8315ce261,Yes,yes,NA,NA,NA,373,2084
NER,prevalence,lab,NA,FSW,Niamey,NA,NA,2015,NA,NA,NA,0.072,0.115,0.176,148,2015 ESDG,NA,KP Atlas_bba1e959ae4eed97b3573669fe49269e,KP Atlas,bab2029e07fc54c648e8b98d760b999c,Yes,yes,NA,NA,NA,373,2085
NER,prevalence,lab,lab,FSW,Tahoua,NA,NA,2015,NA,NA,NA,0.017,0.049,0.135,61,2015 ESDG,NA,KP Atlas_cf9e1d401438d2b50181f4bbadf20188,KP Atlas,9bdb107e97ea1c5d6b529d9a1a2647a7,Yes,yes,NA,NA,NA,373,2089
NER,prevalence,lab,lab,FSW,Tillaberi,NA,NA,2015,NA,NA,NA,0.026,0.066,0.157,61,2015 ESDG,NA,KP Atlas_e3646f3395c076921248a14d02315c71,KP Atlas,d346aea91471ffbee9ca16ef67498c5b,Yes,yes,NA,NA,NA,373,2090
NER,prevalence,lab,lab,FSW,Zinder,NA,NA,2015,NA,NA,NA,0.155,0.22,0.303,118,2015 ESDG,NA,KP Atlas_67f62cce3317a96e3fe1a5ed7d345c3b,KP Atlas,7699ba6dd2264bcb7a3e09f4d939fad0,Yes,yes,NA,NA,NA,373,2091
NER,prevalence,lab,lab,FSW,Agadez,NA,NA,2017,NA,NA,NA,0.0257,0.0508,0.0759,301,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,2093
NER,prevalence,lab,lab,FSW,Maradi,NA,NA,2017,NA,NA,NA,0.1129,0.1538,0.1948,300,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,2100
NER,prevalence,lab,lab,FSW,Niamey,NA,NA,2017,NA,NA,NA,0.0233,0.0478,0.0722,302,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,2104
MOZ,prevalence,lab,lab,FSW,Biera,NA,Y015_019,2021,NA,NA,NA,NA,0.02173913,NA,230,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2129
MOZ,prevalence,lab,lab,FSW,Biera,NA,Y020_024,2021,NA,NA,NA,0.0478,0.10099999999999999,0.153,142,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2131
MOZ,prevalence,lab,lab,FSW,Biera,NA,Y025_029,2021,NA,NA,NA,0.336,0.45399999999999996,0.5720000000000001,75,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2132
MOZ,prevalence,lab,lab,FSW,Biera,NA,Y035_049,2021,NA,NA,NA,0.377,0.499,0.62,67,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2133
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,Y015_019,2021,NA,NA,NA,0.039,0.121,0.2025,50,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2134
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,Y020_024,2021,NA,NA,NA,0.125,0.209,0.292,117,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2135
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,Y025_029,2021,NA,NA,NA,0.327,0.434,0.541,84,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2136
MOZ,prevalence,lab,lab,FSW,Cidade de Maputo,NA,Y035_049,2021,NA,NA,NA,0.665,0.716,0.7659999999999999,227,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2137
MOZ,prevalence,lab,lab,FSW,Nampula,NA,Y015_019,2021,NA,NA,NA,NA,0.032894737,NA,152,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2138
MOZ,prevalence,lab,lab,FSW,Nampula,NA,Y020_024,2021,NA,NA,NA,0.033,0.076,0.11900000000000001,164,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2139
MOZ,prevalence,lab,lab,FSW,Nampula,NA,Y025_029,2021,NA,NA,NA,0.08460000000000001,0.17800000000000002,0.271,73,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2140
MOZ,prevalence,lab,lab,FSW,Nampula,NA,Y035_049,2021,NA,NA,NA,0.157,0.252,0.345,75,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2141
MOZ,prevalence,lab,lab,FSW,Quelimane,NA,Y015_019,2021,NA,NA,NA,NA,0.086705202,NA,173,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2142
MOZ,prevalence,lab,lab,FSW,Quelimane,NA,Y020_024,2021,NA,NA,NA,0.24,0.32,0.39899999999999997,146,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2143
MOZ,prevalence,lab,lab,FSW,Quelimane,NA,Y025_029,2021,NA,NA,NA,0.28,0.41200000000000003,0.545,69,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2145
MOZ,prevalence,lab,lab,FSW,Quelimane,NA,Y035_049,2021,NA,NA,NA,0.28,0.419,0.563,66,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2146
MOZ,prevalence,lab,lab,FSW,Tete,NA,Y015_019,2021,NA,NA,NA,NA,0.043165468,NA,139,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2147
MOZ,prevalence,lab,lab,FSW,Tete,NA,Y020_024,2021,NA,NA,NA,0.10400000000000001,0.18100000000000002,0.258,93,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2148
MOZ,prevalence,lab,lab,FSW,Tete,NA,Y025_029,2021,NA,NA,NA,0.429,0.518,0.608,91,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2162
MOZ,prevalence,lab,lab,FSW,Tete,NA,Y035_049,2021,NA,NA,NA,0.597,0.6709999999999999,0.7440000000000001,194,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,143,2163
MWI,prevalence,lab,NA,FSW,Malawi,NA,NA,2013,NA,NA,NA,NA,0.627,NA,668,BBS 2013,NA,KP Atlas_6b7680a3bbb07e24caf2829e07c9234a,KP Atlas,a609a4d180b24aeb2f72115aaf983c52,Yes,yes,NA,NA,NA,146,2164
MWI,prevalence,lab,NA,MSM,Blantyre,NA,NA,2012,NA,NA,NA,NA,0.154,NA,338,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_e46546c96063a3dbe29c2be9e66291bb,GF,c6881a9d30ec16d4a400d867f8e70144,Yes,yes,NA,NA,NA,149,2165
MWI,prevalence,lab,NA,MSM,Lilongwe,NA,NA,2013,NA,NA,NA,NA,0.135,NA,362,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_0d2ff880abc6611aede6dd89f6e3de2c,GF,ec46c7ef864d0c21612f39bda0a779b1,Yes,yes,NA,NA,NA,149,2166
MWI,prevalence,lab,NA,MSM,Mzuzu,NA,NA,2013,NA,NA,NA,NA,0.054,NA,353,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_e0c785284340fde21b9a9401e5669e38,GF,49953269cd740d9645f319d3d9de85d6,Yes,yes,NA,NA,NA,149,2167
MWI,prevalence,lab,NA,MSM,Chikwawa,NA,NA,2014,NA,NA,NA,NA,0.198,NA,350,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_7967f5bdef148e04350406341d701f24,GF,557635dffd490068bcbc8e774f1a6304,Yes,yes,NA,NA,NA,149,2168
MWI,prevalence,lab,NA,MSM,Mangochi,NA,NA,2014,NA,NA,NA,NA,0.204,NA,351,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_0f577fbc8d3a7382b8d165e797b8318d,GF,847f2df5e99fd32edaeec42048b89893,Yes,yes,NA,NA,NA,149,2169
MWI,prevalence,lab,NA,MSM,Mulanje,NA,NA,2014,NA,NA,NA,NA,0.247,NA,348,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_d2e45479f48d5faf778fa9000672b9ac,GF,3893a5448efc4f765bd308c4705b5ffd,Yes,yes,NA,NA,NA,149,2170
MWI,prevalence,lab,NA,MSM,Nkata Bay,NA,NA,2014,NA,NA,NA,NA,0.217,NA,350,HIV Prevalence and Sociobehavioral Characteristics Among Men Who Have Sex with Men Across Seven Sites in Malawi,NA,GF_0ea9b998934cc631d483a110f816e992,GF,3316b7ddefdcc3e94b458bdc4abccd5d,Yes,yes,NA,NA,NA,149,2171
MWI,prevalence,lab,NA,FSW,Blantyre,NA,NA,2020,NA,NA,NA,NA,0.571,NA,375,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2174
MWI,prevalence,lab,NA,FSW,Karonga,NA,NA,2020,NA,NA,NA,NA,0.496,NA,226,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2175
MWI,prevalence,lab,NA,FSW,Lilongwe,NA,NA,2020,NA,NA,NA,NA,0.483,NA,472,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2176
MWI,prevalence,lab,NA,FSW,Mangochi,NA,NA,2020,NA,NA,NA,NA,0.448,NA,305,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2179
MWI,prevalence,lab,NA,FSW,Mchinji,NA,NA,2020,NA,NA,NA,NA,0.565,NA,386,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2180
MWI,prevalence,lab,NA,FSW,Mwanza,NA,NA,2020,NA,NA,NA,NA,0.542,NA,439,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2181
MLI,prevalence,lab,NA,MSM,Koulikoro,NA,Y015_049,2019,NA,NA,NA,0.096,0.154,0.212,149,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_9f6fb4dc95632f7dfe9f691e7202fa3a,KP Atlas,b587fb325955ce5a30e092fc5b894338,Yes,yes,NA,NA,NA,131,2182
MLI,prevalence,lab,NA,MSM,Mopti,NA,Y015_049,2019,NA,NA,NA,0.07,0.137,0.204,102,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_47e5b562437560ad741ec86d5be257b1,KP Atlas,ef3db8e88739609eeae40c4381c20d1d,Yes,yes,NA,NA,NA,131,2183
MLI,prevalence,lab,NA,MSM,Segou,NA,Y015_049,2019,NA,NA,NA,0.032,0.073,0.114,151,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_862690bfb3fe6998cb1778fbcbf446e2,KP Atlas,64fd3265376ded9cc0e9a863967fc4d6,Yes,yes,NA,NA,NA,131,2184
MWI,prevalence,lab,NA,FSW,Nkata Bay,NA,NA,2020,NA,NA,NA,NA,0.403,NA,305,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2185
MWI,prevalence,lab,NA,FSW,Zomba,NA,NA,2020,NA,NA,NA,NA,0.468,NA,594,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2186
MLI,prevalence,lab,NA,MSM,Sikasso,NA,Y015_049,2019,NA,NA,NA,0.032,0.074,0.116,149,Cartographie et Estimation de la taille des Professionnelles de Sexe (PS) et des Hommes ayant des rapports Sexuels avec díautres Hommes (HSH) couplees ‡ líetude bio-comportementale chez les HSH en matiËre de VIH au Mali,NA,KP Atlas_65bc4ad8497d51e6f04b3d477a2fe130,KP Atlas,6ef3e3fce6b2368fe859501b0f06218c,Yes,yes,NA,NA,NA,131,2187
MWI,prevalence,lab,NA,MSM,Blantyre,NA,NA,2020,NA,NA,NA,NA,0.162,NA,352,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2193
MWI,prevalence,lab,NA,MSM,Karonga,NA,NA,2020,NA,NA,NA,NA,0.03,NA,67,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2194
MWI,prevalence,lab,NA,MSM,Lilongwe,NA,NA,2020,NA,NA,NA,NA,0.074,NA,392,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2195
MWI,prevalence,lab,NA,MSM,Malawi,NA,Y015_049,2014,NA,NA,NA,NA,0.173,NA,2452,Wirtz et al,NA,KP Atlas_bd7d271da755db3984068d7b477b0672,KP Atlas,7c009e3ce42492ed97db0aab251d53d9,Yes,yes,NA,NA,NA,154,2200
NAM,prevalence,lab,NA,FSW,Oshikango,NA,NA,2013,NA,NA,NA,NA,0.31,NA,256,IBBS 2015,NA,KP Atlas_8e5bab5d1e184c787fd2c72e112c60cc,KP Atlas,46a1b358557c797df0f31e3af9d05d3f,Yes,yes,NA,NA,NA,155,2202
NAM,prevalence,lab,NA,FSW,Walvis Bay/Swakopmund,NA,NA,2013,NA,NA,NA,NA,0.373,NA,307,IBBS 2015,NA,KP Atlas_e189bf8b41239cb609b2f733079e442e,KP Atlas,ec76d128a9f34280a216eac1d8f3af13,Yes,yes,NA,NA,NA,155,2203
NAM,prevalence,lab,NA,FSW,Windhoek,NA,NA,2013,NA,NA,NA,NA,0.393,NA,316,IBBS 2015,NA,CDC_7c3378177fe80b731151d9484c80fc9c,CDC,5721d604555eb48997cdc7d127f8dd29,Yes,yes,NA,NA,NA,155,2204
NAM,prevalence,lab,NA,MSM,Windhoek,NA,NA,2012,NA,NA,NA,0.16,0.209,0.256,283,BBS 2014,NA,CDC_1e075153f0f07160f424552688010c74,CDC,37bb7720a1ece207ea005c9094baf848,Yes,yes,NA,NA,NA,156,2205
NAM,prevalence,lab,NA,MSM,Keetmanshoop,NA,NA,2013,NA,NA,NA,0.046,0.102,0.181,316,BBS 2014,NA,CDC_c773ffe04f67923d2b7815d2551da86e,CDC,dde4a35a5707acff7ea7d24148da29c3,Yes,yes,NA,NA,NA,156,2206
NAM,prevalence,lab,NA,MSM,Oshikati,NA,NA,2013,NA,NA,NA,0.022,0.071,0.138,186,BBS 2014,NA,CDC_f03059f01b7f405dfa2f2e11792f8d49,CDC,13cfb17e78a0d4852dc9034d070628ea,Yes,yes,NA,NA,NA,156,2212
NAM,prevalence,lab,NA,MSM,Walvis Bay/Swakopmund,NA,Y015_049,2013,NA,NA,NA,0.128,0.17,0.212,312,BBS 2014,NA,KP Atlas_b376bc9ec1cea2f03a81cadcdfe13363,KP Atlas,52390bcaa97177d5331c05b607bd4cbf,Yes,yes,NA,NA,NA,156,2219
NAM,prevalence,lab,NA,FSW,Katima Mulilo,NA,NA,2019,NA,NA,NA,0.38,0.442,0.504,271,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,157,2221
NAM,prevalence,lab,NA,FSW,Walvis Bay/Swakopmund,NA,NA,2019,NA,NA,NA,0.163,0.203,0.243,417,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,157,2222
NAM,prevalence,lab,NA,FSW,Windhoek,NA,NA,2019,NA,NA,NA,0.11800000000000001,0.213,0.307,230,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,157,2223
NGA,prevalence,lab,NA,MSM,Abuja,NA,NA,2010,NA,NA,NA,0.255,0.349,0.45899999999999996,194,Vu 2013,NA,CDC_838ee489fdc71c12d4a3ec7d51a23026,CDC,3f03030753834bf162e291ccee33c39f,Yes,yes,NA,NA,NA,158,2224
NGA,prevalence,lab,NA,MSM,Ibadan,NA,NA,2010,NA,NA,NA,0.051,0.113,0.168,210,Vu 2013,NA,CDC_fe8f06147f07f8b4380e09bd24e5b911,CDC,0d1a30ee3a63196b938f2184e6dcd594,Yes,yes,NA,NA,NA,158,2225
NGA,prevalence,lab,NA,MSM,Lagos,NA,NA,2010,NA,NA,NA,0.09699999999999999,0.152,0.212,308,Vu 2013,NA,CDC_a870675de31dc2e9bbdab2ed975df957,CDC,eb6049c914e8319bd0b7bb8a4b28ee3c,Yes,yes,NA,NA,NA,158,2226
NGA,prevalence,lab,NA,FSW,Anambra,NA,NA,2010,NA,NA,NA,NA,0.132,NA,250,BBS 2010,NA,GF_c239a74e5a9e49b389f72298ff96d600,GF,bfc686fdcb4b0212a7d49afbacd754c6,Yes,yes,NA,NA,NA,159,2227
NGA,prevalence,lab,NA,FSW,Anambra,NA,NA,2010,NA,NA,NA,NA,0.228,NA,249,BBS 2010,NA,GF_1e93e530581b85d8989449aac8914de2,GF,ae35c5cb6454df9357e8c9269a61582c,Yes,yes,NA,NA,NA,159,2228
NGA,prevalence,lab,NA,FSW,Benue,NA,NA,2010,NA,NA,NA,NA,0.275,NA,247,BBS 2010,NA,GF_e3a1f1dd2e3698029fb7f9d1a2e5a9a6,GF,a1fae018ed598922d442455eecfbcb5c,Yes,yes,NA,NA,NA,159,2229
NGA,prevalence,lab,NA,FSW,Benue,NA,NA,2010,NA,NA,NA,NA,0.467,NA,251,BBS 2010,NA,GF_f959e45cfbcce09bd5ff7d05af928f5a,GF,544b08fac602dee1ca240acd7f639689,Yes,yes,NA,NA,NA,159,2230
NGA,prevalence,lab,NA,FSW,Cross River,NA,NA,2010,NA,NA,NA,NA,0.083,NA,250,BBS 2010,NA,GF_ef04034046456b719c3bd018c620819a,GF,d1b54530926a9bcffcf2806123dffefb,Yes,yes,NA,NA,NA,159,2231
NGA,prevalence,lab,NA,FSW,Cross River,NA,NA,2010,NA,NA,NA,NA,0.207,NA,237,BBS 2010,NA,GF_09618763ab71f0607df96f784a8555a9,GF,2105b710f18efbfb72a9e52904206be2,Yes,yes,NA,NA,NA,159,2232
NGA,prevalence,lab,NA,MSM,Cross River,NA,NA,2010,NA,NA,NA,NA,0.024,NA,313,BBS 2010,NA,GF_b96f0b7ab2bad585f52f7472d6b99d6d,GF,62ee31c70566087bc8b7a808560b00d6,Yes,yes,NA,NA,NA,159,2233
NGA,prevalence,lab,NA,PWID,Cross River,NA,NA,2010,NA,NA,NA,NA,0.033,NA,273,BBS 2010,NA,GF_1f9fd58a86af7b5c8b90047171ca4300,GF,cd62d25e9f2b7ef03d488b9cac4ad11b,Yes,yes,NA,NA,NA,159,2234
NGA,prevalence,lab,NA,FSW,Edo,NA,NA,2010,NA,NA,NA,NA,0.144,NA,181,BBS 2010,NA,GF_ec6c0349fc42438d342ab10a6a170bb3,GF,b9d197b2930c84169cb5c783d5e01af4,Yes,yes,NA,NA,NA,159,2235
NGA,prevalence,lab,NA,FSW,Edo,NA,NA,2010,NA,NA,NA,NA,0.183,NA,255,BBS 2010,NA,GF_67fb91d4dfd1715beeadc3ae1464337e,GF,fd1149e6a143a8b11d805a578690d558,Yes,yes,NA,NA,NA,159,2236
NGA,prevalence,lab,NA,FSW,FCT,NA,NA,2010,NA,NA,NA,NA,0.219,NA,249,BBS 2010,NA,GF_5b0b08da33f54e0a609af67750692c43,GF,d437e08c632d3abf592f4e5ded33950a,Yes,yes,NA,NA,NA,159,2237
NGA,prevalence,lab,NA,FSW,FCT,NA,NA,2010,NA,NA,NA,NA,0.341,NA,249,BBS 2010,NA,GF_ed0d1f0382f1361b45ce39403302f217,GF,2870e35aa680cb6bc84d9d73975c71b3,Yes,yes,NA,NA,NA,159,2238
NGA,prevalence,lab,NA,MSM,FCT,NA,NA,2010,NA,NA,NA,NA,0.376,NA,199,BBS 2010,NA,GF_24f3ff6e1d544b9364be87c56a69fb93,GF,950ce806fd5fec53dfdd1dc1ce21386a,Yes,yes,NA,NA,NA,159,2239
NGA,prevalence,lab,NA,PWID,FCT,NA,NA,2010,NA,NA,NA,NA,0.093,NA,271,BBS 2010,NA,GF_90ee854c705ac3a7e85f3830424301c5,GF,64723a7b71e14c306264950b88b3cd4d,Yes,yes,NA,NA,NA,159,2240
NGA,prevalence,lab,NA,FSW,Kaduna,NA,NA,2010,NA,NA,NA,NA,0.217,NA,253,BBS 2010,NA,GF_be37d1cb9263cc263e0e15e6ec65563a,GF,fa27398173eabe6357dfb305d189f8ba,Yes,yes,NA,NA,NA,159,2241
NGA,prevalence,lab,NA,FSW,Kaduna,NA,NA,2010,NA,NA,NA,NA,0.319,NA,250,BBS 2010,NA,GF_f10efecbf97f23c650da44c7ce76139a,GF,abbe5325d880f3deac55993dda577031,Yes,yes,NA,NA,NA,159,2242
NGA,prevalence,lab,NA,MSM,Kaduna,NA,NA,2010,NA,NA,NA,NA,0.162,NA,286,BBS 2010,NA,GF_f23994f74e7e630244b4c6795c27f72f,GF,3dad9970c93a1ef86587ad2fe4d1defe,Yes,yes,NA,NA,NA,159,2243
NGA,prevalence,lab,NA,PWID,Kaduna,NA,NA,2010,NA,NA,NA,NA,0.058,NA,262,BBS 2010,NA,GF_0cb73e5703372840a7e32dca3029c1b1,GF,7e5c93e53a7cc6bf159c5dd9c2c00200,Yes,yes,NA,NA,NA,159,2244
NGA,prevalence,lab,NA,FSW,Kano,NA,NA,2010,NA,NA,NA,NA,0.294,NA,267,BBS 2010,NA,GF_395f3cfe83ad637eefa1b333c4f916d0,GF,b6b5d7c2ffde1512c3cc0f4de1020ffe,Yes,yes,NA,NA,NA,159,2245
NGA,prevalence,lab,NA,FSW,Kano,NA,NA,2010,NA,NA,NA,NA,0.392,NA,249,BBS 2010,NA,GF_673aae42d1e51b651976617007e0854e,GF,0b59e5a6be97c69debff609ed40b8f27,Yes,yes,NA,NA,NA,159,2246
NGA,prevalence,lab,NA,MSM,Kano,NA,NA,2010,NA,NA,NA,NA,0.083,NA,299,BBS 2010,NA,GF_e5e69ac32963e0d73341b6f820c19e53,GF,14c512c641b9f1cbb1d891336cec56e5,Yes,yes,NA,NA,NA,159,2247
NGA,prevalence,lab,NA,PWID,Kano,NA,NA,2010,NA,NA,NA,NA,0.048,NA,269,BBS 2010,NA,GF_060ea9dcf85fb300aa1885db22e34bf9,GF,cf7a28ea1a7c34188c1e8a5aec2ce35f,Yes,yes,NA,NA,NA,159,2248
NGA,prevalence,lab,NA,FSW,Lagos,NA,NA,2010,NA,NA,NA,NA,0.121,NA,276,BBS 2010,NA,GF_197f6f89e090d6c98b5e006a82301f7b,GF,17da25d2c89e9c92d6b5473d8b0413b3,Yes,yes,NA,NA,NA,159,2249
NGA,prevalence,lab,NA,FSW,Lagos,NA,NA,2010,NA,NA,NA,NA,0.13,NA,250,BBS 2010,NA,GF_9be2187ae3880975a6a59bef4f9e2eef,GF,5f45357a0eb9979f4cf510330f499a57,Yes,yes,NA,NA,NA,159,2250
NGA,prevalence,lab,NA,MSM,Lagos,NA,NA,2010,NA,NA,NA,NA,0.158,NA,215,BBS 2010,NA,GF_0454d96374c64c204f64147041f59d26,GF,40630f90e72940880e4c2bd33fbbf824,Yes,yes,NA,NA,NA,159,2251
NGA,prevalence,lab,NA,PWID,Lagos,NA,NA,2010,NA,NA,NA,NA,0.03,NA,197,BBS 2010,NA,GF_7471ec303dd784e80918498e177c8752,GF,5ba1054df5cc4dfa369193f89c330e1b,Yes,yes,NA,NA,NA,159,2252
NGA,prevalence,lab,NA,FSW,Nassarawa,NA,NA,2010,NA,NA,NA,NA,0.321,NA,247,BBS 2010,NA,GF_e23802b5b684b2b07f910ff4276e1877,GF,4076cc2e877c8463c1810958535a47bb,Yes,yes,NA,NA,NA,159,2253
NGA,prevalence,lab,NA,FSW,Nassarawa,NA,NA,2010,NA,NA,NA,NA,0.463,NA,249,BBS 2010,NA,GF_5864a267de746272b73e1dd6900faade,GF,c535e0fee96d7528bad50433ca389c20,Yes,yes,NA,NA,NA,159,2254
NGA,prevalence,lab,NA,MSM,Oyo,NA,NA,2010,NA,NA,NA,NA,0.033,NA,233,BBS 2010,NA,GF_7e0ea999032ddd341c453a767aeac90c,GF,bcc64eb4127898a314a3fe8b450329e4,Yes,yes,NA,NA,NA,159,2255
NGA,prevalence,lab,NA,PWID,Oyo,NA,NA,2010,NA,NA,NA,NA,0.051,NA,273,BBS 2010,NA,GF_48dc3c6b2e7574b858210576f3bf253f,GF,847f7d844c308b2b09490693a371e67a,Yes,yes,NA,NA,NA,159,2256
NGA,prevalence,lab,NA,FSW,Anambra,NA,NA,2014,NA,NA,NA,NA,0.048,NA,302,BBS 2014,NA,GF_6b2a69fd6e3cccec0da511e6a8d5f277,GF,0de975e5d83f616bce3147557e8e1ded,Yes,yes,NA,NA,NA,160,2257
NGA,prevalence,lab,NA,FSW,Anambra,NA,NA,2014,NA,NA,NA,NA,0.157,NA,300,BBS 2014,NA,GF_3cc38b05ad695e38404fd44eea1a316c,GF,5b64bcaef542a07d9b0fd5f0eefb3a6d,Yes,yes,NA,NA,NA,160,2258
NGA,prevalence,lab,NA,FSW,Benue,NA,NA,2014,NA,NA,NA,NA,0.142,NA,299,BBS 2014,NA,GF_5d9262273b8ee5cab2db4b8246b01266,GF,0167870ad462656eec2b727074039676,Yes,yes,NA,NA,NA,160,2259
NGA,prevalence,lab,NA,FSW,Benue,NA,NA,2014,NA,NA,NA,NA,0.365,NA,300,BBS 2014,NA,GF_b42e77db30cd06cd3a1af9eb390b8cf0,GF,dac5ad075cd48df157e8670765c937ab,Yes,yes,NA,NA,NA,160,2260
NGA,prevalence,lab,NA,FSW,Cross River,NA,NA,2014,NA,NA,NA,NA,0.092,NA,165,BBS 2014,NA,GF_f01723d80e6bb6eea120c9edfe00a9d1,GF,333c98a02b5d2f7f889540373c06e847,Yes,yes,NA,NA,NA,160,2264
NGA,prevalence,lab,NA,FSW,Cross River,NA,NA,2014,NA,NA,NA,NA,0.135,NA,255,BBS 2014,NA,GF_2850161838d8b2a5c4c5918f066b496f,GF,8ea2b1156198758c5691e7437f693d08,Yes,yes,NA,NA,NA,160,2265
NGA,prevalence,lab,NA,FSW,Edo,NA,NA,2014,NA,NA,NA,NA,0.065,NA,301,BBS 2014,NA,GF_a98c3562463a97977b1fccd4542da7db,GF,dbaa59eefc326cb772e203c4e3dc604a,Yes,yes,NA,NA,NA,160,2266
NGA,prevalence,lab,NA,FSW,Edo,NA,NA,2014,NA,NA,NA,NA,0.073,NA,298,BBS 2014,NA,GF_a2953d0573eeada29965dd8c02c841d0,GF,5061d07242038dfa0f7967736c6077b5,Yes,yes,NA,NA,NA,160,2267
NGA,prevalence,lab,NA,FSW,Enugu,NA,NA,2014,NA,NA,NA,NA,0.071,NA,251,BBS 2014,NA,GF_733f3f4026652f2e1556d0b287b088aa,GF,75bc7da638c042c8bc19587f9889619d,Yes,yes,NA,NA,NA,160,2268
NGA,prevalence,lab,NA,FSW,Enugu,NA,NA,2014,NA,NA,NA,NA,0.15,NA,274,BBS 2014,NA,GF_5e80b5d651a4c4266949d1ae43c673d3,GF,71db7d15927a6cef492a930c431ee102,Yes,yes,NA,NA,NA,160,2269
NGA,prevalence,lab,NA,FSW,FCT,NA,NA,2014,NA,NA,NA,NA,0.078,NA,301,BBS 2014,NA,GF_317624d498b3ebf169e815b9817325ba,GF,b384689ba9a86c68f2db54f2939cf80e,Yes,yes,NA,NA,NA,160,2270
NGA,prevalence,lab,NA,FSW,FCT,NA,NA,2014,NA,NA,NA,NA,0.168,NA,298,BBS 2014,NA,GF_05b4e16bbf445a6c8b7d385c0f2f41b4,GF,925d4e691795df002b10bad94b7c8a7b,Yes,yes,NA,NA,NA,160,2271
NGA,prevalence,lab,NA,FSW,Kaduna,NA,NA,2014,NA,NA,NA,NA,0.07,NA,298,BBS 2014,NA,GF_2975232d21bcec85d5584fa76d3f38f6,GF,8528e4c359fc3c6733ca94b1f731d978,Yes,yes,NA,NA,NA,160,2272
NGA,prevalence,lab,NA,FSW,Kaduna,NA,NA,2014,NA,NA,NA,NA,0.278,NA,299,BBS 2014,NA,GF_b70feed0f17897a58ce82850f513dde6,GF,1f2342277cb179831dd5d33379cdcde0,Yes,yes,NA,NA,NA,160,2273
NGA,prevalence,lab,NA,FSW,Kano,NA,NA,2014,NA,NA,NA,NA,0.19,NA,276,BBS 2014,NA,GF_2afc8a41c60ad5182124f35945225a2c,GF,90891443a8709e9aefcd1d91099284d4,Yes,yes,NA,NA,NA,160,2274
NGA,prevalence,lab,NA,FSW,Kano,NA,NA,2014,NA,NA,NA,NA,0.295,NA,299,BBS 2014,NA,GF_215be0e7e9d18c0d9c176352a756fe12,GF,fa0131a43e6ab1622506afd2bc666641,Yes,yes,NA,NA,NA,160,2275
NGA,prevalence,lab,NA,FSW,Lagos,NA,NA,2014,NA,NA,NA,NA,0.075,NA,296,BBS 2014,NA,GF_e952c71bca86cde494d07549bb96848e,GF,0da9ca60808218ec86d99b1f048195e1,Yes,yes,NA,NA,NA,160,2276
NGA,prevalence,lab,NA,FSW,Lagos,NA,NA,2014,NA,NA,NA,NA,0.084,NA,300,BBS 2014,NA,GF_fbc5f92f3926b931cd1fee5f90bd63fe,GF,50b06208cc00dd47167bc830cdd127ed,Yes,yes,NA,NA,NA,160,2277
NGA,prevalence,lab,NA,FSW,Nassarawa,NA,NA,2014,NA,NA,NA,NA,0.067,NA,300,BBS 2014,NA,GF_1cad50e633a6c366f28c2c94e469281b,GF,cb55c0e1d9ae073bc877512f6e1cdfd7,Yes,yes,NA,NA,NA,160,2278
NGA,prevalence,lab,NA,FSW,Nassarawa,NA,NA,2014,NA,NA,NA,NA,0.277,NA,300,BBS 2014,NA,GF_8ec54c1690aec0151c1c1afd5d326145,GF,4ce076aa28fb3b276f0b2365b99da871,Yes,yes,NA,NA,NA,160,2279
NGA,prevalence,lab,NA,FSW,Oyo,NA,NA,2014,NA,NA,NA,NA,0.064,NA,292,BBS 2014,NA,GF_060a825e770a75d2aa7c7d0f5e89175b,GF,87bef07b71c5c06024b0962b7bebf811,Yes,yes,NA,NA,NA,160,2280
NGA,prevalence,lab,NA,FSW,Oyo,NA,NA,2014,NA,NA,NA,NA,0.08,NA,300,BBS 2014,NA,GF_2ebbaed4cde1371c38ab4f2ecd710506,GF,6ffb48a75ef993b17e341b2abb021e36,Yes,yes,NA,NA,NA,160,2281
NGA,prevalence,lab,NA,FSW,Rivers,NA,NA,2014,NA,NA,NA,NA,0.077,NA,302,BBS 2014,NA,GF_3da954a7687fc06edcaa6e693c5ded05,GF,c6ce9485fa25e3295725589169e08a5d,Yes,yes,NA,NA,NA,160,2282
NGA,prevalence,lab,NA,FSW,Rivers,NA,NA,2014,NA,NA,NA,NA,0.117,NA,301,BBS 2014,NA,GF_6c206ad96f1498e3d8b5b38df2361054,GF,b7610b81ac17ae9155979a7e1c709f8b,Yes,yes,NA,NA,NA,160,2283
NGA,prevalence,lab,NA,FSW,Taraba,NA,NA,2014,NA,NA,NA,NA,0.124,NA,297,BBS 2014,NA,GF_29b73135be4e9e5e649c6f52f52f074f,GF,12569c4210839d223bcedb303d05fbf4,Yes,yes,NA,NA,NA,160,2284
NGA,prevalence,lab,NA,FSW,Taraba,NA,NA,2014,NA,NA,NA,NA,0.472,NA,300,BBS 2014,NA,GF_ac1bf0b2e74e93a702bf076d17b87d2b,GF,52c89b4fabe4841e86e60c6f624aa79e,Yes,yes,NA,NA,NA,160,2285
NGA,prevalence,lab,NA,MSM,Cross River,NA,NA,2014,NA,NA,NA,NA,0.113,NA,504,BBS 2014,NA,GF_05948ba82f0d6445b0575465ccd3a749,GF,33830d139c2e1ffcf4a25e89eb202092,Yes,yes,NA,NA,NA,160,2287
NGA,prevalence,lab,NA,MSM,Enugu,NA,NA,2014,NA,NA,NA,NA,0.168,NA,458,BBS 2014,NA,GF_ff2755111719f745c49d87c63f7717cb,GF,edb5c8fe9b826f8fceb090e8f1f6acea,Yes,yes,NA,NA,NA,160,2288
NGA,prevalence,lab,NA,MSM,FCT,NA,NA,2014,NA,NA,NA,NA,0.25,NA,637,BBS 2014,NA,GF_1a4cc46eb7f9681e437eac192158a364,GF,78a54b5bc2655276b0f7997fc74cbc4a,Yes,yes,NA,NA,NA,160,2289
NGA,prevalence,lab,NA,MSM,Kaduna,NA,NA,2014,NA,NA,NA,NA,0.148,NA,505,BBS 2014,NA,GF_bc24aea5eab0edadcc4547a1817be021,GF,8a0e037637aff6f0f2a82b93832c430c,Yes,yes,NA,NA,NA,160,2290
NGA,prevalence,lab,NA,MSM,Kano,NA,NA,2014,NA,NA,NA,NA,0.171,NA,125,BBS 2014,NA,GF_a4f3a59b54674b85ed784877eef7b5b5,GF,de4c5367111c8da4e7bc4340b332b09c,Yes,yes,NA,NA,NA,160,2291
NGA,prevalence,lab,NA,MSM,Lagos,NA,NA,2014,NA,NA,NA,NA,0.323,NA,426,BBS 2014,NA,GF_738f336f30e209ccd47753ab66817ee2,GF,4e2ed78c511014286fc42ada4024ab31,Yes,yes,NA,NA,NA,160,2292
BEN,prevalence,lab,NA,FSW,Oueme,NA,NA,2017,NA,NA,NA,NA,0.11800000000000001,NA,79,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,2294
NGA,prevalence,lab,NA,MSM,Oyo,NA,NA,2014,NA,NA,NA,NA,0.136,NA,452,BBS 2014,NA,GF_10d586c47b8dce712941d4495808475a,GF,af239f68e44fafd6915e3c4506222fa5,Yes,yes,NA,NA,NA,160,2298
NGA,prevalence,lab,NA,MSM,Rivers,NA,NA,2014,NA,NA,NA,NA,0.307,NA,504,BBS 2014,NA,GF_f552b9859b12a96ed2e60adf4c2d1cc7,GF,5bb31ea529bb21916b71ca9bd40d6528,Yes,yes,NA,NA,NA,160,2299
NGA,prevalence,lab,NA,PWID,Cross River,NA,NA,2014,NA,NA,NA,NA,0.058,NA,226,BBS 2014,NA,GF_37255d9df5b0c40061443fd74fd5dd6e,GF,8d2e56f8e561826ef8b3ace3e7ee0f20,Yes,yes,NA,NA,NA,160,2303
NGA,prevalence,lab,NA,PWID,Enugu,NA,NA,2014,NA,NA,NA,NA,0.022,NA,375,BBS 2014,NA,GF_e2d9af490a655cb231b71d10c5b8ea51,GF,9d11ad27e54bff55d4d8b5b4b59ff062,Yes,yes,NA,NA,NA,160,2304
NGA,prevalence,lab,NA,PWID,FCT,NA,NA,2014,NA,NA,NA,NA,0.047,NA,669,BBS 2014,NA,GF_d06940671b576f2e5f1f411a7b1cba95,GF,fc7666b78c76fd718b09fa290fb5239e,Yes,yes,NA,NA,NA,160,2305
NGA,prevalence,lab,NA,PWID,Kaduna,NA,NA,2014,NA,NA,NA,NA,0.018,NA,504,BBS 2014,NA,GF_96006055cddcdaea6560774a4ee7c65e,GF,c5652b60f56437c23f7ae26cdc938649,Yes,yes,NA,NA,NA,160,2306
NGA,prevalence,lab,NA,PWID,Kano,NA,NA,2014,NA,NA,NA,NA,0.07,NA,285,BBS 2014,NA,GF_d122dd7d805c0df335c083c6db1e1dfb,GF,f0c75541d596cb0730e05cfcb6ed6bd3,Yes,yes,NA,NA,NA,160,2307
NGA,prevalence,lab,NA,PWID,Lagos,NA,NA,2014,NA,NA,NA,NA,0.025,NA,391,BBS 2014,NA,GF_7d56617397fb67f17ba3f83e054a22b6,GF,c320e281ba6097b76c242900bd5739aa,Yes,yes,NA,NA,NA,160,2308
NGA,prevalence,lab,NA,MSM,Abuja,NA,NA,2016,NA,NA,NA,NA,0.36,NA,1460,Crowell et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,162,2310
NGA,prevalence,lab,NA,TGW,Abuja,NA,NA,2016,NA,NA,NA,NA,0.397,NA,151,Crowell et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,162,2311
NGA,prevalence,lab,NA,MSM,Lagos,NA,NA,2016,NA,NA,NA,NA,0.534,NA,1170,Crowell et al,NA,GF_806c580e6472ae075b3d74fd5aea7710,GF,1128a39e06424e23cae23d71adfa3559,Yes,yes,NA,NA,NA,162,2312
NGA,prevalence,lab,NA,MSM,Lagos,NA,NA,2016,NA,NA,NA,NA,0.557,NA,469,Crowell et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,162,2313
NGA,prevalence,lab,NA,TGW,Lagos,NA,NA,2016,NA,NA,NA,NA,0.716,NA,88,Crowell et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,162,2314
TZA,prevalence,lab,lab,PWID,Dar-es-salaam,NA,Y015_049,2013,NA,NA,NA,NA,0.155,NA,610,Integrated Bio-Behavioral Survey Among People Who Inject Drugs in Dar-es-salaam,NA,KP Atlas_9959ed3f57c2cf1bc36bdfd77a618f18,KP Atlas,60554ee701fab3fce144e6292430f5df,Yes,yes,NA,NA,NA,218,2316
TZA,prevalence,lab,lab,FSW,Dar-es-salaam,NA,Y015_049,2017,NA,NA,NA,0.122,0.153,0.184,948,"Integrated Bio-Behavioral Surveillance Survey among Female Sex Workers in Dar-es-salaam, 2017",NA,KP Atlas_1cc197325fdf1ae03435173d8c3a9842,KP Atlas,00cf93d8f6ce3f5e0eb2c24c917f5be5,Yes,yes,NA,NA,NA,215,2318
TZA,prevalence,lab,lab,MSM,Dar-es-salaam,NA,Y015_049,2017,NA,NA,NA,0.063,0.083,0.109,753,"Integrated Bio-Behavioral Surveillance Survey among Men who have Sex with Men in Dar-es-salaam, 2017",NA,KP Atlas_89bdce52a0b2ba8c269ff1ab1acd5126,KP Atlas,197b61f05f695150dafdf5c69f20fda9,Yes,yes,NA,NA,NA,223,2319
TZA,prevalence,lab,NA,PWID,Dar-es-salaam,NA,Y015_049,2017,NA,NA,NA,0.064,0.087,0.11800000000000001,607,"Integrated Bio-Behavioral Surveillance Survey among People who Inject Drugs in Dar es Salaam, 2017",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,216,2320
ZAF,prevalence,lab,NA,FSW,Port Elizabeth,NA,NA,2015,NA,NA,NA,NA,0.637,NA,410,"Engagement in the HIV care cascade and predictors of uptake of antiretroviral therapy among female sex workers in Port Elizabeth, South Africa",NA,KP Atlas_904df6490fea2302f01c29ed4d6a6ff0,KP Atlas,9660f72f8d7c43bbf65aef16d3c291f1,Yes,yes,NA,NA,NA,252,2321
ZWE,prevalence,lab,NA,FSW,Zimbabwe,NA,Y015_024,2017,NA,NA,NA,NA,0.281,NA,429,Hensen 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887898/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,264,2332
ZWE,prevalence,lab,NA,FSW,Zimbabwe,NA,Y015_024,2013,NA,NA,NA,NA,0.359,NA,640,Chabata 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535417/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,266,2333
ZWE,prevalence,lab,NA,FSW,Zimbabwe,NA,Y015_024,2016,NA,NA,NA,NA,0.344,NA,503,Chabata 2019,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535417/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,266,2334
BEN,prevalence,lab,yes,MSM,Benin,NA,Y015_049,2017,NA,NA,NA,NA,0.07,NA,359,ENQUETE DE SURVEILLANCE DE DEUXIEME GENERATION (ESDG) SUR LE VIH ET LE SIDA AU SEIN DE LA POPULATION DES HOMMES AYANT DES RAPPORTS SEXUELS AVEC D‚ÄôAUTRES HOMMES (HSH) AU BENIN,NA,KP Atlas_83ebdee19549e37dbfc4d1d24152ef04,KP Atlas,92200cf87c35d13ba5969b0e9b8fa7dd,Yes,yes,NA,NA,NA,12,2336
BEN,prevalence,lab,NA,MSM,Benin,NA,Y015_049,2015,NA,NA,NA,NA,0.077,NA,364,Enquete De Surveillance De Deuxieme Generation (ESDG) Sur Le VIH Au Sein De La Population Des Hommes Ayant Des Rapports Sexuels Avec d'Autres Hommes (HSH) Au Benin,NA,KP Atlas_64ee95c9702000d451c67a694486d42d,KP Atlas,6df72ecd5adde3302b6dc13b7e1f62c7,Yes,yes,NA,NA,NA,16,2337
CIV,prevalence,lab,NA,PWID,Abidjan,NA,Y015_049,2014,NA,NA,NA,0,0.053,0.11199999999999999,57,"Sante des personnes usagËres de drogue ‡ Abidjan en CÙte díIvoire: Prevalence et pratiques ‡ risque díinfection par le VIH, les hepatites virales, et autres infections",NA,GF_31ec7b7533a5a76b12f8932989524e96,GF,830797ae35ebfe27e2527aa5f331804d,Yes,yes,NA,NA,NA,39,2338
UGA,prevalence,lab,NA,FSW,Greater Masaka,NA,Y015_049,2020,NA,NA,NA,NA,0.4059,NA,220,Kiyingi et al.,https://link.springer.com/article/10.1007/s10461-022-03837-9,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,236,2339
NGA,prevalence,lab,NA,PWID,Oyo,NA,NA,2014,NA,NA,NA,NA,0.019,NA,310,BBS 2014,NA,GF_b953bfde3c7faf8982a1f7788528e7e3,GF,24e230a6df2ef7c064a443d6bfe909c8,Yes,yes,NA,NA,NA,160,2354
NGA,prevalence,lab,NA,PWID,Rivers,NA,NA,2014,NA,NA,NA,NA,0.009,NA,390,BBS 2014,NA,GF_061b32e9bd1819b62079f49236f1999b,GF,b2696aa6e09255f8cc27c5556e636d72,Yes,yes,NA,NA,NA,160,2355
NGA,prevalence,lab,NA,TGW,Nassarawa,NA,Y015_049,2020,NA,NA,NA,NA,0.14800000000000002,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,2356
NGA,prevalence,lab,NA,TGW,Oyo,NA,Y015_049,2020,NA,NA,NA,NA,0.465,NA,372,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,2357
MWI,prevalence,lab,NA,MSM,Blantyre,NA,NA,2016,NA,NA,NA,NA,0.179,NA,84,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,2426
ZAF,prevalence,lab,NA,MSM,Cape Town,NA,NA,2016,NA,NA,NA,NA,0.284,NA,109,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,2428
RWA,prevalence,lab,NA,FSW,Eastern Province,NA,NA,2010,NA,NA,NA,NA,0.33,NA,123,BBS 2010,NA,GF_36a6dee77c957e58aa565f5cf2873dc5,GF,033913b87cddf926ce1c1cd7810bd130,Yes,yes,NA,NA,NA,171,2429
RWA,prevalence,lab,NA,FSW,Kigali,NA,NA,2010,NA,NA,NA,NA,0.56,NA,233,BBS 2010,NA,CDC_196ceda467cd5fd9c57e8e3771dd2d95,CDC,21e2b8272735b75fa609a107ffe7cc7b,Yes,yes,NA,NA,NA,171,2430
RWA,prevalence,lab,NA,FSW,Northern Province,NA,NA,2010,NA,NA,NA,NA,0.47,NA,260,BBS 2010,NA,GF_15b164f914b1de2f9a7197b1ee0b42f8,GF,6052a9d5735fe8939261a81a8a7548e5,Yes,yes,NA,NA,NA,171,2431
RWA,prevalence,lab,NA,FSW,Southern Province,NA,NA,2010,NA,NA,NA,NA,0.55,NA,245,BBS 2010,NA,GF_299c28de7f974c6a0625a65b3d991cd6,GF,5ba5a52ea6ea2b04db334895ecc4ef0b,Yes,yes,NA,NA,NA,171,2432
RWA,prevalence,lab,NA,FSW,Western Province,NA,NA,2010,NA,NA,NA,NA,0.55,NA,251,BBS 2010,NA,GF_aed2b8cf91a697d3d1b366f9f2eb9658,GF,ccae51fe42c789ec7997b83a9062c643,Yes,yes,NA,NA,NA,171,2433
RWA,prevalence,lab,NA,PWID,Kigali,NA,NA,2020,NA,NA,NA,NA,0.095,NA,307,Twahirwa Rwema et al,https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-021-00579-0,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,174,2434
SEN,prevalence,lab,NA,PWID,Dakar,NA,NA,2011,NA,NA,NA,NA,0.094,NA,139,"ENQUETE DE PREVALENCE ET DE PRATIQUES A RISQUES D’INFECTION A VIH, VHB, ET VHC CHEZ LES USAGERS DE DROGUES DANS LA REGION DE DAKAR (SENEGAL).",NA,KP Atlas_904a03c86f62b9737877a2266b0a1c4d,KP Atlas,54fafd97f5010d068cbe1ef4a40a787e,Yes,yes,NA,NA,NA,175,2435
SEN,prevalence,lab,lab,MSM,Dakar,NA,NA,2014,NA,NA,NA,NA,0.16,NA,325,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2440
SEN,prevalence,lab,lab,MSM,Diourbel,NA,NA,2014,NA,NA,NA,NA,0.12,NA,50,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2441
SEN,prevalence,lab,lab,MSM,Kaolack,NA,NA,2014,NA,NA,NA,NA,0.163,NA,104,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2442
SEN,prevalence,lab,lab,MSM,Louga,NA,NA,2014,NA,NA,NA,NA,0.14300000000000002,NA,42,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2443
SEN,prevalence,lab,lab,MSM,Saint-Louis,NA,NA,2014,NA,NA,NA,NA,0.124,NA,97,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2444
SEN,prevalence,lab,lab,MSM,Sedhiou,NA,NA,2014,NA,NA,NA,NA,0.33299999999999996,NA,51,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2447
SEN,prevalence,lab,lab,MSM,Tamba,NA,NA,2014,NA,NA,NA,NA,0.184,NA,38,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2448
SEN,prevalence,lab,lab,MSM,Thies/Mbour,NA,NA,2014,NA,NA,NA,NA,0.183,NA,203,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2449
SEN,prevalence,lab,lab,MSM,Ziguinchor,NA,NA,2014,NA,NA,NA,NA,0.245,NA,102,RAPPORT ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL (2014),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,177,2451
SEN,prevalence,lab,NA,FSW,Dakar,NA,NA,2015,NA,NA,NA,NA,0.053,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2452
SEN,prevalence,lab,NA,FSW,Kaolack,NA,NA,2015,NA,NA,NA,NA,0.09,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2454
SEN,prevalence,lab,NA,FSW,Kedougou,NA,NA,2015,NA,NA,NA,NA,0.037000000000000005,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2455
SEN,prevalence,lab,NA,FSW,Kolda,NA,NA,2015,NA,NA,NA,NA,0.04,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2457
SEN,prevalence,lab,NA,FSW,Sedhiou,NA,NA,2015,NA,NA,NA,NA,0.055999999999999994,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2458
SEN,prevalence,lab,NA,FSW,Tambacounda,NA,NA,2015,NA,NA,NA,NA,0.107,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2463
SEN,prevalence,lab,NA,FSW,Ziguinchor,NA,NA,2015,NA,NA,NA,NA,0.135,NA,NA,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2015),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,0,178,2464
SEN,prevalence,lab,NA,MSM,Dakar,NA,NA,2017,NA,NA,NA,0.444,0.496,0.5479999999999999,355,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2465
SEN,prevalence,lab,NA,MSM,Diourbel,NA,NA,2017,NA,NA,NA,0.22399999999999998,0.348,0.496,46,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2466
SEN,prevalence,lab,NA,MSM,Kaffrine,NA,NA,2017,NA,NA,NA,0.005,0.04,0.243,125,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2467
SEN,prevalence,lab,NA,MSM,Kaolack,NA,NA,2017,NA,NA,NA,0.069,0.12,0.2,100,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2468
SEN,prevalence,lab,NA,MSM,Kolda,NA,NA,2017,NA,NA,NA,NA,0,NA,50,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2472
SEN,prevalence,lab,NA,MSM,Louga,NA,NA,2017,NA,NA,NA,0.17300000000000001,0.293,0.45,43,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2473
SEN,prevalence,lab,NA,MSM,Matam,NA,NA,2017,NA,NA,NA,0.02,0.083,0.285,24,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2474
SEN,prevalence,lab,NA,MSM,Mbour,NA,NA,2017,NA,NA,NA,0.243,0.327,0.423,101,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2475
SEN,prevalence,lab,NA,MSM,Saint-Louis,NA,NA,2017,NA,NA,NA,0.22,0.303,0.4,99,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2476
SEN,prevalence,lab,NA,MSM,Sedhiou,NA,NA,2017,NA,NA,NA,0.009,0.038,0.14300000000000002,52,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2477
SEN,prevalence,lab,NA,MSM,Tambacounda,NA,NA,2017,NA,NA,NA,0.019,0.06,0.172,51,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2480
SEN,prevalence,lab,NA,MSM,Ziguinchor,NA,NA,2017,NA,NA,NA,0.033,0.069,0.139,102,ENQUETE COMBINEE CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC DES HOMMES (HSH) AU SENEGAL,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,179,2481
SEN,prevalence,lab,NA,MSM,"Dakar, Mbour, Thies",NA,NA,2017,NA,NA,NA,NA,0.235,NA,219,Achieving an AIDS Free Generation in Senegal,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,180,2482
SEN,prevalence,lab,NA,FSW,"Dakar, Mbour",NA,NA,2017,NA,NA,NA,NA,0.033,NA,40,Achieving an AIDS Free Generation in Senegal,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,180,2483
SEN,prevalence,lab,NA,FSW,Dakar,NA,NA,2019,NA,NA,NA,NA,0.065,NA,355,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_ee70e7a17325569621be4f07056f9f4b,KP Atlas,a5a0da2ad3a974b22f71c9d600bfd83e,Yes,yes,NA,NA,0,181,2484
SEN,prevalence,lab,NA,FSW,Diourbel,NA,NA,2019,NA,NA,NA,NA,0.034,NA,29,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_0bedb023ee44f560a3e99ac90530ff26,KP Atlas,049f87cdb953de633e28041a0dacd90a,Yes,yes,NA,NA,0,181,2485
SEN,prevalence,lab,NA,FSW,Fatick,NA,NA,2019,NA,NA,NA,NA,0.063,NA,16,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_e8ad45440c4ab7303d902b384685888d,KP Atlas,c4c647fcbe3030fce29f938ccbcb6b4a,Yes,yes,NA,NA,0,181,2486
SEN,prevalence,lab,NA,FSW,Kaolack,NA,NA,2019,NA,NA,NA,NA,0.049,NA,205,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_da6bae2b7843551c63fb2d3e61b4f5ea,KP Atlas,67afd580d91832c56f72423976cd0313,Yes,yes,NA,NA,0,181,2487
SEN,prevalence,lab,NA,FSW,Kedougou,NA,NA,2019,NA,NA,NA,NA,0.026,NA,191,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_c247d09531a4897b89f0db47cba31bfb,KP Atlas,22f37cc689599d894b4a6b9cd49c67ec,Yes,yes,NA,NA,0,181,2488
SEN,prevalence,lab,NA,FSW,Kolda,NA,NA,2019,NA,NA,NA,NA,0.055,NA,200,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_3518afb5495fb158a004275a3c12e700,KP Atlas,2cd7e821e036fd8ecca8741d437e5ef6,Yes,yes,NA,NA,0,181,2489
SEN,prevalence,lab,NA,FSW,Louga,NA,NA,2019,NA,NA,NA,NA,0.043,NA,23,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_34adce70340af8e8a0723607ae68c8e9,KP Atlas,68b7921c9a712a8214e2fddf4dc2b96a,Yes,yes,NA,NA,0,181,2490
SEN,prevalence,lab,NA,FSW,Saint-Louis,NA,NA,2019,NA,NA,NA,NA,0.068,NA,44,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_c908acf445c42ffd03151c54a695c35e,KP Atlas,219ac833f408876f751204641bf55d5c,Yes,yes,NA,NA,0,181,2491
SEN,prevalence,lab,NA,FSW,Sedhiou,NA,NA,2019,NA,NA,NA,NA,0.005,NA,202,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_60933232181c052d428affe2b59893ac,KP Atlas,395f637b6d46e6c90744e5cc40192869,Yes,yes,NA,NA,0,181,2492
SEN,prevalence,lab,NA,FSW,Tambacounda,NA,NA,2019,NA,NA,NA,NA,0.063,NA,205,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_514796c9c2f9fa68cb862b26d1feda85,KP Atlas,9a4aaf4d64139234f638f046c87c764b,Yes,yes,NA,NA,0,181,2497
SEN,prevalence,lab,NA,FSW,Thies,NA,NA,2019,NA,NA,NA,NA,0.025,NA,79,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_af40b0b573fe3973d92a3a2fa139ec3d,KP Atlas,1ab2283bf27c433b6c7820e3792769ae,Yes,yes,NA,NA,0,181,2498
SEN,prevalence,lab,NA,FSW,Ziguinchor,NA,NA,2019,NA,NA,NA,NA,0.065,NA,200,ENQUE_TE NATIONALE DE SURVEILLANCE COMBINEE DES IST ET DU VIH/SIDA (ENSC 2019),NA,KP Atlas_8f2942807e5b520ffd4ca51be83ce68e,KP Atlas,0f75917153d48df9ce2db902b2de0137,Yes,yes,NA,NA,0,181,2499
SEN,prevalence,lab,NA,FSW,Senegal,NA,NA,2013,NA,NA,NA,0.015,0.033,0.052,758,Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147043/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,183,2500
SEN,prevalence,lab,NA,MSM,Senegal,NA,NA,2013,NA,NA,NA,0.186,0.235,0.284,724,Potential Impact of Integrated Stigma Mitigation Interventions in Improving HIV/AIDS Service Delivery and Uptake for Key Populations in Senegal,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147043/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,183,2501
SEN,prevalence,lab,NA,PWID,Dakar,NA,NA,2019,NA,NA,NA,0.018000000000000002,0.035,0.052000000000000005,312,Rapport díEstimation de la Taille et díEnquÍte Bio comportementale chez les Consommateurs de Drogue Injectables au Senegal,NA,KP Atlas_f7a8d060fbc2a416491461e51b11ed4d,KP Atlas,18bd3c6a07f9b21ecadc29fb571c9c08,Yes,yes,NA,NA,NA,184,2502
SEN,prevalence,lab,NA,PWID,Kaolack,NA,NA,2019,NA,NA,NA,0.022000000000000002,0.039,0.065,357,Rapport díEstimation de la Taille et díEnquÍte Bio comportementale chez les Consommateurs de Drogue Injectables au Senegal,NA,KP Atlas_1b71209deff0c977fbffc90fd16d3e38,KP Atlas,8ac1157489e5d65ad7125ab0fd373bac,Yes,yes,NA,NA,NA,184,2503
SLE,prevalence,lab,NA,FSW,Bo,NA,NA,2021,NA,NA,NA,0.055099999999999996,0.1176,0.23370000000000002,204,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2506
ZAF,prevalence,lab,NA,MSM,Johannesburg,NA,NA,2016,NA,NA,NA,NA,0.437,NA,135,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,2507
SLE,prevalence,lab,NA,PWID,Bo,NA,NA,2021,NA,NA,NA,0.0016,0.0115,0.07730000000000001,158,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2508
ZAF,prevalence,lab,NA,TGW,Johannesburg,NA,NA,2016,NA,NA,NA,NA,0.694,NA,36,HPTN 075 (Sandfort et al),https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC6544251/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,113,2512
SLE,prevalence,lab,NA,PWID,Bombali,NA,NA,2021,NA,NA,NA,0.047400000000000005,0.09609999999999999,0.18510000000000001,159,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2513
RWA,prevalence,lab,NA,TGW,Kigali,NA,NA,2018,NA,NA,NA,NA,0.094,NA,106,"HIV infection and engagement in HIV care cascade among men who have sex with men and transgender women in Kigali, Rwanda: a cross-sectional study",https://pubmed.ncbi.nlm.nih.gov/33000912/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,168,2514
SLE,prevalence,lab,NA,FSW,Freetown,NA,NA,2021,NA,NA,NA,0.17600000000000002,0.20879999999999999,0.2458,388,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2515
SLE,prevalence,lab,NA,FSW,Kenema,NA,NA,2021,NA,NA,NA,0.0508,0.0833,0.13390000000000002,228,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2516
RWA,prevalence,lab,NA,MSM,Kigali,NA,NA,2018,NA,NA,NA,NA,0.102,NA,630,"HIV infection and engagement in HIV care cascade among men who have sex with men and transgender women in Kigali, Rwanda: a cross-sectional study",https://pubmed.ncbi.nlm.nih.gov/33000912/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,168,2517
SLE,prevalence,lab,NA,PWID,Kenema,NA,NA,2021,NA,NA,NA,0.02,0.050300000000000004,0.1209,133,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2518
SLE,prevalence,lab,NA,TGW,Bo,NA,NA,2021,NA,NA,NA,0.83,0.0218,0.0556,93,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2519
SLE,prevalence,lab,NA,TGW,Bombali,NA,NA,2021,NA,NA,NA,0.0246,0.0509,0.1023,88,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2520
SLE,prevalence,lab,NA,FSW,Lingui,NA,NA,2021,NA,NA,NA,0.059000000000000004,0.11109999999999999,0.19949999999999998,225,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2521
SLE,prevalence,lab,NA,FSW,Makeni,NA,NA,2021,NA,NA,NA,0.029900000000000003,0.0538,0.095,223,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2522
SLE,prevalence,lab,NA,TGW,Kenema,NA,NA,2021,NA,NA,NA,0.0048,0.019299999999999998,0.0736,96,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2523
SLE,prevalence,lab,NA,PWID,Port Loko,NA,NA,2021,NA,NA,NA,0.31,0.0149,0.0689,172,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2524
SLE,prevalence,lab,NA,FSW,Waterloo,NA,NA,2021,NA,NA,NA,0.025699999999999997,0.0432,0.0717,162,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2525
SLE,prevalence,lab,NA,MSM,Bo,NA,NA,2021,NA,NA,NA,0.002,0.013999999999999999,0.09380000000000001,75,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2526
SLE,prevalence,lab,NA,PWID,Western Area Rural,NA,NA,2021,NA,NA,NA,0.004,0.0281,0.17329999999999998,110,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2527
SLE,prevalence,lab,NA,TGW,Western Area Rural,NA,NA,2021,NA,NA,NA,0.0683,0.133,0.2429,65,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2528
SLE,prevalence,lab,NA,MSM,Bombali,NA,NA,2021,NA,NA,NA,2e-4,0.0014,0.0104,89,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2529
SLE,prevalence,lab,NA,PWID,Western Area Urban,NA,NA,2021,NA,NA,NA,0.0253,0.055,0.11560000000000001,273,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2530
SLE,prevalence,lab,NA,TGW,Western Area Urban,NA,NA,2021,NA,NA,NA,0.0213,0.0431,0.08529999999999999,145,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2531
SLE,prevalence,lab,NA,PWID,Sierra Leone,NA,NA,2015,NA,NA,NA,NA,0.085,NA,258,"HIV Sero-Prevalence Study for Key Populations, May 2015",NA,KP Atlas_bd272ed48e18b1271103ed6437df8b65,KP Atlas,27704d53c336edb67e23cdad5ad8894b,Yes,yes,NA,NA,NA,187,2534
SLE,prevalence,lab,NA,TGW,Sierra Leone,NA,NA,2015,NA,NA,NA,NA,0.043,NA,93,"HIV Sero-Prevalence Study for Key Populations, May 2015",NA,KP Atlas_be3a9f7951ee75be95cbd4c18db380d3,KP Atlas,3ccc22d3f5a7fef358497680ae5e0fe1,Yes,yes,NA,NA,NA,187,2536
SLE,prevalence,lab,NA,MSM,Sierra Leone,NA,NA,2015,NA,NA,NA,NA,0.14,NA,408,"HIV Sero-Prevalence Study for Key Populations, May 2015",NA,KP Atlas_0bf2f106a30f45e37dafe16a29955e07,KP Atlas,3e56ab6a9bfb493d35e229a4c1b54a5f,Yes,yes,NA,NA,NA,187,2539
SLE,prevalence,lab,NA,FSW,Sierra Leone,NA,NA,2015,NA,NA,NA,NA,0.067,NA,1490,"HIV Sero-Prevalence Study for Key Populations, May 2015",NA,KP Atlas_e04a84c9464557a595bbc84fb56520dd,KP Atlas,d1247406072e2c3f25d8bcf0179248cb,Yes,yes,NA,NA,NA,187,2540
SSD,prevalence,lab,NA,FSW,Juba,NA,NA,2016,NA,NA,NA,0.336,0.379,0.422,835,Eagle Survey (Juba),NA,CDC_f6fc6463eed602ddbfba3cb36c6133ab,CDC,cf1ea514d5973b7d33b21acb33370914,Yes,yes,NA,NA,NA,188,2541
SSD,prevalence,lab,NA,FSW,Wau,NA,NA,2019,NA,NA,NA,0.040999999999999995,0.067,0.094,679,"BIO-BEHAVIOUR SURVEY AMONG FEMALE SEX WORKERS IN WAU, SOUTH SUDAN EAGLE 11 SURVEY, 2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,190,2542
SSD,prevalence,lab,NA,FSW,Yambio,NA,NA,2019,NA,NA,NA,0.106,0.136,0.165,605,"BIO-BEHAVIOUR SURVEY AMONG FEMALE SEX WORKERS IN YAMBIO, SOUTH SUDAN EAGLE 11 SURVEY, 2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,191,2546
SSD,prevalence,lab,NA,FSW,Nimule,NA,NA,2017,NA,NA,NA,0.19399999999999998,0.24,0.285,409,A Bio-Behavioral HIV Survey of Female Sex Workers in Nimule South Sudan,NA,CDC_28e8b86be8ee08e8ebf77c47ad4cd621,CDC,f729e00724b1a74c93fab5b0c364cc96,Yes,yes,NA,NA,NA,192,2547
SLE,prevalence,lab,NA,MSM,Kenema,NA,NA,2021,NA,NA,NA,0.0011,0.008,0.0555,84,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2569
SWZ,prevalence,lab,NA,FSW,Manzini,NA,NA,2020,NA,NA,NA,0.56,0.633,0.701,266,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2570
SLE,prevalence,lab,NA,MSM,Kono,NA,NA,2021,NA,NA,NA,NA,0,NA,68,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2571
SWZ,prevalence,lab,NA,FSW,Mbabane,NA,NA,2020,NA,NA,NA,0.41100000000000003,0.507,0.602,206,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2572
SLE,prevalence,lab,NA,MSM,Port Loko,NA,NA,2021,NA,NA,NA,NA,0,NA,64,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2573
SWZ,prevalence,lab,NA,FSW,Nhlangano,NA,NA,2020,NA,NA,NA,0.369,0.531,0.637,52,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2574
SLE,prevalence,lab,NA,MSM,Western Area Rural,NA,NA,2021,NA,NA,NA,NA,0,NA,50,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2575
SWZ,prevalence,lab,NA,FSW,Piggs Peak,NA,NA,2020,NA,NA,NA,0.43799999999999994,0.593,0.732,100,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2576
SLE,prevalence,lab,NA,MSM,Western Area Urban,NA,NA,2021,NA,NA,NA,0.0663,0.1198,0.20679999999999998,132,BIO-BEHAVIOURAL SURVEY FIELD IMPLEMENTATION 2021,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,186,2577
SWZ,prevalence,lab,NA,FSW,Siteki,NA,NA,2020,NA,NA,NA,0.424,0.68,0.804,52,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2578
SWZ,prevalence,lab,NA,TGW,eSwatini,NA,NA,2020,NA,NA,NA,0.19899999999999998,0.41200000000000003,0.6629999999999999,17,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2579
TGO,prevalence,lab,NA,MSM,Aneho,NA,NA,2011,NA,NA,NA,NA,0.057,NA,35,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_e0b029c902a84dac60c7f7ee9dfc09a5,KP Atlas,4cdf8acb0c3e6f641d0273030d254ae3,Yes,yes,NA,NA,NA,196,2580
TGO,prevalence,lab,NA,MSM,Kara,NA,NA,2011,NA,NA,NA,NA,0.035,NA,34,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_d1b9071636be544a8b7aefa8fbc68bb9,KP Atlas,de3981291962226a78bdeae3cdf04d61,Yes,yes,NA,NA,NA,196,2581
TGO,prevalence,lab,NA,MSM,Kpalime,NA,NA,2011,NA,NA,NA,NA,0.044,NA,19,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_0c260aae96086b1128fbc330e5eb383e,KP Atlas,726ddbf3f2bc5f462585586fc395b9b1,Yes,yes,NA,NA,NA,196,2582
TGO,prevalence,lab,NA,MSM,Lome,NA,NA,2011,NA,NA,NA,NA,0.298,NA,245,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_86348f7c0f8d1cd1b934f158157195b7,KP Atlas,d4ecb4fe8627d0234f36b38cb9736fed,Yes,yes,NA,NA,NA,196,2583
TGO,prevalence,lab,NA,MSM,Sokode,NA,NA,2011,NA,NA,NA,NA,0,NA,43,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_a2f07caff7bb4465fedecc19cd777205,KP Atlas,3cb630f0e05b2623f637d7f1a93b6f85,Yes,yes,NA,NA,NA,196,2584
TGO,prevalence,lab,NA,MSM,Togo,NA,NA,2011,NA,NA,NA,0.159,0.196,0.238,408,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_a692dca443635e9ef6cc87fd926249d7,KP Atlas,73350712b3098d252ce66875cf1c39a6,Yes,yes,NA,NA,NA,196,2585
TGO,prevalence,lab,NA,MSM,Tsevie,NA,NA,2011,NA,NA,NA,NA,0.063,NA,32,2011 TOGO 2011 report on behavioural study and HIV prevalence among MSM.pdf,NA,KP Atlas_09e93b047aa3d98aeef3c4ce9d133517,KP Atlas,014a6c2bf659f3d97d41e555a0a4d15b,Yes,yes,NA,NA,NA,196,2586
TGO,prevalence,lab,NA,FSW,Centrale,NA,NA,2011,NA,NA,NA,NA,0.179,NA,39,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_fb4db812bbd733cdc2af4f6eb6ec522a,GF,3bb527ae4654901e5e4f22f65976e4d0,Yes,yes,NA,NA,NA,197,2622
TGO,prevalence,lab,NA,FSW,Kara,NA,NA,2011,NA,NA,NA,NA,0.078,NA,90,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_787cfbd7a7b332579403e8e1542492a3,GF,0198baeca7a2f98b36c946615555574d,Yes,yes,NA,NA,NA,197,2623
TGO,prevalence,lab,NA,FSW,Lome,NA,NA,2011,NA,NA,NA,NA,0.194,NA,453,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_e4c659a0333d53a8d5c96ea6f6d895c5,GF,4bf603ec10af24dc0da45b1c52233248,Yes,yes,NA,NA,NA,197,2625
TGO,prevalence,lab,NA,FSW,Maritime,NA,NA,2011,NA,NA,NA,NA,0.102,NA,127,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_8d01622be7b47ebbb4f43f00f8c1bd4f,GF,1645b6a5f522c1d346060652684bf7fc,Yes,yes,NA,NA,NA,197,2626
TGO,prevalence,lab,NA,FSW,Plateaux,NA,NA,2011,NA,NA,NA,NA,0.074,NA,204,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_a3f1b578a78db7122b17f8dce4b23e30,GF,6c62d9a2c1aa0ee9fed07401a74718a3,Yes,yes,NA,NA,NA,197,2628
TGO,prevalence,lab,NA,FSW,Savanes,NA,NA,2011,NA,NA,NA,NA,0.078,NA,193,EnquÍte comportementale et de seroprevalence du VIH chez les professionnels de sexe et leurs clients au Togo en 2011,https://www.pnls.tg/rapports/Rapport3.pdf,GF_5b815d5bbc2c1b6681f18acb96401fb1,GF,24b7f5460a45ca79c4625c59f88113c0,Yes,yes,NA,NA,NA,197,2629
TGO,prevalence,lab,NA,FSW,Kara,NA,NA,2014,NA,NA,NA,NA,0.1,NA,330,Examining Risk Factors for HIV and Access to Services among Female Sex Workers and Men who have Sex with Men in Togo,https://www.jhsph.edu/research/centers-and-institutes/research-to-prevention/publications/togo-brief.pdf,GF_a471b23c765d4fe3ad3fc8d10eb448de,GF,c7b94abd8c8b3fc3762e55772c07458b,Yes,yes,NA,NA,NA,198,2630
TGO,prevalence,lab,NA,MSM,Kara,NA,NA,2014,NA,NA,NA,NA,0.006,NA,329,Examining Risk Factors for HIV and Access to Services among Female Sex Workers and Men who have Sex with Men in Togo,https://www.jhsph.edu/research/centers-and-institutes/research-to-prevention/publications/togo-brief.pdf,KP Atlas_7ebeb688d70724bc114cd60037025005,KP Atlas,ba922f05aa1427b59ba61b455b34f8f6,Yes,yes,NA,NA,NA,198,2632
TGO,prevalence,lab,NA,FSW,Lome,NA,NA,2014,NA,NA,NA,NA,0.271,NA,354,Examining Risk Factors for HIV and Access to Services among Female Sex Workers and Men who have Sex with Men in Togo,https://www.jhsph.edu/research/centers-and-institutes/research-to-prevention/publications/togo-brief.pdf,GF_41f4990767b9395210b1a4ae1e219784,GF,eb58fedae96e2cd10d1b604c25465acf,Yes,yes,NA,NA,NA,198,2634
TGO,prevalence,lab,NA,MSM,Lome,NA,NA,2014,NA,NA,NA,NA,0.185,NA,354,Examining Risk Factors for HIV and Access to Services among Female Sex Workers and Men who have Sex with Men in Togo,https://www.jhsph.edu/research/centers-and-institutes/research-to-prevention/publications/togo-brief.pdf,KP Atlas_4fbb65ed6081c9457914925f85b324b9,KP Atlas,5afc7ecaa19073a446c255cd46ddae15,Yes,yes,NA,NA,NA,198,2635
TGO,prevalence,lab,NA,FSW,Centrale,NA,NA,2015,NA,NA,NA,NA,0.157,NA,51,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_95c6896f1b52628bd412ff99184b37b4,KP Atlas,104f2fb32205ab311f6943d94ced1dd1,Yes,yes,NA,NA,NA,199,2636
TGO,prevalence,lab,NA,FSW,Kara,NA,NA,2015,NA,NA,NA,NA,0.02,NA,99,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_a187aa37388a957cea88bdb7b574ef1c,KP Atlas,f3cd7b91b400c0f5ecb5246b79ded025,Yes,yes,NA,NA,NA,199,2637
TGO,prevalence,lab,NA,FSW,Lome,NA,NA,2015,NA,NA,NA,NA,0.134,NA,545,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_15143ef5f619b686bb7cf5975180f2fe,KP Atlas,899fb8390550f574307d4f2f32108a5d,Yes,yes,NA,NA,NA,199,2638
TGO,prevalence,lab,NA,FSW,Maritime,NA,NA,2015,NA,NA,NA,NA,0.155,NA,200,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_98c571c3f6d99db3f97f78a1cc1d9e88,KP Atlas,0af38a1340bb601897c5e34f896007b1,Yes,yes,NA,NA,NA,199,2639
TGO,prevalence,lab,NA,FSW,Plateaux,NA,NA,2015,NA,NA,NA,NA,0.066,NA,182,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_e0f299d84b9d997aed1eb2951caab42b,KP Atlas,75a0481ae199f9f8de0b473e39378f0d,Yes,yes,NA,NA,NA,199,2640
TGO,prevalence,lab,NA,FSW,Savanes,NA,NA,2015,NA,NA,NA,NA,0.112,NA,107,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_db3bec0817b8504d9e27e355d58e9b75,KP Atlas,0f4d0da5ac14c7fbfea317749b7ff4fc,Yes,yes,NA,NA,NA,199,2641
TGO,prevalence,lab,NA,FSW,Togo,NA,NA,2015,NA,NA,NA,NA,0.117,NA,1184,EnquÍte sero-comportementale VIH de deuxiËme generation chez les professionnelles du sexe et leurs clients au Togo,NA,KP Atlas_b77a75fe363c8261396dea062b661832,KP Atlas,404e8e56f4f4c622f7ef3b1bcd6f0ff5,Yes,yes,NA,NA,NA,199,2642
TGO,prevalence,lab,NA,FSW,Atakpame,NA,NA,2017,NA,NA,NA,NA,0.034,NA,59,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,199,2644
TGO,prevalence,lab,NA,FSW,Kpalime,NA,NA,2017,NA,NA,NA,NA,0.136,NA,59,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,199,2647
TGO,prevalence,lab,NA,FSW,Sokode,NA,NA,2017,NA,NA,NA,NA,0.083,NA,60,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,199,2649
SWZ,prevalence,lab,NA,MSM,Manzini,NA,NA,2020,NA,NA,NA,0.166,0.23399999999999999,0.319,152,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2650
SWZ,prevalence,lab,NA,MSM,Mbabane,NA,NA,2020,NA,NA,NA,0.069,0.111,0.175,146,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2651
SWZ,prevalence,lab,NA,MSM,Nhlangano,NA,NA,2020,NA,NA,NA,0.07200000000000001,0.205,0.462,34,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2652
SWZ,prevalence,lab,NA,MSM,Piggs Peak,NA,NA,2020,NA,NA,NA,0.13,0.223,0.35600000000000004,53,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2653
SWZ,prevalence,lab,NA,MSM,Siteki,NA,NA,2020,NA,NA,NA,0.252,0.43799999999999994,0.642,30,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,195,2654
BFA,prevalence,lab,NA,TGW,"Bobo-Dioulasso, Ouagadougou",NA,NA,2016,NA,NA,NA,NA,0.051,NA,5,Stahlman et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,2656
TGO,prevalence,lab,NA,TGW,"Kara, Lome",NA,NA,2013,NA,NA,NA,NA,0.188,NA,9,Stahlman et al 2016,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,2657
TGO,prevalence,lab,NA,FSW,Aneho,NA,NA,2017,NA,NA,NA,NA,0.07,NA,57,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,203,2658
TGO,prevalence,lab,NA,FSW,Dapaong,NA,NA,2017,NA,NA,NA,NA,0.031,NA,65,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,203,2660
TGO,prevalence,lab,NA,FSW,Kara,NA,NA,2017,NA,NA,NA,NA,0.268,NA,71,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,KP Atlas_492a11b57134ae24f1c21611c3bfc2ee,KP Atlas,ce1b1e9a05d7f559feb5a738d205ed79,Yes,yes,NA,NA,NA,203,2661
TGO,prevalence,lab,NA,FSW,Lome,NA,NA,2017,NA,NA,NA,NA,0.149,NA,571,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,203,2662
TGO,prevalence,lab,NA,FSW,Tsevie,NA,NA,2017,NA,NA,NA,NA,0.115,NA,61,Enque_te sero-comportementale de deuxieme generation chez les professionnelles du sexe et leurs clients au Togo en 2017 o-en,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,203,2663
TGO,prevalence,lab,NA,PWID,Atakpame,NA,NA,2011,NA,NA,NA,NA,0,NA,32,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2664
TGO,prevalence,lab,NA,PWID,Dapaong,NA,NA,2011,NA,NA,NA,NA,0.035,NA,28,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2665
TGO,prevalence,lab,NA,PWID,Kara,NA,NA,2011,NA,NA,NA,NA,0.044,NA,45,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2666
TGO,prevalence,lab,NA,PWID,Kpalime,NA,NA,2011,NA,NA,NA,NA,0,NA,18,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2667
TGO,prevalence,lab,NA,PWID,Lome,NA,NA,2011,NA,NA,NA,NA,0.064,NA,234,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2668
TGO,prevalence,lab,NA,PWID,Sokode,NA,NA,2011,NA,NA,NA,NA,0.094,NA,24,EnquÍte comportementale et de seroprevalence du VIH chez les utilisateurs de drogues au Togo en 2011,https://www.pnls.tg/rapports/Rapport1.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,205,2669
TGO,prevalence,lab,NA,MSM,Aneho,NA,NA,2015,NA,NA,NA,NA,0.241,NA,29,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_ffa253c45a9068bce1c8b2e605f1310d,KP Atlas,af0931adacbf4e4d09330037b7ca45f7,Yes,yes,NA,NA,NA,206,2670
TGO,prevalence,lab,NA,MSM,Atakpame,NA,NA,2015,NA,NA,NA,NA,0,NA,40,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,GF_a857f65851e5066438512ddd7d759cdd,GF,df283d675dbafbfa0d007b60af8b00a2,Yes,yes,NA,NA,NA,206,2671
TGO,prevalence,lab,NA,MSM,Dapaong,NA,NA,2015,NA,NA,NA,NA,0.025,NA,40,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_dc9c8b436b2b0e405cb6986265803922,KP Atlas,d0bbf5b773cbf244468adf3e0def9656,Yes,yes,NA,NA,NA,206,2672
TGO,prevalence,lab,NA,MSM,Kara,NA,NA,2015,NA,NA,NA,NA,0,NA,41,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_19a3b5b889f05092bba05b62db1f5651,KP Atlas,df450f4a1daacd8992b169c71054bb67,Yes,yes,NA,NA,NA,206,2673
TGO,prevalence,lab,NA,MSM,Kpalime,NA,NA,2015,NA,NA,NA,NA,0.075,NA,40,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_c50527c538954019b22189eb36c818de,KP Atlas,88e29fefc854a897fda9276a1a5bf2e6,Yes,yes,NA,NA,NA,206,2674
TGO,prevalence,lab,NA,MSM,Lome,NA,NA,2015,NA,NA,NA,NA,0.223,NA,215,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_7978730874d5937343b787380b06be74,KP Atlas,af991b2a4a8272bf516526efdffc6321,Yes,yes,NA,NA,NA,206,2676
TGO,prevalence,lab,NA,MSM,Sokode,NA,NA,2015,NA,NA,NA,NA,0,NA,39,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_1c0da3348537a7a5ab32e71275ee07ef,KP Atlas,a7896586294119d47673accc3dface31,Yes,yes,NA,NA,NA,206,2677
TGO,prevalence,lab,NA,MSM,Tsevie,NA,NA,2015,NA,NA,NA,NA,0.106,NA,47,2015 Rapport_Etude SSG HSH_13 juin 2015_30_09_0K(1).pdf,NA,KP Atlas_5dc050beafe39858b2dba5b6922ae905,KP Atlas,7b8d5a1e1d70844d2283d915c66f4f23,Yes,yes,NA,NA,NA,206,2678
TGO,prevalence,lab,NA,PWID,Togo,NA,NA,2017,NA,NA,NA,0.0101,0.039,0.1173,77,Enque_te sero-comportementale de deuxieme generation chez les usagers de drogues au Togo en 2017 011-,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,207,2679
TGO,prevalence,lab,NA,MSM,Aneho,NA,NA,2017,NA,NA,NA,NA,0.053,NA,19,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2680
TGO,prevalence,lab,NA,MSM,Atakpame,NA,NA,2017,NA,NA,NA,NA,0,NA,25,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2681
TGO,prevalence,lab,NA,MSM,Dapaong,NA,NA,2017,NA,NA,NA,NA,0,NA,35,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2682
TGO,prevalence,lab,NA,MSM,Kara,NA,NA,2017,NA,NA,NA,NA,0,NA,45,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,KP Atlas_eb1bef085352823a906d2ab9e20b9935,KP Atlas,ba303300c0c29154b001814f523386a6,Yes,yes,NA,NA,NA,208,2683
TGO,prevalence,lab,NA,MSM,Kpalime,NA,NA,2017,NA,NA,NA,NA,0.132,NA,38,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2684
TGO,prevalence,lab,NA,MSM,Lome,NA,NA,2017,NA,NA,NA,NA,0.2982,NA,466,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,KP Atlas_cc74698fed6eb5374b9ca95bf4e0d139,KP Atlas,2a0dd527accf629ba331069a9e92cfd3,Yes,yes,NA,NA,NA,208,2685
TGO,prevalence,lab,NA,MSM,Sokode,NA,NA,2017,NA,NA,NA,NA,0,NA,30,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2686
TGO,prevalence,lab,NA,MSM,Tsevie,NA,NA,2017,NA,NA,NA,NA,0.2,NA,20,EnquÍte sero-comportementale de deuxiËme generation chez les hommes ayant des rapports sexuels avec díautres hommes au Togo en 2017,https://cnlstogo.org/download/etudes_et_enquEtes/Enquete-Sero-comportementale-de-deuxieme-generation-chez-les-HSH-au-Togo-en-2017.pdf,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,208,2687
TZA,prevalence,lab,NA,PWID,Dar-es-salaam,NA,NA,2016,NA,NA,NA,NA,0.424,NA,153,Mohamed et al.,https://onlinelibrary.wiley.com/doi/10.1111/jvh.12966,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,209,2688
TZA,prevalence,lab,NA,PWID,Temeke MC,NA,NA,2011,NA,NA,NA,0.29100000000000004,0.348,0.409,267,"Bowring | Degenhardt et al., 2017",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,211,2694
TZA,prevalence,lab,NA,PWID,Dar-es-salaam,NA,NA,2011,NA,NA,NA,NA,0.23,NA,150,"Gupta | Degenhardt et al., 2017",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,212,2695
TZA,prevalence,lab,NA,FSW,Pemba,NA,NA,2018,NA,NA,NA,NA,0.054000000000000006,NA,56,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2698
TZA,prevalence,lab,NA,FSW,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2018,NA,NA,NA,0.095,0.121,0.153,578,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2699
TZA,prevalence,lab,NA,MSM,Pemba,NA,NA,2018,NA,NA,NA,NA,0,NA,50,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2700
TZA,prevalence,lab,NA,MSM,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2018,NA,NA,NA,0.031,0.05,0.079,341,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2701
TZA,prevalence,lab,NA,PWID,Pemba,NA,NA,2018,NA,NA,NA,NA,0.105,NA,57,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2703
TZA,prevalence,lab,NA,PWID,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2018,NA,NA,NA,0.028999999999999998,0.051,0.086,419,"Integrated Behavioral and Biological Surveillance Survey among Key populations in Zanzibar, 2018-2019",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,213,2705
TZA,prevalence,lab,NA,FSW,Pemba,NA,NA,2011,NA,NA,NA,NA,0.188,NA,32,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2710
TZA,prevalence,lab,NA,FSW,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2011,NA,NA,NA,0.142,0.193,0.256,316,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2711
TZA,prevalence,lab,NA,MSM,Pemba,NA,NA,2011,NA,NA,NA,NA,0.05,NA,20,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2715
TZA,prevalence,lab,NA,MSM,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2011,NA,NA,NA,1,0.026000000000000002,0.047,339,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2716
TZA,prevalence,lab,NA,PWID,"Kaskazini Unguja, Kusini Unguja, Mjini Magharibi",NA,NA,2011,NA,NA,NA,0.077,0.113,0.152,408,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2718
TZA,prevalence,lab,NA,PWID,Pemba,NA,NA,2011,NA,NA,NA,NA,0.08800000000000001,NA,34,"Integrated Behavioral and Biological Surveillance Survey among Key populations at risk in Zanzibar, 2011-2012",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,214,2719
MWI,prevalence,lab,NA,MSM,Mangochi,NA,NA,2020,NA,NA,NA,NA,0.26,NA,204,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2721
MWI,prevalence,lab,NA,MSM,Nkhatabay,NA,NA,2020,NA,NA,NA,NA,0.082,NA,122,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,2722
BEN,prevalence,lab,NA,FSW,Plateau,NA,NA,2017,NA,NA,NA,NA,0.105,NA,38,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,2731
TZA,prevalence,lab,NA,PWID,Dar-es-salaam,NA,NA,2013,NA,NA,NA,0.35,0.39,0.44,629,"Lambdin  | Degenhardt et al., 2017",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,219,2736
TZA,prevalence,lab,NA,MSM,Dar-es-salaam,NA,NA,2012,NA,NA,NA,NA,0.223,NA,753,"Prevalence of the Human Immunodeficiency Virus, other sexually transmitted infections, and health-related perceptions, reflections, experiences and practices among men having sex with men in Dar-es-salaam",NA,GF_86665665c9c13a345d9f14a9f2f3ef6c,GF,2ea6d4f55aa7995a0d9ffaf2c801d012,Yes,yes,NA,NA,NA,220,2739
TZA,prevalence,lab,NA,MSM,Dodoma,NA,NA,2014,NA,NA,NA,0.126,0.17,0.254,386,"Mmbaga EJ, Moen K, Makyao N, et al.  HIV and STI s among men who have sex with men in Dodoma municipality, Tanzania: a cross-sectional study.",NA,CDC_9627ce5f2b64d6a3d0b89c4b7d07098c,CDC,88cb33829aa1cd9f4d590c5a171df500,Yes,yes,NA,NA,NA,221,2741
TZA,prevalence,lab,NA,PWID,Dar-es-salaam,NA,NA,2017,NA,NA,NA,0.278,0.33799999999999997,0.405,219,"Kawambwa et al., 2020",https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-8294-8#Sec9,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,222,2743
NGA,prevalence,lab,NA,TGW,Rivers,NA,Y015_049,2020,NA,NA,NA,NA,0.345,NA,229,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,2746
NGA,prevalence,lab,NA,TGW,Taraba,NA,Y015_049,2020,NA,NA,NA,NA,0.16399999999999998,NA,256,BBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,164,2747
TZA,prevalence,lab,NA,MSM,Dar-es-salaam,NA,NA,2013,NA,NA,NA,NA,0.302,NA,172,Ross et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,224,2749
TZA,prevalence,lab,NA,MSM,Tanga,NA,NA,2013,NA,NA,NA,NA,0.111,NA,90,Ross et al,NA,GF_327ebdb7adf36b373938462e19c4e1ba,GF,c4a009493655c9b68d64c22e124fa386,Yes,yes,NA,NA,NA,224,2750
TZA,prevalence,lab,NA,FSW,Dar-es-salaam,NA,NA,2013,NA,NA,NA,0.24,0.32,0.39,342,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,CDC_f0d6f44df9d407e5dbc69bf410bd01ac,CDC,2e2321106be80d0eb266682443f6a036,Yes,yes,NA,NA,NA,225,2756
TZA,prevalence,lab,NA,FSW,Iringa,NA,NA,2013,NA,NA,NA,0.253,0.329,0.40700000000000003,220,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,GF_6277b2cab120717c2a239304775986ef,GF,3b378443d2f9765d28c3f251fd08602a,Yes,yes,NA,NA,NA,225,2757
BEN,prevalence,lab,NA,FSW,Zou,NA,NA,2017,NA,NA,NA,NA,0.08,NA,165,"Enquete De Surveillance De Deuxieme Generation Relative Aux IST, VIH Et Sida Au Benin (Esdg-2017) (Travailleuses de Sexe, Serveuses de Bar et Restaurants & Clients PS)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,11,2769
TZA,prevalence,lab,NA,FSW,Mara,NA,NA,2013,NA,NA,NA,0.113,0.178,0.255,205,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,GF_f58471a0fcaf6e202bbcf877f64601a2,GF,8bde595e4cdd2e66fd743292c8fe5b5c,Yes,yes,NA,NA,NA,225,2770
TZA,prevalence,lab,NA,FSW,Mbeya,NA,NA,2013,NA,NA,NA,0.21600000000000003,0.292,0.375,244,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,CDC_79f918b4ac846ece5c7a6ba68de58aa3,CDC,0d6a4fc4b7a63eac23adc86aaebf5946,Yes,yes,NA,NA,NA,225,2772
TZA,prevalence,lab,NA,FSW,Mwanza,NA,NA,2013,NA,NA,NA,0.142,0.19,0.25,350,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,CDC_8fe6045bbc475b4524383a1cb99083e3,CDC,dacac3c3ed34beeacbe5077cbbf194b4,Yes,yes,NA,NA,NA,225,2773
TZA,prevalence,lab,NA,FSW,Shinyanga,NA,NA,2013,NA,NA,NA,0.308,0.375,0.451,320,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,GF_843b4dc892ce28f6ee083bc3cc72c4a7,GF,abbe0d95f5338c562308a61ffa94cf6a,Yes,yes,NA,NA,NA,225,2775
TZA,prevalence,lab,NA,FSW,Tabora,NA,NA,2013,NA,NA,NA,0.091,0.14,0.20600000000000002,228,"HIV AND STI BIOLOGICAL AND BEHAVIORAL SURVEY, 2013",NA,CDC_98a7e33c7b33b7ccf103bb8380c595d8,CDC,37326d75e05a37ecaf1958e9550e527e,Yes,yes,NA,NA,NA,225,2777
UGA,prevalence,lab,NA,TGW,Kampala,NA,NA,2012,NA,NA,NA,NA,0.2,NA,45,CRANE survey data,https://pubmed.ncbi.nlm.nih.gov/30328785/,CDC_9a5389aff91c06ade42c8b1efc9a3152,CDC,276d589438e351752bbb358464b07fa2,Yes,yes,NA,NA,NA,228,2787
UGA,prevalence,lab,NA,MSM,Kampala,NA,NA,2013,NA,NA,NA,0.079,0.122,0.159,607,Hladik 2017,https://link.springer.com/article/10.1007/s10461-016-1535-2,CDC_e4301a6a7f10ef8903908011747f7af8,CDC,1f78e3826061ed69fd4d42537582c302,Yes,yes,NA,NA,NA,228,2788
UGA,prevalence,lab,NA,FSW,Kampala,NA,NA,2012,NA,NA,NA,0.29,0.313,0.337,1487,Crane Survey Data (Doshi et al.),NA,KP Atlas_4e4244617546433657ea6f1301f43759,KP Atlas,6809bb734555b4c5d3a5425a5848c48f,Yes,yes,NA,NA,NA,229,2793
UGA,prevalence,lab,lab,FSW,Kampala,NA,NA,2021,NA,NA,NA,NA,0.31,NA,1589,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,2846
ZAF,prevalence,lab,NA,FSW,Soweto,NA,Y015_049,2016,NA,NA,NA,0.475,0.536,0.599,508,Coetzee et al,https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0184775#sec009,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,255,2958
BFA,prevalence,lab,NA,MSM,"Bobo-Dioulasso, Ouagadougou",NA,NA,2016,NA,NA,NA,NA,0.05,NA,22,Stahlman et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,2972
ZAF,prevalence,lab,NA,PWID,Gauteng,NA,NA,2013,NA,NA,NA,NA,0.16,NA,150,Scheibe et al (2016),NA,CDC_d4d345ec17b68a2e35c9ea134a665d9d,CDC,1d20b7796ff5aef5a75b33a01cfbe5d8,Yes,yes,NA,NA,NA,238,2977
CIV,prevalence,lab,NA,MSM,"Abidjan, Bouake, Gagnoa, Yamoussoukro",NA,NA,2015,NA,NA,NA,NA,0.073,NA,55,Stahlman et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,2978
ZMB,prevalence,lab,NA,FSW,Chirundu,NA,NA,2015,NA,NA,NA,NA,0.733,NA,116,Integrated Biological and Behavioural Surveillance Survey among Female Sex Workers in Zambia,https://www.nac.org.zm/sites/default/files/publications/IBBS%202015%20Final%20Report%204%20March%202016.pdf,KP Atlas_9e51e1c510a9709d73405616ede935c4,KP Atlas,b229d472d656d11a8cd02fa091720ebc,Yes,yes,NA,NA,NA,261,2996
ZMB,prevalence,lab,NA,FSW,Kapiri Mposhi,NA,NA,2015,NA,NA,NA,NA,0.576,NA,311,Integrated Biological and Behavioural Surveillance Survey among Female Sex Workers in Zambia,https://www.nac.org.zm/sites/default/files/publications/IBBS%202015%20Final%20Report%204%20March%202016.pdf,KP Atlas_27cabd59abf2f66b0199a10efb7d99a8,KP Atlas,118c94f5c9a482e54ae4339767dd6aae,Yes,yes,NA,NA,NA,261,2997
ZMB,prevalence,lab,NA,FSW,Livingstone,NA,NA,2015,NA,NA,NA,NA,0.46,NA,261,Integrated Biological and Behavioural Surveillance Survey among Female Sex Workers in Zambia,https://www.nac.org.zm/sites/default/files/publications/IBBS%202015%20Final%20Report%204%20March%202016.pdf,KP Atlas_81c8dc8fa593cf3921696431c8f8258a,KP Atlas,e7451cab803c820948f2dacf74f8b43c,Yes,yes,NA,NA,NA,261,2998
ZMB,prevalence,lab,NA,FSW,Ndola,NA,NA,2015,NA,NA,NA,NA,0.616,NA,164,Integrated Biological and Behavioural Surveillance Survey among Female Sex Workers in Zambia,https://www.nac.org.zm/sites/default/files/publications/IBBS%202015%20Final%20Report%204%20March%202016.pdf,KP Atlas_921102703dfd28cce02939f94ad83fd2,KP Atlas,3a8990d46b34f04164ad90edea2ad3fa,Yes,yes,NA,NA,NA,261,2999
ZMB,prevalence,lab,NA,FSW,Solwezi,NA,NA,2015,NA,NA,NA,NA,0.548,NA,263,Integrated Biological and Behavioural Surveillance Survey among Female Sex Workers in Zambia,https://www.nac.org.zm/sites/default/files/publications/IBBS%202015%20Final%20Report%204%20March%202016.pdf,KP Atlas_54a3b02944b3997aeacbaf1ce3c24343,KP Atlas,f6f04aa50416a58cee414e79e24ee158,Yes,yes,NA,NA,NA,261,3000
ZMB,prevalence,lab,NA,FSW,Livingstone,NA,NA,2017,NA,NA,NA,0.482,0.53,0.578,498,2017 IBBS,NA,CDC_f8b52a23f4cefc49c092947741712671,CDC,21882b47ecea78cddb09aead5caf8ea5,Yes,yes,NA,NA,NA,259,3001
ZMB,prevalence,lab,NA,FSW,Lusaka,NA,NA,2017,NA,NA,NA,0.408,0.459,0.509,497,2017 IBBS,NA,CDC_b801aa0697292e50965aa7a0145215c8,CDC,31a3a9ecf632b2cf3ef52e26d86ce042,Yes,yes,NA,NA,NA,259,3002
ZMB,prevalence,lab,NA,FSW,Ndola,NA,NA,2017,NA,NA,NA,0.416,0.464,0.513,496,2017 IBBS,NA,CDC_e077e2e64d61ffe57245bc6d9ec84c80,CDC,c19ed486e254ae9ca534c0f13a78838a,Yes,yes,NA,NA,NA,259,3003
ZAF,prevalence,lab,NA,MSM,Johannesburg,NA,NA,2016,NA,NA,NA,NA,0.584,NA,1107,Rees et al,https://journals.lww.com/stdjournal/Fulltext/2017/12000/Utilization_of_Sexually_Transmitted_Infection.10.aspx,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,254,3016
ZAF,prevalence,lab,NA,MSM,South Africa,NA,NA,2016,NA,NA,NA,NA,0.18998596,NA,2137,SAMHMS,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515746/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,351,3019
ZAF,prevalence,lab,NA,MSM,Cape Town/Port Elizabeth,NA,NA,2016,NA,NA,NA,NA,0.418250951,NA,263,Sullivan et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7527763/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,247,3020
ZAF,prevalence,lab,NA,MSM,Johannesburg,NA,NA,2017,NA,NA,NA,0.27899999999999997,0.387,0.494,233,TRANSFORM,https://researchonline.lshtm.ac.uk/id/eprint/4657216/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,116,3026
CIV,prevalence,lab,NA,TGW,"Abidjan, Bouake, Gagnoa, Yamoussoukro",NA,NA,2015,NA,NA,NA,NA,0.235,NA,68,Stahlman et al,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,3027
ZAF,prevalence,lab,NA,MSM,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.313333333,NA,150,Jobson et al,https://www.tandfonline.com/doi/full/10.1080/09540121.2018.1465175?scroll=top&needAccess=true,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,245,3029
ZMB,prevalence,lab,NA,FSW,Solwezi,NA,NA,2017,NA,NA,NA,0.453,0.5,0.547,495,2017 IBBS,NA,CDC_cb60cba955beaf1ae38af69cc81e9003,CDC,216aabea89f6a7e8c4a69dce75aeb9e7,Yes,yes,NA,NA,NA,259,3031
ZAF,prevalence,lab,NA,FSW,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.18,NA,384,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3053
TGO,prevalence,lab,NA,MSM,"Kara, Lome",NA,NA,2013,NA,NA,NA,NA,0.076,NA,42,Stahlman et al 2016,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4949310/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,200,3055
ZAF,prevalence,lab,NA,MSM,Cape Town,NA,NA,2017,NA,NA,NA,NA,0.4,NA,250,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3056
ZAF,prevalence,lab,NA,FSW,Durban,NA,NA,2017,NA,NA,NA,NA,0.55,NA,399,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3060
ZWE,prevalence,lab,NA,MSM,Harare,NA,NA,2019,NA,NA,NA,NA,0.171,NA,431,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,262,3063
ZWE,prevalence,lab,NA,TGW,Harare,NA,NA,2019,NA,NA,NA,NA,0.28,NA,287,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,262,3064
ZWE,prevalence,lab,NA,MSM,Bulawayo,NA,NA,2019,NA,NA,NA,NA,0.233,NA,763,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,262,3065
ZWE,prevalence,lab,NA,TGW,Bulawayo,NA,NA,2019,NA,NA,NA,NA,0.25,NA,57,IBBS 2020,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,262,3066
ZAF,prevalence,lab,NA,MSM,Johannesburg,NA,NA,2017,NA,NA,NA,NA,0.49,NA,250,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3078
ZWE,prevalence,lab,NA,FSW,Bindura,NA,NA,2013,NA,NA,NA,NA,0.6075,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3081
ZAF,prevalence,lab,NA,FSW,Mthatha,NA,NA,2017,NA,NA,NA,NA,0.56,NA,248,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3082
ZWE,prevalence,lab,NA,FSW,Chinhoyi,NA,NA,2013,NA,NA,NA,NA,0.732,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3083
ZWE,prevalence,lab,NA,FSW,Chipinge,NA,NA,2013,NA,NA,NA,NA,0.5483,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3084
ZWE,prevalence,lab,NA,FSW,Chivhu,NA,NA,2013,NA,NA,NA,NA,0.5257999999999999,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3085
ZWE,prevalence,lab,NA,FSW,Gutu,NA,NA,2013,NA,NA,NA,NA,0.5307,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3086
ZWE,prevalence,lab,NA,FSW,Gwanda,NA,NA,2013,NA,NA,NA,NA,0.5103,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3088
ZWE,prevalence,lab,NA,FSW,Hwange,NA,NA,2013,NA,NA,NA,NA,0.44770000000000004,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3089
ZWE,prevalence,lab,NA,FSW,Juru,NA,NA,2013,NA,NA,NA,NA,0.47100000000000003,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3090
ZWE,prevalence,lab,NA,FSW,Kadoma,NA,NA,2013,NA,NA,NA,NA,0.6448999999999999,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3091
ZWE,prevalence,lab,NA,FSW,Kariba,NA,NA,2013,NA,NA,NA,NA,0.6462,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3097
ZWE,prevalence,lab,NA,FSW,Magunje,NA,NA,2013,NA,NA,NA,NA,0.4347,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3098
ZWE,prevalence,lab,NA,FSW,Marondera,NA,NA,2013,NA,NA,NA,NA,0.6598,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3099
ZWE,prevalence,lab,NA,FSW,Ngundu,NA,NA,2013,NA,NA,NA,NA,0.5671,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3100
ZWE,prevalence,lab,NA,FSW,Zvishavane,NA,NA,2013,NA,NA,NA,NA,0.7843000000000001,NA,194,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3102
ZWE,prevalence,lab,NA,FSW,Bindura,NA,NA,2016,NA,NA,NA,NA,0.6648999999999999,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3103
ZWE,prevalence,lab,NA,FSW,Bulawayo,NA,NA,2016,NA,NA,NA,NA,0.5251,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3104
ZAF,prevalence,lab,NA,FSW,Pietermaritzburg,NA,NA,2017,NA,NA,NA,NA,0.8,NA,249,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3106
ZWE,prevalence,lab,NA,FSW,Chinhoyi,NA,NA,2016,NA,NA,NA,NA,0.6537000000000001,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3107
ZAF,prevalence,lab,NA,FSW,Port Elizabeth,NA,NA,2017,NA,NA,NA,NA,0.38,NA,248,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3109
ZWE,prevalence,lab,NA,FSW,Chipinge,NA,NA,2016,NA,NA,NA,NA,0.5963,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3117
ZWE,prevalence,lab,NA,FSW,Chivhu,NA,NA,2016,NA,NA,NA,NA,0.5978,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3119
ZWE,prevalence,lab,NA,FSW,Gutu,NA,NA,2016,NA,NA,NA,NA,0.5279,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3120
ZWE,prevalence,lab,NA,FSW,Gwanda,NA,NA,2016,NA,NA,NA,NA,0.5235,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3121
ZWE,prevalence,lab,NA,FSW,Harare,NA,NA,2016,NA,NA,NA,NA,0.5442,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3123
ZWE,prevalence,lab,NA,FSW,Hwange,NA,NA,2016,NA,NA,NA,NA,0.4105,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3126
ZWE,prevalence,lab,NA,FSW,Juru,NA,NA,2016,NA,NA,NA,NA,0.5351,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3127
ZWE,prevalence,lab,NA,FSW,Kadoma,NA,NA,2016,NA,NA,NA,NA,0.6454000000000001,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3128
ZWE,prevalence,lab,NA,FSW,Kariba,NA,NA,2016,NA,NA,NA,NA,0.6207,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3132
ZWE,prevalence,lab,NA,FSW,Magunje,NA,NA,2016,NA,NA,NA,NA,0.4236,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3133
ZWE,prevalence,lab,NA,FSW,Maronder,NA,NA,2016,NA,NA,NA,NA,0.6665000000000001,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3136
ZWE,prevalence,lab,NA,FSW,Ngundu,NA,NA,2016,NA,NA,NA,NA,0.5623,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3137
ZWE,prevalence,lab,NA,FSW,Shamva,NA,NA,2016,NA,NA,NA,NA,0.5397,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3139
ZWE,prevalence,lab,NA,FSW,Zvishava,NA,NA,2016,NA,NA,NA,NA,0.7875,NA,299,Cowan 2018,https://www.thelancet.com/journals/lanhiv/article/PIIS2352-3018(18)30111-5/fulltext#sec1,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,265,3140
MWI,prevalence,lab,NA,MSM,Zomba,NA,NA,2020,NA,NA,NA,NA,0.094,NA,288,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,3141
ZWE,prevalence,lab,NA,FSW,Hwange,NA,NA,2015,NA,NA,NA,0.34600000000000003,0.413,0.48100000000000004,255,Ndori-Mharadze 2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055130/,KP Atlas_f0baf17a30f2b654e3b928c822742af7,KP Atlas,569a98ce27be091169387ea4bcdde24f,Yes,yes,NA,NA,NA,267,3143
ZWE,prevalence,lab,NA,FSW,Mutare,NA,NA,2015,NA,NA,NA,0.5820000000000001,0.637,0.6920000000000001,507,Ndori-Mharadze 2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055130/,KP Atlas_4c6a758639705ee41f46e9e07818af54,KP Atlas,3b089c3ddf76692c483269665da23d32,Yes,yes,NA,NA,NA,267,3144
ZWE,prevalence,lab,NA,FSW,Victoria Falls,NA,NA,2015,NA,NA,NA,0.5529999999999999,0.621,0.687,251,Ndori-Mharadze 2018,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055130/,KP Atlas_2c3e896d21877907ae628036dfae2ec5,KP Atlas,2bb3ecd227a5e4f7196ff6aa936753e0,Yes,yes,NA,NA,NA,267,3145
ZWE,prevalence,lab,NA,FSW,Hwange,NA,NA,2011,NA,NA,NA,0.417,0.506,0.59,237,Cowan 2013,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797143/,KP Atlas_f0baf17a30f2b654e3b928c822742af7,KP Atlas,569a98ce27be091169387ea4bcdde24f,Yes,yes,NA,NA,NA,269,3147
ZWE,prevalence,lab,NA,FSW,Mutare,NA,NA,2011,NA,NA,NA,0.435,0.506,0.586,338,Cowan 2013,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797143/,KP Atlas_4c6a758639705ee41f46e9e07818af54,KP Atlas,3b089c3ddf76692c483269665da23d32,Yes,yes,NA,NA,NA,269,3148
ZWE,prevalence,lab,NA,FSW,Victoria Falls,NA,NA,2011,NA,NA,NA,0.617,0.696,0.767,229,Cowan 2013,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797143/,KP Atlas_2c3e896d21877907ae628036dfae2ec5,KP Atlas,2bb3ecd227a5e4f7196ff6aa936753e0,Yes,yes,NA,NA,NA,269,3149
CIV,prevalence,lab,NA,TGW,Abidjan,NA,NA,2019,NA,NA,NA,NA,0.247,NA,178,RAPPORT DE L‚Äô√âTUDE POUR L‚ÄôIDENTIFICATION DES BESOINS SP√âCIFIQUES EN MATI√àRE DE PR√âVENTION ET PRISE EN CHARGE IST-VIH/SIDA CHEZ LES PERSONNES TRANSGENRES A ABIDJAN ‚Äi COTE D‚ÄôIVOIRE,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,272,3153
ZAF,prevalence,lab,NA,PWID,KwaZulu-Natal,NA,NA,2013,NA,NA,NA,NA,0.173,NA,150,Scheibe et al (2016),NA,CDC_20575faeddfb6ed81dd10d1d56c9baf9,CDC,3c28c3b6900d68a317c57521e6badcc6,Yes,yes,NA,NA,NA,238,3157
ERI,prevalence,lab,lab,FSW,Asmara,NA,Y015_049,2017,NA,NA,NA,NA,0.074,NA,NA,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3158
ERI,prevalence,lab,lab,FSW,Central Highlands,NA,Y015_049,2017,NA,NA,NA,NA,0.137,NA,NA,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3165
ERI,prevalence,lab,lab,FSW,Eastern Lowlands,NA,Y015_049,2017,NA,NA,NA,NA,0.28,NA,NA,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV Risk Behaviors Survey among Commercial Sex Workers in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3166
ERI,prevalence,lab,lab,FSW,Western Lowlands,NA,Y015_049,2017,NA,NA,NA,NA,0.215,NA,NA,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3167
ERI,prevalence,lab,lab,FSW,Asmara,NA,Y015_049,2019,NA,NA,NA,NA,0.076,NA,327,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3168
ERI,prevalence,lab,lab,FSW,Central Highlands,NA,Y015_049,2019,NA,NA,NA,NA,0.086,NA,63,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3175
ERI,prevalence,lab,lab,FSW,Eastern Lowlands,NA,Y015_049,2019,NA,NA,NA,NA,0.278,NA,74,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3176
ERI,prevalence,lab,lab,FSW,Western Lowlands,NA,Y015_049,2019,NA,NA,NA,NA,0.209,NA,291,"2019 BBS (HIV, HBsAg, HCV Ab and Syphilis Prevalence and HIV 
Risk Behaviors Survey among Commercial Sex Workers 
in Eritrea-2019)",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,310,3178
ERI,prevalence,lab,NA,FSW,Asmara,NA,NA,2014,NA,NA,NA,0.039,0.065,0.106,436,CSWS Survey 2014,NA,GF_e9e53f3a99ef9394f3031c53491f64c5,GF,9ea9be3829c9c51b9578ca52e5b6b539,Yes,yes,NA,NA,NA,311,3179
CIV,prevalence,lab,NA,PWID,Abidjan,NA,Y030_049,2020,NA,NA,NA,0.02,0.04,0.062,379,Enquete Bio-Comportementale Chez Les Usagers De Drogues Y Compris Les Usagers De Drogues Injectables A Abidjan,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,47,3182
ERI,prevalence,lab,NA,FSW,Other towns,NA,NA,2014,NA,NA,NA,0.062,0.128,0.246,273,CSWS Survey 2014,NA,GF_9f299dba36549b834bbe30e7eea629e8,GF,686101df44034a70313fb23d5f6dfc9e,Yes,yes,NA,NA,NA,311,3183
ZMB,prevalence,lab,NA,MSM,Kitwe,NA,Y015_049,2021,NA,NA,NA,0.081,0.094,0.107,249,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,258,3221
ZMB,prevalence,lab,NA,MSM,Livingstone,NA,Y015_049,2021,NA,NA,NA,0.1,0.109,0.118,339,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,258,3224
ZMB,prevalence,lab,NA,MSM,Lusaka,NA,Y015_049,2021,NA,NA,NA,0.205,0.229,0.251,310,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,258,3225
ZMB,prevalence,lab,NA,MSM,Solwezi,NA,Y015_049,2021,NA,NA,NA,0.05,0.059,0.068,190,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,258,3226
BEN,prevalence,lab,lab,FSW,Alibori,NA,NA,2021,NA,NA,NA,NA,0.151,NA,73,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3233
BEN,prevalence,lab,lab,FSW,Atacora,NA,NA,2021,NA,NA,NA,NA,0.046,NA,65,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3234
BEN,prevalence,lab,lab,FSW,Atlantique,NA,NA,2021,NA,NA,NA,NA,0.034,NA,89,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3235
BEN,prevalence,lab,lab,FSW,Borgou,NA,NA,2021,NA,NA,NA,NA,0.041,NA,148,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3236
BEN,prevalence,lab,lab,FSW,Collines,NA,NA,2021,NA,NA,NA,NA,0.045,NA,22,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3237
BEN,prevalence,lab,lab,FSW,Couffo,NA,NA,2021,NA,NA,NA,NA,0.111,NA,27,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3238
BEN,prevalence,lab,lab,FSW,Donga,NA,NA,2021,NA,NA,NA,NA,0.067,NA,15,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3239
BEN,prevalence,lab,lab,FSW,Littoral,NA,NA,2021,NA,NA,NA,NA,0.097,NA,383,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3240
BEN,prevalence,lab,lab,FSW,Mono,NA,NA,2021,NA,NA,NA,NA,0.107,NA,28,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3241
BEN,prevalence,lab,lab,FSW,Oueme,NA,NA,2021,NA,NA,NA,NA,0.088,NA,68,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3242
BEN,prevalence,lab,lab,FSW,Plateau,NA,NA,2021,NA,NA,NA,NA,0.093,NA,54,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3243
BEN,prevalence,lab,lab,FSW,Zou,NA,NA,2021,NA,NA,NA,NA,0.029,NA,208,2021 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,321,3244
BEN,prevalence,lab,lab,PWID,Abomey,NA,NA,2022,NA,NA,NA,NA,0,NA,47,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3259
BEN,prevalence,lab,lab,PWID,Abomey-Calavi,NA,NA,2022,NA,NA,NA,0,0.013,0.038,77,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3260
BEN,prevalence,lab,lab,PWID,Cotonou,NA,NA,2022,NA,NA,NA,NA,0,NA,74,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3261
BEN,prevalence,lab,lab,PWID,Grand Popo,NA,NA,2022,NA,NA,NA,0,0.047,0.109,43,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3262
BEN,prevalence,lab,lab,PWID,Natitingou,NA,NA,2022,NA,NA,NA,0,0.036,0.104,28,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3263
BEN,prevalence,lab,lab,PWID,Parakou,NA,NA,2022,NA,NA,NA,0,0.028,0.081,36,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3264
BEN,prevalence,lab,lab,PWID,Porto-Novo,NA,NA,2022,NA,NA,NA,0,0.038,0.081,78,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,3265
GIN,prevalence,lab,lab,FSW,Boke,NA,Y015_049,2022,NA,NA,NA,0.104,0.122,0.139,204,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3295
GIN,prevalence,lab,lab,FSW,Conakry,NA,Y015_049,2022,NA,NA,NA,0.061,0.068,0.075,248,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3296
GIN,prevalence,lab,lab,FSW,Faranah,NA,Y015_049,2022,NA,NA,NA,0.005,0.016,0.028,50,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3297
GIN,prevalence,lab,lab,FSW,Kankan,NA,Y015_049,2022,NA,NA,NA,0.009,0.015,0.021,122,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3298
GIN,prevalence,lab,lab,FSW,Kindia,NA,Y015_049,2022,NA,NA,NA,0.005,0.033,0.062,72,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3299
GIN,prevalence,lab,lab,FSW,Labe,NA,Y015_049,2022,NA,NA,NA,0.038,0.052,0.066,65,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3301
GIN,prevalence,lab,lab,FSW,Mamou,NA,Y015_049,2022,NA,NA,NA,0.006,0.015,0.025,59,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3302
GIN,prevalence,lab,lab,FSW,Nzerekore,NA,Y015_049,2022,NA,NA,NA,0.047,0.061,0.074,103,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3303
GIN,prevalence,lab,lab,PWID,Conakry,NA,NA,2022,NA,NA,NA,0.02,0.036,0.052,64,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,3304
RWA,prevalence,lab,NA,FSW,Eastern Province,NA,NA,2015,NA,NA,NA,0.309,0.377,0.449,642,Biological &Behavioral Surveillance among Female Sexual Workers in Rwanda in 2015,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,325,3305
RWA,prevalence,lab,NA,FSW,Kigali,NA,NA,2015,NA,NA,NA,0.503,0.55,0.605,293,Biological &Behavioral Surveillance among Female Sexual Workers in Rwanda in 2015,NA,CDC_8ab7feead3148502bd1bd12311789824,CDC,c40c094c9552e241475d3efb7d9ba0f7,Yes,yes,NA,NA,NA,325,3306
RWA,prevalence,lab,NA,FSW,Northern Province,NA,NA,2015,NA,NA,NA,0.29100000000000004,0.35100000000000003,0.41600000000000004,388,Biological &Behavioral Surveillance among Female Sexual Workers in Rwanda in 2015,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,325,3307
RWA,prevalence,lab,NA,FSW,Southern Province,NA,NA,2015,NA,NA,NA,0.384,0.46,0.5379999999999999,322,Biological &Behavioral Surveillance among Female Sexual Workers in Rwanda in 2015,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,325,3308
RWA,prevalence,lab,NA,FSW,Western Province,NA,NA,2015,NA,NA,NA,0.27399999999999997,0.434,0.496,322,Biological &Behavioral Surveillance among Female Sexual Workers in Rwanda in 2015,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,325,3309
COG,prevalence,lab,NA,FSW,Brazzaville,NA,NA,2018,NA,NA,NA,0.07,0.105,0.14,200,"ENQUETE COMPORTEMENTALE COUPLEE A LA SEROLOGIE VIH CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC LES HOMMES, LES PROFESSIONNELLES DE SEXE, LES CONSOMMATEURS DE DROGUES INJECTABLES ET LES DETENUS EN REPUBLIQUE DU CONGO",NA,KP Atlas_57855810e1186ed4d20df7e137937db0,KP Atlas,3ca66ae5ee0291c04b6648114a592471,Yes,yes,NA,NA,NA,327,3310
COG,prevalence,lab,NA,MSM,Brazzaville,NA,Y015_049,2018,NA,NA,NA,0.259,0.352,0.459,88,NA,NA,KP Atlas_6f95391db080f8038ecd0fee6ad23710,KP Atlas,14a4a1a5d55a1a90a42edcb157cf0d8a,Yes,yes,NA,NA,NA,327,3311
COG,prevalence,lab,NA,FSW,Dolisie,NA,NA,2018,NA,NA,NA,0.08,0.13,0.19,100,NA,NA,KP Atlas_32b26bf1c43f66ebdb73423555452811,KP Atlas,567fba7ef9a0f5a6fce9a99b2c20f78a,Yes,yes,NA,NA,NA,327,3312
COG,prevalence,lab,NA,FSW,Ouesso,NA,NA,2018,NA,NA,NA,0.01,0.045,0.08,88,NA,NA,KP Atlas_dd089a179e583c8f2acf2f5a3016dc50,KP Atlas,af870cf436f2675db740b1c580f2218c,Yes,yes,NA,NA,NA,327,3313
COG,prevalence,lab,NA,FSW,Pointe-Noire,NA,NA,2018,NA,NA,NA,0.03,0.056,0.09,196,NA,NA,KP Atlas_c7dda31153c8d568c73967d9b579ae2d,KP Atlas,ec54c48f6d3d3dc6c0e80699dff70a02,Yes,yes,NA,NA,NA,327,3314
COG,prevalence,lab,NA,MSM,Pointe-Noire,NA,Y015_049,2018,NA,NA,NA,0.369,0.468,0.57,94,"ENQUETE COMPORTEMENTALE COUPLEE A LA SEROLOGIE VIH CHEZ LES HOMMES AYANT DES RAPPORTS SEXUELS AVEC LES HOMMES, LES PROFESSIONNELLES DE SEXE, LES CONSOMMATEURS DE DROGUES INJECTABLES ET LES DETENUS EN REPUBLIQUE DU CONGO",NA,KP Atlas_a1e3c163cf2e34b389aea351f6a646cd,KP Atlas,aef3af2b9475f679f80c6379990df2f2,Yes,yes,NA,NA,NA,327,3315
COG,prevalence,lab,NA,FSW,Pokola,NA,NA,2018,NA,NA,NA,0.02,0.063,0.12,95,NA,NA,KP Atlas_163dc22e0c73a0682d73ea17f21e494c,KP Atlas,7793c276cdb46e56bdee5206087a32c2,Yes,yes,NA,NA,NA,327,3316
KEN,prevalence,lab,NA,FSW,Nairobi,NA,NA,2010,NA,NA,NA,0.184,0.231,0.282,572,Migrant sex worker BBS 2010,NA,KP Atlas_7f4a2208a46285a512115c35bd59267a,KP Atlas,a819b3e0d646a6cef25dfc4d4df75867,Yes,yes,NA,NA,NA,328,3317
CIV,prevalence,lab,NA,FSW,San Pedro,NA,NA,2017,NA,NA,NA,NA,0.0625,NA,400,"Incidence of HIV infection and associated factors among female sex workers in CÙte díIvoire, results of the ANRS 12361 PrEP-CI study using recent infection assays",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271988,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,330,3367
CIV,prevalence,lab,NA,FSW,Abidjan,NA,NA,2017,NA,NA,NA,NA,0.0233,NA,600,"Incidence of HIV infection and associated factors among female sex workers in CÙte díIvoire, results of the ANRS 12361 PrEP-CI study using recent infection assays",https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0271988,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,330,3368
ZAF,prevalence,lab,NA,MSM,Pretoria,NA,NA,2017,NA,NA,NA,NA,0.41,NA,246,Scheibe et al.,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475946/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,3369
BFA,prevalence,lab,NA,MSM,Ouagadougou,NA,NA,2013,NA,NA,NA,NA,0.047,NA,339,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,27,3447
BFA,prevalence,lab,NA,MSM,Bobo Dioulasso,NA,NA,2013,NA,NA,NA,NA,0.049,NA,329,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,27,3448
BFA,prevalence,lab,NA,FSW,Ouagadougou,NA,NA,2013,NA,NA,NA,NA,0.089,NA,349,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,27,3449
BFA,prevalence,lab,NA,FSW,Bobo Dioulasso,NA,NA,2013,NA,NA,NA,NA,0.329,NA,350,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,27,3450
TGO,prevalence,lab,NA,MSM,Lome,NA,NA,2013,NA,NA,NA,NA,0.185,NA,354,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,KP Atlas_b5afbcd155431e2bf04fc6c0c76c5ec3,KP Atlas,6eb0299cf58109641e9cfd8987674128,Yes,yes,NA,NA,NA,27,3451
TGO,prevalence,lab,NA,MSM,Kara,NA,NA,2013,NA,NA,NA,NA,0.006,NA,329,Holland et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5230836/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,27,3452
BDI,prevalence,lab,lab,MSM,"Gitega, Cankuzo, Rutana, Ruyigi",NA,NA,2021,NA,NA,NA,NA,0.0461,NA,110,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3528
BDI,prevalence,lab,lab,PWID,"Gitega, Cankuzo, Rutana, Ruyigi",NA,NA,2021,NA,NA,NA,NA,1,NA,48,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3529
BDI,prevalence,lab,lab,FSW,"Ngozi, Karuzi, Kayanza, Kirundo, Muyinga",NA,NA,2021,NA,NA,NA,NA,0.314,NA,223,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3530
BDI,prevalence,lab,lab,MSM,"Ngozi, Karuzi, Kayanza, Kirundo, Muyinga",NA,NA,2021,NA,NA,NA,NA,0.0418,NA,127,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3531
BDI,prevalence,lab,lab,PWID,"Ngozi, Karuzi, Kayanza, Kirundo, Muyinga",NA,NA,2021,NA,NA,NA,NA,0.024,NA,37,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3563
BDI,prevalence,lab,lab,FSW,"Makamba, Bururi, Rumonge",NA,NA,2021,NA,NA,NA,NA,0.27399999999999997,NA,221,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3564
BDI,prevalence,lab,lab,MSM,"Makamba, Bururi, Rumonge",NA,NA,2021,NA,NA,NA,NA,0.0348,NA,128,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3565
BDI,prevalence,lab,lab,PWID,"Makamba, Bururi, Rumonge",NA,NA,2021,NA,NA,NA,NA,0.033,NA,30,2021 BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,7,3566
ZAF,prevalence,lab,NA,FSW,Cape Town,NA,NA,2018,NA,NA,NA,0.374,0.425,0.478,777,SAHMS II (FSW),NA,KP Atlas_982f67aac15f91dd5cac958f5bdcff68,KP Atlas,944810fca484272d66ca1ddaac973f15,Yes,yes,NA,NA,NA,249,4340
ZAF,prevalence,lab,NA,FSW,Durban,NA,NA,2018,NA,NA,NA,0.7290000000000001,0.777,0.8190000000000001,550,SAHMS II (FSW),NA,KP Atlas_c5d151aae4aff6bb4efe49ecab4180c6,KP Atlas,44c9c5f5f7525032a6b9929c85347248,Yes,yes,NA,NA,NA,249,4349
ZAF,prevalence,lab,NA,FSW,Johannesburg,NA,NA,2018,NA,NA,NA,0.529,0.583,0.635,537,SAHMS II (FSW),NA,KP Atlas_d5c666570a95d9989cfda93e4da31737,KP Atlas,d099b198925493612213049fcad76f4b,Yes,yes,NA,NA,NA,249,4362
NER,prevalence,lab,lab,FSW,Tahoua,NA,NA,2017,NA,NA,NA,0.048,0.079,0.1101,300,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,6056
NER,prevalence,lab,lab,FSW,Zinder,NA,NA,2017,NA,NA,NA,0.1058,0.1463,0.1867,302,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,6068
ZAF,prevalence,lab,NA,FSW,Eastern Cape,NA,NA,2019,NA,NA,NA,NA,0.6513,NA,261,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7150
ZAF,prevalence,lab,NA,FSW,Free State,NA,NA,2019,NA,NA,NA,NA,0.7316,NA,190,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7151
ZAF,prevalence,lab,NA,FSW,Gauteng,NA,NA,2019,NA,NA,NA,NA,0.6509,NA,865,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7153
ZAF,prevalence,lab,NA,FSW,KwaZulu-Natal,NA,NA,2019,NA,NA,NA,NA,0.8492,NA,431,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7155
ZAF,prevalence,lab,NA,FSW,Limpopo,NA,NA,2019,NA,NA,NA,NA,0.3654,NA,260,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7156
ZAF,prevalence,lab,NA,FSW,Mpumalanga,NA,NA,2019,NA,NA,NA,NA,0.7041,NA,267,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7158
ZAF,prevalence,lab,NA,PWID,Pretoria,NA,NA,2017,NA,NA,NA,NA,0.2,NA,280,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec8,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,7161
ZAF,prevalence,lab,NA,PWID,Pretoria,NA,NA,2017,NA,NA,NA,NA,0.26,NA,44,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec9,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,7162
ZAF,prevalence,lab,NA,FSW,North-West,NA,NA,2019,NA,NA,NA,NA,0.6985,NA,272,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7163
ZAF,prevalence,lab,NA,FSW,Northern Cape,NA,NA,2019,NA,NA,NA,NA,0.6707,NA,82,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7164
ZMB,prevalence,lab,NA,TGW,Kitwe,NA,Y015_049,2021,NA,NA,NA,0.124,0.141,0.16,14,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,258,7206
ZMB,prevalence,lab,NA,TGW,Livingstone,NA,Y015_049,2021,NA,NA,NA,0.069,0.1,0.133,14,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,258,7207
ZMB,prevalence,lab,NA,TGW,Lusaka,NA,Y015_049,2021,NA,NA,NA,0.258,0.28300000000000003,0.308,41,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,258,7208
ZMB,prevalence,lab,NA,TGW,Solwezi,NA,Y015_049,2021,NA,NA,NA,0.062,0.071,0.081,8,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,258,7209
ZAF,prevalence,lab,NA,FSW,Western Cape,NA,NA,2019,NA,NA,NA,NA,0.2546,NA,377,Milovanovic et al,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330713/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,257,7213
ZAF,prevalence,lab,NA,PWID,Tshwane MM,NA,NA,2017,NA,NA,NA,0.529,0.584,0.638,544,TipVal 2017,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,239,7304
ZAF,prevalence,lab,NA,PWID,Tshwane MM,NA,NA,2017,NA,NA,NA,NA,0.37654321,NA,324,Scheibe et al (2019),https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2#Sec9,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,240,7305
ZAF,prevalence,lab,NA,PWID,Western Cape,NA,NA,2013,NA,NA,NA,NA,0.09,NA,150,Scheibe et al (2016),NA,CDC_c74363491660727b3f2cab7e583ce204,CDC,2460ff704cf42e20382f4b49f31b1a1b,Yes,yes,NA,NA,NA,238,7320
ZWE,prevalence,lab,lab,FSW,Zimbabwe,NA,NA,2021,NA,NA,NA,0.34600000000000003,0.484,0.547,2137,Cowan et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,344,7527
TCD,prevalence,lab,lab,MSM,N'Djamena,NA,NA,2021,NA,NA,NA,0.016,0.039,0.061,322,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7545
TCD,prevalence,lab,lab,MSM,Ati,NA,NA,2021,NA,NA,NA,0.004,0.05,0.095,45,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7546
TCD,prevalence,lab,lab,MSM,Oum-Hadjer,NA,NA,2021,NA,NA,NA,0.07200000000000001,0.191,0.31,60,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7547
TCD,prevalence,lab,lab,MSM,Moundou,NA,NA,2021,NA,NA,NA,0,0.009,0.026000000000000002,99,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7548
TCD,prevalence,lab,lab,MSM,Abeche,NA,NA,2021,NA,NA,NA,0.04,0.11199999999999999,0.183,113,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7549
TCD,prevalence,lab,lab,MSM,Sarh,NA,NA,2021,NA,NA,NA,0,0.018000000000000002,0.043,133,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7550
TCD,prevalence,lab,lab,MSM,Koumra,NA,NA,2021,NA,NA,NA,0.023,0.051,0.079,119,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7551
TCD,prevalence,lab,lab,MSM,Bongor,NA,NA,2021,NA,NA,NA,0.006,0.043,0.08,103,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,346,7552
BFA,prevalence,lab,lab,MSM,"Ouagadougou, Bobo Dioulasso",NA,NA,2022,NA,NA,NA,0.205,0.248,0.295,420,NA,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,7781
BFA,prevalence,lab,lab,TGW,"Ouagadougou, Bobo Dioulasso",NA,NA,2022,NA,NA,NA,NA,0.411,NA,90,NA,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,7782
BFA,prevalence,lab,lab,PWID,Ouagadougou,NA,NA,2022,NA,NA,NA,0.002,0.006,0.02,173,NA,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,7797
BFA,prevalence,lab,lab,PWID,Bobo-Dioulasso,NA,NA,2022,NA,NA,NA,NA,0,NA,150,NA,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,7798
GNB,prevalence,lab,lab,PWID,Bissau,NA,NA,2019,NA,NA,NA,0.026000000000000002,0.055,0.106,143,NA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,348,7844
GNB,prevalence,lab,lab,PWID,Bafata,NA,NA,2019,NA,NA,NA,0.013999999999999999,0.051,0.098,117,NA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,348,7845
GNB,prevalence,lab,lab,PWID,Gabu,NA,NA,2019,NA,NA,NA,0.018000000000000002,0.064,0.107,140,NA,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,348,7846
ZAF,prevalence,lab,NA,MSM,Cape Town,NA,NA,2019,NA,NA,NA,0.226,0.268,0.314,737,SAMHMS II (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,244,7847
ZAF,prevalence,lab,NA,MSM,Johannesburg,NA,NA,2019,NA,NA,NA,0.392,0.44299999999999995,0.496,604,SAMHMS II (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,244,7848
ZAF,prevalence,lab,NA,MSM,Mahikeng LM,NA,NA,2019,NA,NA,NA,0.14,0.16699999999999998,0.198,804,SAMHMS II (MSM),NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,244,7849
ZAF,prevalence,lab,lab,MSM,Johannesburg MM,NA,NA,2016,NA,NA,NA,0.27,0.336,0.394,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7856
ZAF,prevalence,lab,lab,MSM,Cape Town MM,NA,NA,2016,NA,NA,NA,0.15,0.225,0.3,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7857
ZAF,prevalence,lab,lab,MSM,Capricorn DM,NA,NA,2016,NA,NA,NA,0.141,0.192,0.256,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7858
ZAF,prevalence,lab,lab,MSM,NM Molema DM,NA,NA,2016,NA,NA,NA,0.122,0.166,0.222,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7859
ZAF,prevalence,lab,lab,MSM,Manguang DM,NA,NA,2016,NA,NA,NA,0.086,0.125,0.17,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7860
ZAF,prevalence,lab,lab,MSM,Nelson Mandela Bay Metro,NA,NA,2016,NA,NA,NA,0.099,0.138,0.178,NA,SAHMHS Report,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7861
ZAF,prevalence,lab,lab,MSM,Pretoria,NA,NA,2016,NA,NA,NA,NA,0.447,NA,427,SAHMHS Report (eThekewini and Pretoria Addendum),NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7883
ZAF,prevalence,lab,lab,MSM,eThekwini,NA,NA,2016,NA,NA,NA,NA,0.515,NA,394,SAHMHS Report (eThekewini and Pretoria Addendum),NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,351,7884
TZA,prevalence,lab,lab,PWID,Unguja,NA,NA,2023,NA,NA,NA,0.061,0.093,0.125,455,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,7889
TZA,prevalence,lab,lab,MSM,Unguja,NA,NA,2023,NA,NA,NA,0.083,0.114,0.145,485,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,7890
TZA,prevalence,lab,lab,FSW,Unguja,NA,NA,2023,NA,NA,NA,0.172,0.211,0.25,598,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,7891
ZMB,prevalence,lab,lab,PWID,Livingstone,NA,NA,2021,NA,NA,NA,NA,0.122,NA,235,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,338,7910
ZMB,prevalence,lab,lab,PWID,Lusaka,NA,NA,2021,NA,NA,NA,NA,0.073,NA,349,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,338,7911
ZMB,prevalence,lab,lab,PWID,Ndola,NA,NA,2021,NA,NA,NA,NA,0.213,NA,259,2021 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,338,7912
ZMB,prevalence,lab,lab,FSW,Chipata,NA,NA,2023,NA,NA,NA,0.37799999999999995,0.444,0.51,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7916
ZMB,prevalence,lab,lab,FSW,Kitwe,NA,NA,2023,NA,NA,NA,0.322,0.387,0.452,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7917
ZMB,prevalence,lab,lab,FSW,Lusaka,NA,NA,2023,NA,NA,NA,0.261,0.32,0.379,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7918
ZMB,prevalence,lab,lab,FSW,Mazabuka,NA,NA,2023,NA,NA,NA,0.31,0.276,0.442,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7919
ZMB,prevalence,lab,lab,FSW,Mongu,NA,NA,2023,NA,NA,NA,0.387,0.45399999999999996,0.518,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7920
ZMB,prevalence,lab,lab,FSW,Solwezi,NA,NA,2023,NA,NA,NA,0.317,0.386,0.455,385,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,339,7921
LBR,prevalence,lab,lab,TGW,Montserrado,NA,NA,2017,NA,NA,NA,NA,0.286,NA,203,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7928
LBR,prevalence,lab,lab,TGW,Grand Gedeh,NA,NA,2017,NA,NA,NA,NA,0,NA,32,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7929
LBR,prevalence,lab,lab,TGW,Grand Bassa,NA,NA,2017,NA,NA,NA,NA,0.421,NA,55,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7930
LBR,prevalence,lab,lab,MSM,Montserrado,NA,NA,2017,NA,NA,NA,NA,0.411,NA,471,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7931
LBR,prevalence,lab,lab,MSM,Grand Gedeh,NA,NA,2017,NA,NA,NA,NA,0.038,NA,63,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7932
LBR,prevalence,lab,lab,MSM,Grand Bassa,NA,NA,2017,NA,NA,NA,NA,0.667,NA,30,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7933
LBR,prevalence,lab,lab,MSM,Margibi,NA,NA,2017,NA,NA,NA,NA,0.147,NA,70,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7934
LBR,prevalence,lab,lab,FSW,Montserrado,NA,NA,2017,NA,NA,NA,NA,0.195,NA,432,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7935
LBR,prevalence,lab,lab,FSW,Lofa,NA,NA,2017,NA,NA,NA,NA,0.138,NA,37,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7936
LBR,prevalence,lab,lab,FSW,Grand Gedeh,NA,NA,2017,NA,NA,NA,NA,0.104,NA,53,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7937
LBR,prevalence,lab,lab,FSW,Grand Cape Mount,NA,NA,2017,NA,NA,NA,NA,0.07,NA,90,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7938
LBR,prevalence,lab,lab,FSW,River Gee,NA,NA,2017,NA,NA,NA,NA,0.045,NA,48,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7939
LBR,prevalence,lab,lab,PWID,Montserrado,NA,NA,2017,NA,NA,NA,NA,0.118,NA,397,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7940
LBR,prevalence,lab,lab,PWID,Grand Gedeh,NA,NA,2017,NA,NA,NA,NA,0.053,NA,37,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7941
LBR,prevalence,lab,lab,PWID,Grand Cape Mount,NA,NA,2017,NA,NA,NA,NA,0.321,NA,65,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7942
LBR,prevalence,lab,lab,PWID,Margibi,NA,NA,2017,NA,NA,NA,NA,0,NA,16,"355. LBR 2018 BBS, pg 78",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,355,7943
NGA,prevalence,lab,NA,PWID,Lagos,NA,NA,2010,NA,NA,NA,0.002,0.009,0.02,328,Tun et al,https://pubmed.ncbi.nlm.nih.gov/23970571/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,360,7945
ZAF,prevalence,lab,NA,TGW,Johannesburg,NA,NA,2017,NA,NA,NA,0.237,0.446,0.655,44,TRANSFORM,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299351/,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,116,7947
MWI,prevalence,lab,NA,TGW,Blantyre,NA,NA,2020,NA,NA,NA,NA,0.159,NA,88,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7948
MWI,prevalence,lab,NA,TGW,Karonga,NA,NA,2020,NA,NA,NA,NA,0,NA,18,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7949
MWI,prevalence,lab,NA,TGW,Lilongwe,NA,NA,2020,NA,NA,NA,NA,0.132,NA,190,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7950
MWI,prevalence,lab,NA,TGW,Mangochi,NA,NA,2020,NA,NA,NA,NA,0.223,NA,94,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7951
MWI,prevalence,lab,NA,TGW,Nkhatabay,NA,NA,2020,NA,NA,NA,NA,0.097,NA,62,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7952
MWI,prevalence,lab,NA,TGW,Zomba,NA,NA,2020,NA,NA,NA,NA,0.08,NA,88,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,151,7953
TGO,prevalence,lab,lab,MSM,Grand Lome,NA,NA,2022,NA,NA,NA,0.252,0.302,0.351,314,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7972
TGO,prevalence,lab,lab,MSM,Tsevie,NA,NA,2022,NA,NA,NA,0.029,0.046,0.063,459,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7973
TGO,prevalence,lab,lab,MSM,Kpalime,NA,NA,2022,NA,NA,NA,0.005,0.019,0.032,336,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7974
TGO,prevalence,lab,lab,MSM,Sokode,NA,NA,2022,NA,NA,NA,0.027,0.055,0.083,199,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7975
TGO,prevalence,lab,lab,MSM,Kara,NA,NA,2022,NA,NA,NA,0.011,0.028,0.044,524,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7976
TGO,prevalence,lab,lab,MSM,Dapaong,NA,NA,2022,NA,NA,NA,0.005,0.022,0.039,251,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7977
TGO,prevalence,lab,lab,FSW,Grand Lome,NA,NA,2022,NA,NA,NA,0.051,0.071,0.091,622,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7993
TGO,prevalence,lab,lab,FSW,Tsevie,NA,NA,2022,NA,NA,NA,0.101,0.132,0.163,451,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7994
TGO,prevalence,lab,lab,FSW,Kpalime,NA,NA,2022,NA,NA,NA,0.011,0.022,0.033,687,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7995
TGO,prevalence,lab,lab,FSW,Sokode,NA,NA,2022,NA,NA,NA,0.041,0.069,0.096,328,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7996
TGO,prevalence,lab,lab,FSW,Kara,NA,NA,2022,NA,NA,NA,0.051,0.074,0.096,523,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7997
TGO,prevalence,lab,lab,FSW,Dapaong,NA,NA,2022,NA,NA,NA,0.023,0.038,0.053,589,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,7998
TGO,prevalence,lab,lab,PWID,Grand Lome,NA,NA,2022,NA,NA,NA,0.018,0.04,0.062,355,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,8008
TGO,prevalence,lab,lab,PWID,Aneho,NA,NA,2022,NA,NA,NA,0.009,0.02,0.031,261,2022 ESDG,https://cnlstogo.org/cnls/download/togo-rapport-ssg-populations-cles-2022/?wpdmdl=2284&refresh=657b20c05738e1702568128,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,362,8009
BEN,prevalence,lab,lab,FSW,"Krake, Hillacondji, Cotonou, Grand popo, Seme-Kpodji, Ouidah, Come, Pahou, Calavi, Porto-Novo, Godomey",NA,NA,2015,NA,NA,NA,0.0797,0.147,0.2232,109,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8027
GHA,prevalence,lab,lab,FSW,"Aflao, Elubo, Accra, Tema, Cape Coast, Sege, Takoradi, Elmina, Winneba",NA,NA,2015,NA,NA,NA,0.0301,0.049,0.0684,466,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8028
TGO,prevalence,lab,lab,FSW,"Sanvee-Condiji, Kodjoviakope, Aneho, Lome, Agoe, Adidogome",NA,NA,2015,NA,NA,NA,0.0593,0.088,0.1166,353,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8029
NGA,prevalence,lab,lab,FSW,"Seme Beach, Badagry, Amuwo-Odofin, Ojo",NA,NA,2015,NA,NA,NA,0.0442,0.087,0.1349,150,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8030
CIV,prevalence,lab,lab,FSW,"Noe, N'zikro, Bonoua, Bassam, Adjouffou, Gonzagueville, Aboisso, Samo, Ehania",NA,NA,2015,NA,NA,NA,0.0721,0.128,0.1949,117,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8031
BEN,prevalence,lab,lab,MSM,"Krake, Hillacondji, Cotonou, Grand popo, Seme-Kpodji, Ouidah, Come, Pahou, Calavi, Porto-Novo, Godomey",NA,NA,2015,NA,NA,NA,0.0677,0.124,0.1825,121,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8032
GHA,prevalence,lab,lab,MSM,"Aflao, Elubo, Accra, Tema, Cape Coast, Sege, Takoradi, Elmina, Winneba",NA,NA,2015,NA,NA,NA,0.0417,0.873,0.1391,126,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8033
TGO,prevalence,lab,lab,MSM,"Sanvee-Condiji, Kodjoviakope, Aneho, Lome, Agoe, Adidogome",NA,NA,2015,NA,NA,NA,0.0959,0.147,0.208,157,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8034
CIV,prevalence,lab,lab,MSM,"Noe, N'zikro, Bonoua, Bassam, Adjouffou, Gonzagueville, Aboisso, Samo, Ehania",NA,NA,2015,NA,NA,NA,0.0385,0.136,0.2439,44,366. Cross border BBS MSM FSW,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,366,8035
CIV,prevalence,lab,lab,PWID,Noe,NA,NA,2017,NA,NA,NA,NA,0,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8036
GHA,prevalence,lab,lab,PWID,Elubo,NA,NA,2017,NA,NA,NA,NA,0,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8037
GHA,prevalence,lab,lab,PWID,Aflao,NA,NA,2017,NA,NA,NA,NA,0,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8038
TGO,prevalence,lab,lab,PWID,Kodjoviakope,NA,NA,2017,NA,NA,NA,NA,0.073,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8039
TGO,prevalence,lab,lab,PWID,Sanvee-Condji,NA,NA,2017,NA,NA,NA,NA,0.052,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8040
BEN,prevalence,lab,lab,PWID,Hillacondji,NA,NA,2017,NA,NA,NA,NA,0.006,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8041
BEN,prevalence,lab,lab,PWID,Krake,NA,NA,2017,NA,NA,NA,NA,0.016,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8042
NGA,prevalence,lab,lab,PWID,Seme,NA,NA,2017,NA,NA,NA,NA,0.013,NA,NA,367. Cross border BBS PWID,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,367,8043
BEN,prevalence,lab,lab,FSW,Cotonou,NA,NA,2017,NA,NA,NA,0.106,0.147,0.198,252,368. BEN 2018 FSW Multicountry BBSS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,368,8052
NGA,prevalence,lab,lab,FSW,Apapa,NA,NA,2017,NA,NA,NA,0.003,0.012,0.037,252,368. BEN 2018 FSW Multicountry BBSS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,368,8053
TGO,prevalence,lab,lab,FSW,Lome,NA,NA,2017,NA,NA,NA,0.109,0.146,0.191,315,368. BEN 2018 FSW Multicountry BBSS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,368,8054
GHA,prevalence,lab,lab,FSW,Tema,NA,NA,2017,NA,NA,NA,0.02,0.04,0.075,248,368. BEN 2018 FSW Multicountry BBSS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,368,8055
CIV,prevalence,lab,lab,FSW,Abidjan,NA,NA,2017,NA,NA,NA,0,0.004,0.026,250,368. BEN 2018 FSW Multicountry BBSS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,368,8056
NER,prevalence,lab,lab,MSM,Maradi,NA,NA,2015,NA,NA,NA,0.01,0.05,0.236,20,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8096
NER,prevalence,lab,lab,MSM,Niamey,NA,NA,2015,NA,NA,NA,0.195,0.286,0.445,49,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8097
NER,prevalence,lab,lab,MSM,Agadez,NA,NA,2015,NA,NA,NA,NA,0,NA,5,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8098
NER,prevalence,lab,lab,MSM,Dosso,NA,NA,2015,NA,NA,NA,NA,0,NA,5,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8099
NER,prevalence,lab,lab,MSM,Tillaberi,NA,NA,2015,NA,NA,NA,NA,0,NA,2,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8100
NER,prevalence,lab,lab,MSM,Zinder,NA,NA,2015,NA,NA,NA,NA,0,NA,6,2015 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,373,8101
NER,prevalence,lab,lab,MSM,Maradi,NA,NA,2017,NA,NA,NA,0.003,0.017,0.032,263,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,8120
NER,prevalence,lab,lab,MSM,Niamey,NA,NA,2017,NA,NA,NA,0.093,0.14,0.186,262,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,8121
NER,prevalence,lab,lab,MSM,Zinder,NA,NA,2017,NA,NA,NA,0.007,0.022,0.037,269,2017 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,374,8125
RWA,prevalence,lab,NA,FSW,Gasabo,NA,NA,2010,NA,NA,NA,0.192,0.241,0.291,214,Braunstein et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,377,8213
RWA,prevalence,lab,NA,FSW,Kicukiro,NA,NA,2010,NA,NA,NA,0.271,0.332,0.393,229,Braunstein et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,377,8214
RWA,prevalence,lab,NA,FSW,Nyarugenge,NA,NA,2010,NA,NA,NA,0.118,0.161,0.205,280,Braunstein et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,377,8215
RWA,prevalence,lab,lab,MSM,Rubavo,NA,NA,2015,NA,NA,NA,NA,0.078,NA,64,Ntale et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,173,8219
RWA,prevalence,lab,lab,MSM,Ruhango,NA,NA,2015,NA,NA,NA,NA,0.048,NA,62,Ntale et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,173,8220
RWA,prevalence,lab,lab,MSM,Musanze,NA,NA,2015,NA,NA,NA,NA,0.046,NA,44,Ntale et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,173,8221
RWA,prevalence,lab,lab,MSM,Kigali,NA,NA,2015,NA,NA,NA,NA,0.044,NA,227,Ntale et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,173,8222
RWA,prevalence,lab,lab,MSM,Huye,NA,NA,2015,NA,NA,NA,NA,0.037,NA,107,Ntale et al,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,173,8223
SEN,prevalence,lab,lab,FSW,Senegal,NA,NA,2010,NA,NA,NA,NA,0.185,NA,694,2010 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,379,8224
TZA,prevalence,lab,lab,PWID,Pemba,NA,NA,2023,NA,NA,NA,NA,0.027,NA,110,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,8231
TZA,prevalence,lab,lab,MSM,Pemba,NA,NA,2023,NA,NA,NA,NA,0.009,NA,107,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,8232
TZA,prevalence,lab,lab,FSW,Pemba,NA,NA,2023,NA,NA,NA,NA,0.083,NA,108,2022/2023 BBS summary sheet,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,354,8233
UGA,prevalence,lab,lab,FSW,Mbarara,NA,NA,2022,NA,NA,NA,NA,0.54,NA,607,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8234
TZA,prevalence,lab,lab,PWID,Dar-es-salaam,NA,NA,2010,NA,NA,NA,NA,0.374,NA,198,"Atkinson | Degenhardt et al., 2017",NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,210,8237
BFA,prevalence,lab,lab,FSW,Bobo-Dioulasso,NA,NA,2022,NA,NA,NA,0.055,0.082,0.122,370,BFA 2022 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,8239
BFA,prevalence,lab,lab,FSW,Ouagadougou,NA,NA,2022,NA,NA,NA,0.045,0.065,0.093,580,BFA 2022 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,8241
BFA,prevalence,lab,lab,FSW,Koudougou,NA,NA,2022,NA,NA,NA,0.036,0.07,0.133,200,BFA 2022 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,8242
BFA,prevalence,lab,lab,FSW,Ouahigouya,NA,NA,2022,NA,NA,NA,0.014,0.035,0.089,194,BFA 2022 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,8243
BFA,prevalence,lab,lab,FSW,Tenkodogo,NA,NA,2022,NA,NA,NA,0.013,0.035,0.093,81,BFA 2022 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,314,8244
MOZ,prevalence,lab,lab,MSM,Biera,NA,NA,2021,NA,NA,NA,0.0675,0.083,0.0949,526,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,320,8245
MOZ,prevalence,lab,lab,MSM,Cidade de Maputo,NA,NA,2021,NA,NA,NA,0.0741,0.147,0.219,526,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,320,8246
MOZ,prevalence,lab,lab,MSM,Tete,NA,NA,2021,NA,NA,NA,0.0247,0.035,0.046,434,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,320,8247
MOZ,prevalence,lab,lab,MSM,Quelimane,NA,NA,2021,NA,NA,NA,0.0195,0.037,0.0551,599,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,320,8248
MOZ,prevalence,lab,lab,MSM,Nampula,NA,NA,2021,NA,NA,NA,0.0337,0.057,0.0807,528,Round II BBS,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,320,8249
BEN,prevalence,lab,lab,MSM,Abomey-Calavey,NA,NA,2022,NA,NA,NA,0.113,0.161,0.208,80,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8250
BEN,prevalence,lab,lab,MSM,Porto-Novo,NA,NA,2022,NA,NA,NA,0.006,0.024,0.042,106,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8251
BEN,prevalence,lab,lab,MSM,Parakou,NA,NA,2022,NA,NA,NA,0.019,0.047,0.075,61,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8252
BEN,prevalence,lab,lab,MSM,Natitingou,NA,NA,2022,NA,NA,NA,0,0.03,0.063,36,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8253
BEN,prevalence,lab,lab,MSM,Lokossa,NA,NA,2022,NA,NA,NA,0.051,0.094,0.136,66,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8254
BEN,prevalence,lab,lab,MSM,Abomey,NA,NA,2022,NA,NA,NA,0.038,0.072,0.106,78,2022 ESDG,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,322,8255
GIN,prevalence,lab,lab,MSM,Boke,NA,NA,2022,NA,NA,NA,0.089,0.105,0.121,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8256
GIN,prevalence,lab,lab,MSM,Conakry,NA,NA,2022,NA,NA,NA,0.123,0.131,0.139,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8257
GIN,prevalence,lab,lab,MSM,Faranah,NA,NA,2022,NA,NA,NA,0.018,0.031,0.043,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8258
GIN,prevalence,lab,lab,MSM,Kankan,NA,NA,2022,NA,NA,NA,0.061,0.076,0.09,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8259
GIN,prevalence,lab,lab,MSM,Kindia,NA,NA,2022,NA,NA,NA,0.043,0.056,0.068,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8260
GIN,prevalence,lab,lab,MSM,Labe,NA,NA,2022,NA,NA,NA,0.04,0.056,0.072,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8261
GIN,prevalence,lab,lab,MSM,Mamou,NA,NA,2022,NA,NA,NA,0,0.004,0.09,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8262
GIN,prevalence,lab,lab,MSM,N'Zerekore,NA,NA,2022,NA,NA,NA,0.095,0.112,0.13,135,2022 ESCOMB,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,324,8263
GHA,prevalence,lab,lab,MSM,Greater Accra,NA,NA,2023,NA,NA,NA,0.316,0.361,0.408,717,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8264
GHA,prevalence,lab,lab,MSM,Ashanti,NA,NA,2023,NA,NA,NA,0.297,0.346,0.399,459,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8265
GHA,prevalence,lab,lab,MSM,Volta,NA,NA,2023,NA,NA,NA,0.226,0.288,0.36,333,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8266
GHA,prevalence,lab,lab,MSM,Western,NA,NA,2023,NA,NA,NA,0.147,0.192,0.247,562,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8267
GHA,prevalence,lab,lab,MSM,Eastern,NA,NA,2023,NA,NA,NA,0.276,0.34,0.41,408,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8268
GHA,prevalence,lab,lab,MSM,Central,NA,NA,2023,NA,NA,NA,0.151,0.199,0.259,327,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8269
GHA,prevalence,lab,lab,MSM,Brong Ahafo,NA,NA,2023,NA,NA,NA,0.151,0.201,0.264,404,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8270
GHA,prevalence,lab,lab,MSM,Northern,NA,NA,2023,NA,NA,NA,0.082,0.128,0.193,202,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8271
GHA,prevalence,lab,lab,MSM,Upper East,NA,NA,2023,NA,NA,NA,0,0,0,90,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8272
GHA,prevalence,lab,lab,MSM,Upper West,NA,NA,2023,NA,NA,NA,0.012,0.03,0.073,86,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8273
CAF,prevalence,lab,lab,MSM,Bangui,NA,NA,2019,NA,NA,NA,NA,0.074,NA,NA,CAF 2019 BBS MSM,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,35,8345
CAF,prevalence,lab,lab,MSM,"Boali, Bouar, Carnot, Berberati",NA,NA,2019,NA,NA,NA,NA,0.03,NA,NA,CAF 2019 BBS MSM,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,35,8347
CIV,prevalence,lab,lab,PWID,Abidjan,NA,NA,2020,NA,NA,NA,0.017,0.034,0.066,452,Enquete Bio-Comportementale Chez Les Usagers De Drogues Y Compris Les Usagers De Drogues Injectables A Abidjan,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,47,8349
UGA,prevalence,lab,lab,FSW,Fort Portal,NA,NA,2022,NA,NA,NA,NA,0.44,NA,463,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8366
UGA,prevalence,lab,lab,FSW,Jinja,NA,NA,2022,NA,NA,NA,NA,0.32,NA,607,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8369
UGA,prevalence,lab,lab,FSW,Masaka,NA,NA,2022,NA,NA,NA,NA,0.45,NA,445,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8372
UGA,prevalence,lab,lab,FSW,Tororo,NA,NA,2022,NA,NA,NA,NA,0.32,NA,675,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8375
UGA,prevalence,lab,lab,MSM,Kampala,NA,NA,2022,NA,NA,NA,NA,0.07,NA,1425,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8378
RWA,prevalence,lab,NA,FSW,Rwanda,NA,NA,2019,NA,NA,NA,0.315,0.355,0.398,1741,BBS 2019,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,337,8380
UGA,prevalence,lab,lab,FSW,Mbale,NA,NA,2022,NA,NA,NA,NA,0.26,NA,759,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8382
UGA,prevalence,lab,lab,FSW,Arua,NA,NA,2022,NA,NA,NA,NA,0.3,NA,651,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8385
UGA,prevalence,lab,lab,FSW,Gulu,NA,NA,2022,NA,NA,NA,NA,0.32,NA,615,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8388
UGA,prevalence,lab,lab,FSW,Busia,NA,NA,2022,NA,NA,NA,NA,0.29,NA,759,CRANE III,NA,NA,Surveillance review,NA,Yes,yes,NA,NA,NA,233,8391
GHA,prevalence,lab,lab,TGW,Ashanti,NA,NA,2023,NA,NA,NA,NA,0.546,NA,53,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8277
GHA,prevalence,lab,lab,TGW,Brong Ahafo,NA,NA,2023,NA,NA,NA,NA,0.43,NA,23,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8279
GHA,prevalence,lab,lab,TGW,Central,NA,NA,2023,NA,NA,NA,NA,0.383,NA,47,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8281
GHA,prevalence,lab,lab,TGW,Eastern,NA,NA,2023,NA,NA,NA,NA,0.808,NA,27,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8283
GHA,prevalence,lab,lab,TGW,Greater Accra,NA,NA,2023,NA,NA,NA,NA,0.517,NA,128,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8394
GHA,prevalence,lab,lab,TGW,Northern,NA,NA,2023,NA,NA,NA,NA,0.204,NA,13,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8396
GHA,prevalence,lab,lab,TGW,Upper East,NA,NA,2023,NA,NA,NA,NA,0.148,NA,12,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8398
GHA,prevalence,lab,lab,TGW,Upper West,NA,NA,2023,NA,NA,NA,NA,0.084,NA,8,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8400
GHA,prevalence,lab,lab,TGW,Volta,NA,NA,2023,NA,NA,NA,NA,0.516,NA,24,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8401
GHA,prevalence,lab,lab,TGW,Western,NA,NA,2023,NA,NA,NA,NA,0.454,NA,41,2023 BBS,NA,NA,Surveillance review,NA,Yes,private,NA,NA,NA,383,8402
